Analysis of TGF - beta RII mRNA expression by RNase protection, with comparison of cells from the chronic, accelerated and blast phases of CML, showed no change in TGF - beta RII transcript levels during disease progression.	"TGF - beta RII	12	26	Gene_or_gene_product"	"RNase	46	51	Gene_or_gene_product"	"cells	83	88	Cell"	"CML	139	142	Cancer"	"TGF - beta RII	164	178	Gene_or_gene_product"	"[{""token"": ""TGF - beta RII"", ""start_span"": 12, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""RNase"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""CML"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Cancer""}, {""token"": ""TGF - beta RII"", ""start_span"": 164, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}]"
N - glycosylation of glucose transporter - 1 ( Glut - 1) is associated with increased transporter affinity for glucose in human leukemic cells.	"glucose transporter - 1	21	44	Gene_or_gene_product"	"Glut - 1	47	55	Gene_or_gene_product"	"glucose	111	118	Chemical"	"human	122	127	Organism"	"leukemic cells	128	142	Cell"	"[{""token"": ""glucose transporter - 1"", ""start_span"": 21, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""Glut - 1"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Organism""}, {""token"": ""leukemic cells"", ""start_span"": 128, ""end_span"": 142, ""type"": ""Cell""}]"
METHODS: The effect of insulin on VEGF expression in vivo was examined by in situ hybridization studies of rat retinal VEGF transcripts.	"insulin	23	30	Gene_or_gene_product"	"VEGF	34	38	Gene_or_gene_product"	"rat	107	110	Organism"	"retinal	111	118	Multi"	"VEGF	119	123	Gene_or_gene_product"	"[{""token"": ""insulin"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""rat"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Organism""}, {""token"": ""retinal"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Multi""}, {""token"": ""VEGF"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}]"
RESULTS: Insulin increased VEGF mRNA levels in the ganglion, inner nuclear, and RPE cell layers.	"Insulin	9	16	Gene_or_gene_product"	"VEGF	27	31	Gene_or_gene_product"	"ganglion	51	59	Tissue"	"inner nuclear	61	74	Tissue"	"RPE cell layers	80	95	Tissue"	"[{""token"": ""Insulin"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""ganglion"", ""start_span"": 51, ""end_span"": 59, ""type"": ""Tissue""}, {""token"": ""inner nuclear"", ""start_span"": 61, ""end_span"": 74, ""type"": ""Tissue""}, {""token"": ""RPE cell layers"", ""start_span"": 80, ""end_span"": 95, ""type"": ""Tissue""}]"
In vitro, insulin increased VEGF mRNA levels in human RPE cells and enhanced VEGF promoter activity without affecting transcript stability.	"insulin	10	17	Gene_or_gene_product"	"VEGF	28	32	Gene_or_gene_product"	"human	48	53	Organism"	"RPE cells	54	63	Cell"	"VEGF	77	81	Gene_or_gene_product"	"[{""token"": ""insulin"", ""start_span"": 10, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Organism""}, {""token"": ""RPE cells"", ""start_span"": 54, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""VEGF"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}]"
Previous work demonstrates that the LMP1 gene of EBV is sufficient to transform certain established rodent fibroblast cell lines and to induce the tumorigenicity of some human epithelial cell lines.	"LMP1	36	40	Gene_or_gene_product"	"EBV	49	52	Organism"	"fibroblast cell lines	107	128	Cell"	"human	170	175	Organism"	"epithelial cell lines	176	197	Cell"	"[{""token"": ""LMP1"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""EBV"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Organism""}, {""token"": ""fibroblast cell lines"", ""start_span"": 107, ""end_span"": 128, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Organism""}, {""token"": ""epithelial cell lines"", ""start_span"": 176, ""end_span"": 197, ""type"": ""Cell""}]"
To examine the roles of LMP1 in cell proliferation and growth regulation in primary culture cells, we constructed a recombinant retrovirus containing an LMP1 gene.	"LMP1	24	28	Gene_or_gene_product"	"cell	32	36	Cell"	"primary culture cells	76	97	Cell"	"retrovirus	128	138	Organism"	"LMP1	153	157	Gene_or_gene_product"	"[{""token"": ""LMP1"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Cell""}, {""token"": ""primary culture cells"", ""start_span"": 76, ""end_span"": 97, ""type"": ""Cell""}, {""token"": ""retrovirus"", ""start_span"": 128, ""end_span"": 138, ""type"": ""Organism""}, {""token"": ""LMP1"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}]"
With this retrovirus, LMP1 was shown to stimulate the proliferation of primary mouse embryonic fibroblasts ( MEF cells).	"retrovirus	10	20	Organism"	"LMP1	22	26	Gene_or_gene_product"	"mouse	79	84	Organism"	"embryonic fibroblasts	85	106	Cell"	"MEF cells	109	118	Cell"	"[{""token"": ""retrovirus"", ""start_span"": 10, ""end_span"": 20, ""type"": ""Organism""}, {""token"": ""LMP1"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Organism""}, {""token"": ""embryonic fibroblasts"", ""start_span"": 85, ""end_span"": 106, ""type"": ""Cell""}, {""token"": ""MEF cells"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Cell""}]"
Autotaxin ( ATX), a potent tumor motogen, augments invasive and metastatic potential of ras - transformed cells.	"Autotaxin	0	9	Gene_or_gene_product"	"ATX	12	15	Gene_or_gene_product"	"tumor	27	32	Cancer"	"ras	88	91	Gene_or_gene_product"	"cells	106	111	Cell"	"[{""token"": ""Autotaxin"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""ATX"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Cancer""}, {""token"": ""ras"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Cell""}]"
Combination of ATX expression with ras transformation produced cells with greatly amplified tumorigenesis and metastatic potential compared to ras - transformed controls.	"ATX	15	18	Gene_or_gene_product"	"ras	35	38	Gene_or_gene_product"	"cells	63	68	Cell"	"ras	143	146	Gene_or_gene_product"	"controls	161	169	Cell"	"[{""token"": ""ATX"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""ras"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Cell""}, {""token"": ""ras"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""controls"", ""start_span"": 161, ""end_span"": 169, ""type"": ""Cell""}]"
The success of current systemic and intravesical therapeutic agents, such as cisplatin, thiotepa, Adriamycin, mitomycin C, and bacillus Calmette - Guerin, is limited with recurrence rates reduced to 17 - 44%.	"cisplatin	77	86	Chemical"	"thiotepa	88	96	Chemical"	"Adriamycin	98	108	Chemical"	"mitomycin C	110	121	Chemical"	"bacillus Calmette - Guerin	127	153	Organism"	"[{""token"": ""cisplatin"", ""start_span"": 77, ""end_span"": 86, ""type"": ""Chemical""}, {""token"": ""thiotepa"", ""start_span"": 88, ""end_span"": 96, ""type"": ""Chemical""}, {""token"": ""Adriamycin"", ""start_span"": 98, ""end_span"": 108, ""type"": ""Chemical""}, {""token"": ""mitomycin C"", ""start_span"": 110, ""end_span"": 121, ""type"": ""Chemical""}, {""token"": ""bacillus Calmette - Guerin"", ""start_span"": 127, ""end_span"": 153, ""type"": ""Organism""}]"
In addition, we found down - regulation of cyclin B, cyclin E, and dephosphorylation of cdk2 in ciprofloxacin - treated bladder tumor cells.	"cyclin B	43	51	Gene_or_gene_product"	"cyclin E	53	61	Gene_or_gene_product"	"cdk2	88	92	Gene_or_gene_product"	"ciprofloxacin	96	109	Chemical"	"bladder tumor cells	120	139	Cell"	"[{""token"": ""cyclin B"", ""start_span"": 43, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""cyclin E"", ""start_span"": 53, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""cdk2"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""ciprofloxacin"", ""start_span"": 96, ""end_span"": 109, ""type"": ""Chemical""}, {""token"": ""bladder tumor cells"", ""start_span"": 120, ""end_span"": 139, ""type"": ""Cell""}]"
The cyclin - dependent kinase inhibitor p21WAF1 level was found to be decreased within 12 h of ciprofloxacin treatment and disappeared completely when HTB9 cells were treated with 200 microg / ml ciprofloxacin for 24 h.	"cyclin - dependent kinase	4	29	Gene_or_gene_product"	"p21WAF1	40	47	Gene_or_gene_product"	"ciprofloxacin	95	108	Chemical"	"HTB9 cells	151	161	Cell"	"ciprofloxacin	196	209	Chemical"	"[{""token"": ""cyclin - dependent kinase"", ""start_span"": 4, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""p21WAF1"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""ciprofloxacin"", ""start_span"": 95, ""end_span"": 108, ""type"": ""Chemical""}, {""token"": ""HTB9 cells"", ""start_span"": 151, ""end_span"": 161, ""type"": ""Cell""}, {""token"": ""ciprofloxacin"", ""start_span"": 196, ""end_span"": 209, ""type"": ""Chemical""}]"
Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long - term peritoneal dialysis.	"Vascular	0	8	Multi"	"endothelial nitric oxide synthase	50	83	Gene_or_gene_product"	"human	87	92	Organism"	"peritoneum	93	103	Multi"	"peritoneal	127	137	Multi"	"[{""token"": ""Vascular"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Multi""}, {""token"": ""endothelial nitric oxide synthase"", ""start_span"": 50, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Organism""}, {""token"": ""peritoneum"", ""start_span"": 93, ""end_span"": 103, ""type"": ""Multi""}, {""token"": ""peritoneal"", ""start_span"": 127, ""end_span"": 137, ""type"": ""Multi""}]"
The biologic relevance of increased NOS in long - term PD was demonstrated by enhanced nitrotyrosine immunoreactivity and a significant increase in vascular density and endothelial area in the peritoneum.	"NOS	36	39	Gene_or_gene_product"	"nitrotyrosine	87	100	Chemical"	"vascular	148	156	Multi"	"endothelial area	169	185	Tissue"	"peritoneum	193	203	Multi"	"[{""token"": ""NOS"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""nitrotyrosine"", ""start_span"": 87, ""end_span"": 100, ""type"": ""Chemical""}, {""token"": ""vascular"", ""start_span"": 148, ""end_span"": 156, ""type"": ""Multi""}, {""token"": ""endothelial area"", ""start_span"": 169, ""end_span"": 185, ""type"": ""Tissue""}, {""token"": ""peritoneum"", ""start_span"": 193, ""end_span"": 203, ""type"": ""Multi""}]"
Immunoblotting and immunostaining studies demonstrated an upregulation of vascular endothelial growth factor ( VEGF) mostly along the endothelium lining peritoneal blood vessels in long - term PD patients.	"vascular endothelial growth factor	74	108	Gene_or_gene_product"	"VEGF	111	115	Gene_or_gene_product"	"endothelium	134	145	Tissue"	"peritoneal blood vessels	153	177	Multi"	"patients	196	204	Organism"	"[{""token"": ""vascular endothelial growth factor"", ""start_span"": 74, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelium"", ""start_span"": 134, ""end_span"": 145, ""type"": ""Tissue""}, {""token"": ""peritoneal blood vessels"", ""start_span"": 153, ""end_span"": 177, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 196, ""end_span"": 204, ""type"": ""Organism""}]"
It has long been noted, however, that hair follicle cycling is associated with prominent changes in skin perfusion, that the epithelial hair bulbs of anagen follicles display angiogenic properties, and that the follicular dermal papilla can produce angiogenic factors.	"hair follicle	38	51	Multi"	"skin	100	104	Organ"	"epithelial hair bulbs	125	146	Tissue"	"anagen follicles	150	166	Multi"	"follicular dermal papilla	211	236	Tissue"	"[{""token"": ""hair follicle"", ""start_span"": 38, ""end_span"": 51, ""type"": ""Multi""}, {""token"": ""skin"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Organ""}, {""token"": ""epithelial hair bulbs"", ""start_span"": 125, ""end_span"": 146, ""type"": ""Tissue""}, {""token"": ""anagen follicles"", ""start_span"": 150, ""end_span"": 166, ""type"": ""Multi""}, {""token"": ""follicular dermal papilla"", ""start_span"": 211, ""end_span"": 236, ""type"": ""Tissue""}]"
Our results indicate that alpha - MSH exerts modulatory effects on the activation of NF - kappa B and AP - 1, and that it can regulate chemokine secretion in human dermal fibroblasts.	"alpha - MSH	26	37	Gene_or_gene_product"	"NF - kappa B	85	97	Gene_or_gene_product"	"AP - 1	102	108	Gene_or_gene_product"	"human	158	163	Organism"	"dermal fibroblasts	164	182	Cell"	"[{""token"": ""alpha - MSH"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappa B"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 1"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Organism""}, {""token"": ""dermal fibroblasts"", ""start_span"": 164, ""end_span"": 182, ""type"": ""Cell""}]"
The value of serum S - 100beta and interleukins as tumour markers in advanced melanoma.	"serum	13	18	Organism_substance"	"S - 100beta	19	30	Gene_or_gene_product"	"interleukins	35	47	Gene_or_gene_product"	"tumour	51	57	Cancer"	"melanoma	78	86	Cancer"	"[{""token"": ""serum"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Organism_substance""}, {""token"": ""S - 100beta"", ""start_span"": 19, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukins"", ""start_span"": 35, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumour"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Cancer""}, {""token"": ""melanoma"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Cancer""}]"
To begin to explain the morphology of Ras - plus TEL - expressing cells, we demonstrated that the endogenous matrix metalloproteinase stromelysin - 1 was repressed by TEL.	"Ras	38	41	Gene_or_gene_product"	"TEL	49	52	Gene_or_gene_product"	"cells	66	71	Cell"	"matrix metalloproteinase stromelysin - 1	109	149	Gene_or_gene_product"	"TEL	167	170	Gene_or_gene_product"	"[{""token"": ""Ras"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""TEL"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Cell""}, {""token"": ""matrix metalloproteinase stromelysin - 1"", ""start_span"": 109, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}, {""token"": ""TEL"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}]"
In this study, we sought to investigate in more detail the role of caspase - 3 in apoptotic processes in cultured cells and in cell - free extracts of breast cancer cells.	"caspase - 3	67	78	Gene_or_gene_product"	"cells	114	119	Cell"	"cell	127	131	Cell"	"extracts	139	147	Organism_substance"	"breast cancer cells	151	170	Cell"	"[{""token"": ""caspase - 3"", ""start_span"": 67, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Cell""}, {""token"": ""extracts"", ""start_span"": 139, ""end_span"": 147, ""type"": ""Organism_substance""}, {""token"": ""breast cancer cells"", ""start_span"": 151, ""end_span"": 170, ""type"": ""Cell""}]"
We further show that in extracts from caspase - 3 - deficient MCF - 7 cells, procaspase - 9 processing is strongly impaired after stimulation with either cytochrome c or recombinant caspase - 8.	"extracts	24	32	Organism_substance"	"caspase - 3	38	49	Gene_or_gene_product"	"procaspase - 9	77	91	Gene_or_gene_product"	"cytochrome c	154	166	Gene_or_gene_product"	"caspase - 8	182	193	Gene_or_gene_product"	"[{""token"": ""extracts"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Organism_substance""}, {""token"": ""caspase - 3"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""procaspase - 9"", ""start_span"": 77, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytochrome c"", ""start_span"": 154, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase - 8"", ""start_span"": 182, ""end_span"": 193, ""type"": ""Gene_or_gene_product""}]"
Expression of wild - type VASP induces marked membrane ruffling and formation of prominent stress fibers in bovine aortic endothelial cells.	"VASP	26	30	Gene_or_gene_product"	"membrane	46	54	Cellular_component"	"stress fibers	91	104	Cellular_component"	"bovine	108	114	Organism"	"aortic endothelial cells	115	139	Cell"	"[{""token"": ""VASP"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""membrane"", ""start_span"": 46, ""end_span"": 54, ""type"": ""Cellular_component""}, {""token"": ""stress fibers"", ""start_span"": 91, ""end_span"": 104, ""type"": ""Cellular_component""}, {""token"": ""bovine"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Organism""}, {""token"": ""aortic endothelial cells"", ""start_span"": 115, ""end_span"": 139, ""type"": ""Cell""}]"
The ability of distinct subdomains within VASP to bind adhesion proteins and induce F - actin bundling in vivo suggests that this protein could function in the aggregation and tethering of actin filaments during the formation of endothelial cell - substrate and cell - cell contacts.	"VASP	42	46	Gene_or_gene_product"	"F - actin	84	93	Gene_or_gene_product"	"actin	189	194	Gene_or_gene_product"	"endothelial cell - substrate	229	257	Cellular_component"	"cell - cell contacts	262	282	Cellular_component"	"[{""token"": ""VASP"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""F - actin"", ""start_span"": 84, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""actin"", ""start_span"": 189, ""end_span"": 194, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell - substrate"", ""start_span"": 229, ""end_span"": 257, ""type"": ""Cellular_component""}, {""token"": ""cell - cell contacts"", ""start_span"": 262, ""end_span"": 282, ""type"": ""Cellular_component""}]"
These data provide a mechanism whereby VASP can influence endothelial migration and organization during capillary formation and modulate vascular permeability via effects on endothelial cell contractility.	"VASP	39	43	Gene_or_gene_product"	"endothelial	58	69	Cell"	"capillary	104	113	Tissue"	"vascular	137	145	Multi"	"endothelial cell	174	190	Cell"	"[{""token"": ""VASP"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial"", ""start_span"": 58, ""end_span"": 69, ""type"": ""Cell""}, {""token"": ""capillary"", ""start_span"": 104, ""end_span"": 113, ""type"": ""Tissue""}, {""token"": ""vascular"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Multi""}, {""token"": ""endothelial cell"", ""start_span"": 174, ""end_span"": 190, ""type"": ""Cell""}]"
This dual activity, together with the initiation of signal transduction pathways by uPAR, is believed to influence cellular behaviour in angiogenesis, inflammation, wound repair and tumor progression / metastasis and open up the way for uPAR - based therapeutic approaches.	"uPAR	84	88	Gene_or_gene_product"	"cellular	115	123	Cell"	"wound	165	170	Pathological_formation"	"tumor	182	187	Cancer"	"uPAR	237	241	Gene_or_gene_product"	"[{""token"": ""uPAR"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""wound"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Pathological_formation""}, {""token"": ""tumor"", ""start_span"": 182, ""end_span"": 187, ""type"": ""Cancer""}, {""token"": ""uPAR"", ""start_span"": 237, ""end_span"": 241, ""type"": ""Gene_or_gene_product""}]"
The p75 receptor belongs to the tumor necrosis factor ( TNF) family of death receptors and has been suggested as a receptor that mediates apoptosis in neuronal and NB cells.	"p75	4	7	Gene_or_gene_product"	"tumor necrosis factor	32	53	Gene_or_gene_product"	"TNF	56	59	Gene_or_gene_product"	"neuronal	151	159	Cell"	"NB cells	164	172	Cell"	"[{""token"": ""p75"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor necrosis factor"", ""start_span"": 32, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""TNF"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuronal"", ""start_span"": 151, ""end_span"": 159, ""type"": ""Cell""}, {""token"": ""NB cells"", ""start_span"": 164, ""end_span"": 172, ""type"": ""Cell""}]"
TRADD domain of Epstein - Barr virus transforming protein LMP1 is essential for inducing immortalization and suppressing senescence of primary rodent fibroblasts.	"TRADD	0	5	Gene_or_gene_product"	"Epstein - Barr virus	16	36	Organism"	"LMP1	58	62	Gene_or_gene_product"	"rodent	143	149	Organism"	"fibroblasts	150	161	Cell"	"[{""token"": ""TRADD"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""Epstein - Barr virus"", ""start_span"": 16, ""end_span"": 36, ""type"": ""Organism""}, {""token"": ""LMP1"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""rodent"", ""start_span"": 143, ""end_span"": 149, ""type"": ""Organism""}, {""token"": ""fibroblasts"", ""start_span"": 150, ""end_span"": 161, ""type"": ""Cell""}]"
Mutation analysis of latent membrane protein 1 ( LMP1) in Epstein - Barr virus ( EBV) - induced B - cell immortalization revealed two transformation effector sites, TES1 and TES2.	"latent membrane protein 1	21	46	Gene_or_gene_product"	"LMP1	49	53	Gene_or_gene_product"	"Epstein - Barr virus	58	78	Organism"	"EBV	81	84	Organism"	"B - cell	96	104	Cell"	"[{""token"": ""latent membrane protein 1"", ""start_span"": 21, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""LMP1"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""Epstein - Barr virus"", ""start_span"": 58, ""end_span"": 78, ""type"": ""Organism""}, {""token"": ""EBV"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Organism""}, {""token"": ""B - cell"", ""start_span"": 96, ""end_span"": 104, ""type"": ""Cell""}]"
The present study shows that a mutant with an LMP1 site - specific mutation at TES2, LMP1 ( TRADD), initially stimulates cell growth and significantly extends the life span of MEF.	"LMP1	46	50	Gene_or_gene_product"	"LMP1	85	89	Gene_or_gene_product"	"TRADD	92	97	Gene_or_gene_product"	"cell	121	125	Cell"	"MEF	176	179	Cell"	"[{""token"": ""LMP1"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""LMP1"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRADD"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Cell""}, {""token"": ""MEF"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Cell""}]"
In vivo IL - 12 - dependent tumor inhibition rests on the ability of IL - 12 to activate a CD8 - mediated cytotoxicity, inhibit angiogenesis, and cause vascular injury.	"IL - 12	8	15	Gene_or_gene_product"	"tumor	28	33	Cancer"	"IL - 12	69	76	Gene_or_gene_product"	"CD8	91	94	Gene_or_gene_product"	"vascular	152	160	Multi"	"[{""token"": ""IL - 12"", ""start_span"": 8, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Cancer""}, {""token"": ""IL - 12"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD8"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular"", ""start_span"": 152, ""end_span"": 160, ""type"": ""Multi""}]"
To elucidate the biological role of the endogenous angiogenesis inhibitor thrombospondin - 2 ( TSP - 2) during multistep carcinogenesis, we subjected TSP - 2 - deficient and wild - type mice to a chemical skin carcinogenesis regimen.	"thrombospondin - 2	74	92	Gene_or_gene_product"	"TSP - 2	95	102	Gene_or_gene_product"	"TSP - 2	150	157	Gene_or_gene_product"	"mice	186	190	Organism"	"skin	205	209	Organ"	"[{""token"": ""thrombospondin - 2"", ""start_span"": 74, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 2"", ""start_span"": 95, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 2"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 186, ""end_span"": 190, ""type"": ""Organism""}, {""token"": ""skin"", ""start_span"": 205, ""end_span"": 209, ""type"": ""Organ""}]"
Surprisingly, TSP - 2 expression was strongly upregulated in the mesenchymal stroma of wild - type mice throughout the consecutive stages of tumorigenesis whereas the angiogenesis factor, vascular endothelial growth factor, was induced predominantly in tumor cells.	"TSP - 2	14	21	Gene_or_gene_product"	"mesenchymal stroma	65	83	Tissue"	"mice	99	103	Organism"	"vascular endothelial growth factor	188	222	Gene_or_gene_product"	"tumor cells	253	264	Cell"	"[{""token"": ""TSP - 2"", ""start_span"": 14, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""mesenchymal stroma"", ""start_span"": 65, ""end_span"": 83, ""type"": ""Tissue""}, {""token"": ""mice"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Organism""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 188, ""end_span"": 222, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cells"", ""start_span"": 253, ""end_span"": 264, ""type"": ""Cell""}]"
Invasion of adjacent organs was more frequent in the RSCM group than in the RSCB group and the Ki - 67 labeling index of the tumors was significantly higher in the former group.	"organs	21	27	Organ"	"RSCM	53	57	Cancer"	"RSCB	76	80	Cancer"	"Ki - 67	95	102	Gene_or_gene_product"	"tumors	125	131	Cancer"	"[{""token"": ""organs"", ""start_span"": 21, ""end_span"": 27, ""type"": ""Organ""}, {""token"": ""RSCM"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Cancer""}, {""token"": ""RSCB"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Cancer""}, {""token"": ""Ki - 67"", ""start_span"": 95, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 125, ""end_span"": 131, ""type"": ""Cancer""}]"
Mutation of p53 may play an important role in the high proliferative activity of tumors in the RSCM group and H. pylori infection may be closely related to carcinogenesis in patients with RSC.	"p53	12	15	Gene_or_gene_product"	"tumors	81	87	Cancer"	"RSCM	95	99	Cancer"	"patients	174	182	Organism"	"RSC	188	191	Cancer"	"[{""token"": ""p53"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Cancer""}, {""token"": ""RSCM"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 174, ""end_span"": 182, ""type"": ""Organism""}, {""token"": ""RSC"", ""start_span"": 188, ""end_span"": 191, ""type"": ""Cancer""}]"
To explore the mechanisms underlying Evi - 1 - induced oncogenesis, we investigated whether Evi - 1 affects the signaling of transforming growth factor beta ( TGF - beta), which inhibits proliferation of a wide range of cell types and is one of the most studied growth regulatory factors.	"Evi - 1	37	44	Gene_or_gene_product"	"Evi - 1	92	99	Gene_or_gene_product"	"transforming growth factor beta	125	156	Gene_or_gene_product"	"TGF - beta	159	169	Gene_or_gene_product"	"cell types	220	230	Cell"	"[{""token"": ""Evi - 1"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""Evi - 1"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""transforming growth factor beta"", ""start_span"": 125, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta"", ""start_span"": 159, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell types"", ""start_span"": 220, ""end_span"": 230, ""type"": ""Cell""}]"
Through this domain, Evi - 1 physically interacts with Smad3, an intracellular mediator of TGF - beta signaling, thereby suppressing the transcriptional activity of Smad3.	"Evi - 1	21	28	Gene_or_gene_product"	"Smad3	55	60	Gene_or_gene_product"	"intracellular	65	78	Immaterial_anatomical_entity"	"TGF - beta	91	101	Gene_or_gene_product"	"Smad3	165	170	Gene_or_gene_product"	"[{""token"": ""Evi - 1"", ""start_span"": 21, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad3"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""intracellular"", ""start_span"": 65, ""end_span"": 78, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""TGF - beta"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad3"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}]"
In this study, we demonstrate that SPARC inhibits human arterial smooth muscle cell proliferation stimulated by platelet - derived growth factor or by adhesion to monomeric type I collagen.	"SPARC	35	40	Gene_or_gene_product"	"human	50	55	Organism"	"arterial smooth muscle cell	56	83	Cell"	"platelet - derived growth factor	112	144	Gene_or_gene_product"	"monomeric type I collagen	163	188	Gene_or_gene_product"	"[{""token"": ""SPARC"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Organism""}, {""token"": ""arterial smooth muscle cell"", ""start_span"": 56, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""platelet - derived growth factor"", ""start_span"": 112, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}, {""token"": ""monomeric type I collagen"", ""start_span"": 163, ""end_span"": 188, ""type"": ""Gene_or_gene_product""}]"
Thus, SPARC, previously characterized as an inhibitor of platelet - derived growth factor binding to its receptor, also antagonizes smooth muscle cell proliferation mediated by monomeric collagen at the level of cyclin - dependent kinase - 2 activity.	"SPARC	6	11	Gene_or_gene_product"	"platelet - derived growth factor	57	89	Gene_or_gene_product"	"smooth muscle cell	132	150	Cell"	"collagen	187	195	Gene_or_gene_product"	"cyclin - dependent kinase - 2	212	241	Gene_or_gene_product"	"[{""token"": ""SPARC"", ""start_span"": 6, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""platelet - derived growth factor"", ""start_span"": 57, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""smooth muscle cell"", ""start_span"": 132, ""end_span"": 150, ""type"": ""Cell""}, {""token"": ""collagen"", ""start_span"": 187, ""end_span"": 195, ""type"": ""Gene_or_gene_product""}, {""token"": ""cyclin - dependent kinase - 2"", ""start_span"": 212, ""end_span"": 241, ""type"": ""Gene_or_gene_product""}]"
Archival tissues from 40 patients with oral squamous cell carcinoma who received primary surgical resection were examined for HSP27 by immunohistochemistry and correlated with clinical stage, lymph node metastasis, histological grade and survival period.	"Archival tissues	0	16	Tissue"	"patients	25	33	Organism"	"oral squamous cell carcinoma	39	67	Cancer"	"HSP27	126	131	Gene_or_gene_product"	"lymph node	192	202	Multi"	"[{""token"": ""Archival tissues"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Tissue""}, {""token"": ""patients"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Organism""}, {""token"": ""oral squamous cell carcinoma"", ""start_span"": 39, ""end_span"": 67, ""type"": ""Cancer""}, {""token"": ""HSP27"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 192, ""end_span"": 202, ""type"": ""Multi""}]"
This study suggests that the expression of HSP27 is frequently promoted in patients with oral squamous cell carcinoma and should be considered an independent prognostic factor of oral squamous cell carcinoma patients.	"HSP27	43	48	Gene_or_gene_product"	"patients	75	83	Organism"	"oral squamous cell carcinoma	89	117	Cancer"	"oral squamous cell carcinoma	179	207	Cancer"	"patients	208	216	Organism"	"[{""token"": ""HSP27"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 75, ""end_span"": 83, ""type"": ""Organism""}, {""token"": ""oral squamous cell carcinoma"", ""start_span"": 89, ""end_span"": 117, ""type"": ""Cancer""}, {""token"": ""oral squamous cell carcinoma"", ""start_span"": 179, ""end_span"": 207, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 208, ""end_span"": 216, ""type"": ""Organism""}]"
What was observed, however, was the multistep acquisition of aberrant cellular genetic changes in marrow cells from patients who transformed, including activating ras oncogene mutations, clonal cytogenetic abnormalities, and G - CSF receptor mutations.	"cellular	70	78	Cell"	"marrow cells	98	110	Cell"	"patients	116	124	Organism"	"ras	163	166	Gene_or_gene_product"	"G - CSF receptor	225	241	Gene_or_gene_product"	"[{""token"": ""cellular"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""marrow cells"", ""start_span"": 98, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""patients"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Organism""}, {""token"": ""ras"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""G - CSF receptor"", ""start_span"": 225, ""end_span"": 241, ""type"": ""Gene_or_gene_product""}]"
The results showed that the expression of full - length T antigen rendered rat embryo fibroblasts ( REF) sensitive to 5 - FU - induced apoptosis.	"T antigen	56	65	Gene_or_gene_product"	"rat	75	78	Organism"	"embryo fibroblasts	79	97	Cell"	"REF	100	103	Cell"	"5 - FU	118	124	Chemical"	"[{""token"": ""T antigen"", ""start_span"": 56, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""rat"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Organism""}, {""token"": ""embryo fibroblasts"", ""start_span"": 79, ""end_span"": 97, ""type"": ""Cell""}, {""token"": ""REF"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Cell""}, {""token"": ""5 - FU"", ""start_span"": 118, ""end_span"": 124, ""type"": ""Chemical""}]"
Thus, neither the p53 - binding region nor the Bcl - 2 homology region of T antigen was sufficient to prevent cell death induced by the DNA - damaging agent.	"p53	18	21	Gene_or_gene_product"	"Bcl - 2	47	54	Gene_or_gene_product"	"T antigen	74	83	Gene_or_gene_product"	"cell	110	114	Cell"	"DNA	136	139	Cellular_component"	"[{""token"": ""p53"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""T antigen"", ""start_span"": 74, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Cellular_component""}]"
CONCLUSIONS: Indocyanine green dye - enhanced photocoagulation of CNV feeder vessels, facilitated by use of a device that permits real - time visualization of the choroidal circulation while aiming the treatment laser beam, appears to minimize the amount of energy applied to the fundus and the volume of fundus tissue affected by treatment, compared with other treatment modalities.	"Indocyanine green dye	13	34	Chemical"	"feeder vessels	70	84	Multi"	"choroidal	163	172	Multi"	"fundus	280	286	Multi"	"fundus tissue	305	318	Tissue"	"[{""token"": ""Indocyanine green dye"", ""start_span"": 13, ""end_span"": 34, ""type"": ""Chemical""}, {""token"": ""feeder vessels"", ""start_span"": 70, ""end_span"": 84, ""type"": ""Multi""}, {""token"": ""choroidal"", ""start_span"": 163, ""end_span"": 172, ""type"": ""Multi""}, {""token"": ""fundus"", ""start_span"": 280, ""end_span"": 286, ""type"": ""Multi""}, {""token"": ""fundus tissue"", ""start_span"": 305, ""end_span"": 318, ""type"": ""Tissue""}]"
In contrast, pellets from the CLA - fed animals contained fewer infiltrating cells, which formed limited branching cellular networks, the majority of which had collapsed lumen and no RBCs.	"CLA	30	33	Chemical"	"cells	77	82	Cell"	"cellular networks	115	132	Multi"	"lumen	170	175	Immaterial_anatomical_entity"	"RBCs	183	187	Cell"	"[{""token"": ""CLA"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Cell""}, {""token"": ""cellular networks"", ""start_span"": 115, ""end_span"": 132, ""type"": ""Multi""}, {""token"": ""lumen"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""RBCs"", ""start_span"": 183, ""end_span"": 187, ""type"": ""Cell""}]"
Stimulatory effects on proliferation and migration of human umbilical vein endothelial cells ( HUVEC) characterized the angiogenic properties of oral cancer cells but not normal oral keratinocytes ( NOK).	"human umbilical vein endothelial cells	54	92	Cell"	"HUVEC	95	100	Cell"	"oral cancer cells	145	162	Cell"	"normal oral keratinocytes	171	196	Cell"	"NOK	199	202	Cell"	"[{""token"": ""human umbilical vein endothelial cells"", ""start_span"": 54, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""HUVEC"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Cell""}, {""token"": ""oral cancer cells"", ""start_span"": 145, ""end_span"": 162, ""type"": ""Cell""}, {""token"": ""normal oral keratinocytes"", ""start_span"": 171, ""end_span"": 196, ""type"": ""Cell""}, {""token"": ""NOK"", ""start_span"": 199, ""end_span"": 202, ""type"": ""Cell""}]"
Enforced expression of tissue inhibitor of matrix metalloproteinase - 3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model.	"tissue inhibitor of matrix metalloproteinase - 3	23	71	Gene_or_gene_product"	"capillary	91	100	Tissue"	"tumor	128	133	Cancer"	"murine	146	152	Organism"	"tumor	153	158	Cancer"	"[{""token"": ""tissue inhibitor of matrix metalloproteinase - 3"", ""start_span"": 23, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""capillary"", ""start_span"": 91, ""end_span"": 100, ""type"": ""Tissue""}, {""token"": ""tumor"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Cancer""}, {""token"": ""murine"", ""start_span"": 146, ""end_span"": 152, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 153, ""end_span"": 158, ""type"": ""Cancer""}]"
Homeostasis of the extracellular matrix is a delicate balance between degradation and remodeling, the balance being maintained by the interaction of activated matrix metalloproteinases ( MMPs) and specific tissue inhibitors of matrix metalloproteinases ( TIMPs).	"extracellular matrix	19	39	Cellular_component"	"matrix metalloproteinases	159	184	Gene_or_gene_product"	"MMPs	187	191	Gene_or_gene_product"	"tissue inhibitors of matrix metalloproteinases	206	252	Gene_or_gene_product"	"TIMPs	255	260	Gene_or_gene_product"	"[{""token"": ""extracellular matrix"", ""start_span"": 19, ""end_span"": 39, ""type"": ""Cellular_component""}, {""token"": ""matrix metalloproteinases"", ""start_span"": 159, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMPs"", ""start_span"": 187, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue inhibitors of matrix metalloproteinases"", ""start_span"": 206, ""end_span"": 252, ""type"": ""Gene_or_gene_product""}, {""token"": ""TIMPs"", ""start_span"": 255, ""end_span"": 260, ""type"": ""Gene_or_gene_product""}]"
We have used retroviral - mediated gene delivery to effect sustained autocrine expression of TIMP - 3 in murine neuroblastoma and melanoma tumor cells in order to further examine the ability of TIMPs to inhibit angiogenesis in vivo.	"TIMP - 3	93	101	Gene_or_gene_product"	"murine	105	111	Organism"	"neuroblastoma	112	125	Cell"	"melanoma tumor cells	130	150	Cell"	"TIMPs	194	199	Gene_or_gene_product"	"[{""token"": ""TIMP - 3"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine"", ""start_span"": 105, ""end_span"": 111, ""type"": ""Organism""}, {""token"": ""neuroblastoma"", ""start_span"": 112, ""end_span"": 125, ""type"": ""Cell""}, {""token"": ""melanoma tumor cells"", ""start_span"": 130, ""end_span"": 150, ""type"": ""Cell""}, {""token"": ""TIMPs"", ""start_span"": 194, ""end_span"": 199, ""type"": ""Gene_or_gene_product""}]"
Roles of cell adhesion molecules in tumor angiogenesis induced by cotransplantation of cancer and endothelial cells to nude rats.	"cell	9	13	Cell"	"tumor	36	41	Cancer"	"cancer	87	93	Cell"	"endothelial cells	98	115	Cell"	"nude rats	119	128	Organism"	"[{""token"": ""cell"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Cell""}, {""token"": ""endothelial cells"", ""start_span"": 98, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""nude rats"", ""start_span"": 119, ""end_span"": 128, ""type"": ""Organism""}]"
This in vitro morphological appearance was exactly reproduced in the in vivo tumors, which were formed when the mixture of A431 and F - 2 cells at the ratio of 10: 1 were cotransplanted s. c. into the back of nude rats.	"tumors	77	83	Cancer"	"A431	123	127	Cell"	"F - 2 cells	132	143	Cell"	"back	201	205	Organism_subdivision"	"nude rats	209	218	Organism"	"[{""token"": ""tumors"", ""start_span"": 77, ""end_span"": 83, ""type"": ""Cancer""}, {""token"": ""A431"", ""start_span"": 123, ""end_span"": 127, ""type"": ""Cell""}, {""token"": ""F - 2 cells"", ""start_span"": 132, ""end_span"": 143, ""type"": ""Cell""}, {""token"": ""back"", ""start_span"": 201, ""end_span"": 205, ""type"": ""Organism_subdivision""}, {""token"": ""nude rats"", ""start_span"": 209, ""end_span"": 218, ""type"": ""Organism""}]"
Deleted in split hand / split foot 1 ( Dss1) is a gene associated with a heterogeneous limb developmental disorder called split hand / split foot malformation.	"Deleted in split hand / split foot 1	0	36	Gene_or_gene_product"	"Dss1	39	43	Gene_or_gene_product"	"limb	87	91	Organism_subdivision"	"hand	128	132	Organism_subdivision"	"foot	141	145	Organism_subdivision"	"[{""token"": ""Deleted in split hand / split foot 1"", ""start_span"": 0, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""Dss1"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""limb"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Organism_subdivision""}, {""token"": ""hand"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Organism_subdivision""}, {""token"": ""foot"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Organism_subdivision""}]"
The anti - apoptotic protein c - FLIP ( cellular Flice - like inhibitory protein), which has been shown to inhibit Fas - mediated apoptosis at the DISC, was down - regulated following AdGFPFasL ( TET) treatment prompting us to investigate its role in inhibiting CH - 11 - induced cell death.	"c - FLIP	29	37	Gene_or_gene_product"	"cellular Flice - like inhibitory protein	40	80	Gene_or_gene_product"	"Fas	115	118	Gene_or_gene_product"	"DISC	147	151	Gene_or_gene_product"	"cell	280	284	Cell"	"[{""token"": ""c - FLIP"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular Flice - like inhibitory protein"", ""start_span"": 40, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""DISC"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 280, ""end_span"": 284, ""type"": ""Cell""}]"
These data suggest that c - FLIP may play a critical role in regulating Fas - mediated apoptosis in prostate cancer cells and that modulation of c - FLIP may enhance Fas signaling based therapies.	"c - FLIP	24	32	Gene_or_gene_product"	"Fas	72	75	Gene_or_gene_product"	"prostate cancer cells	100	121	Cell"	"c - FLIP	145	153	Gene_or_gene_product"	"Fas	166	169	Gene_or_gene_product"	"[{""token"": ""c - FLIP"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate cancer cells"", ""start_span"": 100, ""end_span"": 121, ""type"": ""Cell""}, {""token"": ""c - FLIP"", ""start_span"": 145, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}]"
METHODS: This review discusses our current understanding of the mechanisms of TGF - beta signaling, focusing on the roles of TGF - beta in regulation of vascular wall cells and on the regulation of TGF - beta superfamily signals by inhibitory Smads.	"TGF - beta	78	88	Gene_or_gene_product"	"TGF - beta	125	135	Gene_or_gene_product"	"vascular wall cells	153	172	Cell"	"TGF - beta	198	208	Gene_or_gene_product"	"Smads	243	248	Gene_or_gene_product"	"[{""token"": ""TGF - beta"", ""start_span"": 78, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta"", ""start_span"": 125, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular wall cells"", ""start_span"": 153, ""end_span"": 172, ""type"": ""Cell""}, {""token"": ""TGF - beta"", ""start_span"": 198, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smads"", ""start_span"": 243, ""end_span"": 248, ""type"": ""Gene_or_gene_product""}]"
Interestingly, the human B - lymphoblastoid cell line SKW6. 4, a prototype for mitochondria - independent death receptor - induced apoptosis, was also sensitized to anti - CD95 and TRAIL - induced apoptosis under glucose - free conditions.	"human	19	24	Organism"	"mitochondria	79	91	Cellular_component"	"CD95	172	176	Gene_or_gene_product"	"TRAIL	181	186	Gene_or_gene_product"	"glucose	213	220	Chemical"	"[{""token"": ""human"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Organism""}, {""token"": ""mitochondria"", ""start_span"": 79, ""end_span"": 91, ""type"": ""Cellular_component""}, {""token"": ""CD95"", ""start_span"": 172, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRAIL"", ""start_span"": 181, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 213, ""end_span"": 220, ""type"": ""Chemical""}]"
Bee venom induces apoptosis and inhibits expression of cyclooxygenase - 2 mRNA in human lung cancer cell line NCI - H1299.	"Bee	0	3	Organism"	"venom	4	9	Organism_substance"	"cyclooxygenase - 2	55	73	Gene_or_gene_product"	"human	82	87	Organism"	"lung cancer cell line NCI - H1299	88	121	Cell"	"[{""token"": ""Bee"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Organism""}, {""token"": ""venom"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Organism_substance""}, {""token"": ""cyclooxygenase - 2"", ""start_span"": 55, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Organism""}, {""token"": ""lung cancer cell line NCI - H1299"", ""start_span"": 88, ""end_span"": 121, ""type"": ""Cell""}]"
[ Effects of Epstein - Barr virus latent membrane protein 1 ( EBV - LMP1) on related factors of metastasis of nasopharyngeal carcinoma cell line CNE1].	"Epstein - Barr virus	13	33	Organism"	"latent membrane protein 1	34	59	Gene_or_gene_product"	"EBV	62	65	Organism"	"LMP1	68	72	Gene_or_gene_product"	"nasopharyngeal carcinoma cell line CNE1	110	149	Cell"	"[{""token"": ""Epstein - Barr virus"", ""start_span"": 13, ""end_span"": 33, ""type"": ""Organism""}, {""token"": ""latent membrane protein 1"", ""start_span"": 34, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""EBV"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Organism""}, {""token"": ""LMP1"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""nasopharyngeal carcinoma cell line CNE1"", ""start_span"": 110, ""end_span"": 149, ""type"": ""Cell""}]"
Cell - matrix adhesion assay showed that the adhesive ability of CNE1 - GL with the matrix ( mean A value: 1. 2508 + / - 0. 0711) was higher than that of CNE1 cell ( mean A value: 0. 9519 + / - 0. 068) ( P < 0. 001).	"Cell	0	4	Cell"	"matrix	7	13	Cellular_component"	"CNE1 - GL	65	74	Cell"	"matrix	84	90	Cellular_component"	"CNE1 cell	154	163	Cell"	"[{""token"": ""Cell"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Cell""}, {""token"": ""matrix"", ""start_span"": 7, ""end_span"": 13, ""type"": ""Cellular_component""}, {""token"": ""CNE1 - GL"", ""start_span"": 65, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""matrix"", ""start_span"": 84, ""end_span"": 90, ""type"": ""Cellular_component""}, {""token"": ""CNE1 cell"", ""start_span"": 154, ""end_span"": 163, ""type"": ""Cell""}]"
Truncated galectin - 3 inhibits tumor growth and metastasis in orthotopic nude mouse model of human breast cancer.	"galectin - 3	10	22	Gene_or_gene_product"	"tumor	32	37	Cancer"	"nude mouse	74	84	Organism"	"human	94	99	Organism"	"breast cancer	100	113	Cancer"	"[{""token"": ""galectin - 3"", ""start_span"": 10, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Cancer""}, {""token"": ""nude mouse"", ""start_span"": 74, ""end_span"": 84, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 100, ""end_span"": 113, ""type"": ""Cancer""}]"
EXPERIMENTAL DESIGN: Recombinant human galectin - 3 was produced in Escherichia coli from which galectin - 3C was derived by collagenase enzyme digestion.	"human	33	38	Organism"	"galectin - 3	39	51	Gene_or_gene_product"	"Escherichia coli	68	84	Organism"	"galectin - 3C	96	109	Gene_or_gene_product"	"collagenase	125	136	Gene_or_gene_product"	"[{""token"": ""human"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Organism""}, {""token"": ""galectin - 3"", ""start_span"": 39, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""Escherichia coli"", ""start_span"": 68, ""end_span"": 84, ""type"": ""Organism""}, {""token"": ""galectin - 3C"", ""start_span"": 96, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""collagenase"", ""start_span"": 125, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}]"
The p53 and VEGF staining statuses were coincident in only 21% of the tumors, and no significant correlation was found between p53 and VEGF statuses.	"p53	4	7	Gene_or_gene_product"	"VEGF	12	16	Gene_or_gene_product"	"tumors	70	76	Cancer"	"p53	127	130	Gene_or_gene_product"	"VEGF	135	139	Gene_or_gene_product"	"[{""token"": ""p53"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 70, ""end_span"": 76, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}]"
In conclusion, p53 and VEGF were not correlated with prognosis in patients with stage II and III SCC of the esophagus.	"p53	15	18	Gene_or_gene_product"	"VEGF	23	27	Gene_or_gene_product"	"patients	66	74	Organism"	"SCC	97	100	Cancer"	"esophagus	108	117	Organ"	"[{""token"": ""p53"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 66, ""end_span"": 74, ""type"": ""Organism""}, {""token"": ""SCC"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Cancer""}, {""token"": ""esophagus"", ""start_span"": 108, ""end_span"": 117, ""type"": ""Organ""}]"
When injected in human breast cancer xenografts, pAd - T34A inhibited growth of established tumors and triggered tumor cell apoptosis in vivo.	"human	17	22	Organism"	"breast cancer xenografts	23	47	Cancer"	"pAd - T34A	49	59	Gene_or_gene_product"	"tumors	92	98	Cancer"	"tumor cell	113	123	Cell"	"[{""token"": ""human"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Organism""}, {""token"": ""breast cancer xenografts"", ""start_span"": 23, ""end_span"": 47, ""type"": ""Cancer""}, {""token"": ""pAd - T34A"", ""start_span"": 49, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 92, ""end_span"": 98, ""type"": ""Cancer""}, {""token"": ""tumor cell"", ""start_span"": 113, ""end_span"": 123, ""type"": ""Cell""}]"
The role of organ vascularization and lipoplex - serum initial contact in intravenous murine lipofection.	"organ	12	17	Organ"	"lipoplex	38	46	Chemical"	"serum	49	54	Organism_substance"	"intravenous	74	85	Immaterial_anatomical_entity"	"murine	86	92	Organism"	"[{""token"": ""organ"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Organ""}, {""token"": ""lipoplex"", ""start_span"": 38, ""end_span"": 46, ""type"": ""Chemical""}, {""token"": ""serum"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Organism_substance""}, {""token"": ""intravenous"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""murine"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Organism""}]"
Following intravenous administration of cationic lipid - DNA complexes ( lipoplexes) into mice, transfection ( lipofection) occurs predominantly in the lungs.	"intravenous	10	21	Immaterial_anatomical_entity"	"DNA	57	60	Cellular_component"	"lipoplexes	73	83	Chemical"	"mice	90	94	Organism"	"lungs	152	157	Organ"	"[{""token"": ""intravenous"", ""start_span"": 10, ""end_span"": 21, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""DNA"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Cellular_component""}, {""token"": ""lipoplexes"", ""start_span"": 73, ""end_span"": 83, ""type"": ""Chemical""}, {""token"": ""mice"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Organism""}, {""token"": ""lungs"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Organ""}]"
Accumulating evidences indicate that receptor activator of NF - kB ligand ( RANKL) is the ultimate extracellular mediator that stimulates osteoclast differentiation into mature osteoclasts.	"receptor activator of NF - kB ligand	37	73	Gene_or_gene_product"	"RANKL	76	81	Gene_or_gene_product"	"extracellular	99	112	Immaterial_anatomical_entity"	"osteoclast	138	148	Cell"	"osteoclasts	177	188	Cell"	"[{""token"": ""receptor activator of NF - kB ligand"", ""start_span"": 37, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""RANKL"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular"", ""start_span"": 99, ""end_span"": 112, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""osteoclast"", ""start_span"": 138, ""end_span"": 148, ""type"": ""Cell""}, {""token"": ""osteoclasts"", ""start_span"": 177, ""end_span"": 188, ""type"": ""Cell""}]"
We examined these cell lines and samples from breast cancer by RT - PCR for the expressions of OPG and RANKL mRNA.	"cell lines	18	28	Cell"	"samples	33	40	Tissue"	"breast cancer	46	59	Cancer"	"OPG	95	98	Gene_or_gene_product"	"RANKL	103	108	Gene_or_gene_product"	"[{""token"": ""cell lines"", ""start_span"": 18, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""samples"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Tissue""}, {""token"": ""breast cancer"", ""start_span"": 46, ""end_span"": 59, ""type"": ""Cancer""}, {""token"": ""OPG"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""RANKL"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}]"
Compared to controls, co - culture of MDA - MB - 231 cells with stromal or osteoblastic cells induced an increase in number of osteoclasts and TRAP activities.	"MDA - MB - 231 cells	38	58	Cell"	"stromal	64	71	Cell"	"osteoblastic cells	75	93	Cell"	"osteoclasts	127	138	Cell"	"TRAP	143	147	Gene_or_gene_product"	"[{""token"": ""MDA - MB - 231 cells"", ""start_span"": 38, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""stromal"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Cell""}, {""token"": ""osteoblastic cells"", ""start_span"": 75, ""end_span"": 93, ""type"": ""Cell""}, {""token"": ""osteoclasts"", ""start_span"": 127, ""end_span"": 138, ""type"": ""Cell""}, {""token"": ""TRAP"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}]"
However, co - culture of these cancer cells with stromal or osteoblastic cells induced RANKL mRNA expression and decreased OPG mRNA expression.	"cancer cells	31	43	Cell"	"stromal	49	56	Cell"	"osteoblastic cells	60	78	Cell"	"RANKL	87	92	Gene_or_gene_product"	"OPG	123	126	Gene_or_gene_product"	"[{""token"": ""cancer cells"", ""start_span"": 31, ""end_span"": 43, ""type"": ""Cell""}, {""token"": ""stromal"", ""start_span"": 49, ""end_span"": 56, ""type"": ""Cell""}, {""token"": ""osteoblastic cells"", ""start_span"": 60, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""RANKL"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""OPG"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}]"
In tissues with a normally high metabolic turnover such as skeletal and cardiac muscle, even mild ischemia causes hypoxia, acidosis, and depressed function ( contractility) and eventually threatens myocyte viability and organ function.	"tissues	3	10	Tissue"	"skeletal	59	67	Tissue"	"cardiac muscle	72	86	Tissue"	"myocyte	198	205	Cell"	"organ	220	225	Organ"	"[{""token"": ""tissues"", ""start_span"": 3, ""end_span"": 10, ""type"": ""Tissue""}, {""token"": ""skeletal"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Tissue""}, {""token"": ""cardiac muscle"", ""start_span"": 72, ""end_span"": 86, ""type"": ""Tissue""}, {""token"": ""myocyte"", ""start_span"": 198, ""end_span"": 205, ""type"": ""Cell""}, {""token"": ""organ"", ""start_span"": 220, ""end_span"": 225, ""type"": ""Organ""}]"
Lipid / cholesterol - lowering agents, diet and antiplatelet adherence ( aspirin) therapy may help slow the progression of vessel disease in some instances; but surgical reconstruction may be the only option in advanced stages, and even this is not always an option.	"Lipid	0	5	Chemical"	"cholesterol	8	19	Chemical"	"antiplatelet	48	60	Cell"	"aspirin	73	80	Chemical"	"vessel	123	129	Multi"	"[{""token"": ""Lipid"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Chemical""}, {""token"": ""cholesterol"", ""start_span"": 8, ""end_span"": 19, ""type"": ""Chemical""}, {""token"": ""antiplatelet"", ""start_span"": 48, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""aspirin"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Chemical""}, {""token"": ""vessel"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Multi""}]"
The effects of IGF - 1 are mediated principally through the IGF - 1R but are modulated by complex interactions with multiple IGF binding proteins that themselves are regulated by phosphorylation, proteolysis, polymerization, and cell or matrix association.	"IGF - 1	15	22	Gene_or_gene_product"	"IGF - 1R	60	68	Gene_or_gene_product"	"IGF binding proteins	125	145	Gene_or_gene_product"	"cell	229	233	Cell"	"matrix	237	243	Cellular_component"	"[{""token"": ""IGF - 1"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF - 1R"", ""start_span"": 60, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF binding proteins"", ""start_span"": 125, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 229, ""end_span"": 233, ""type"": ""Cell""}, {""token"": ""matrix"", ""start_span"": 237, ""end_span"": 243, ""type"": ""Cellular_component""}]"
This review will discuss the regulation of expression of IGF - 1, IGF - 1R, and IGF binding proteins in the vasculature and summarize evidence implicating involvement of this system in vascular diseases.	"IGF - 1	57	64	Gene_or_gene_product"	"IGF - 1R	66	74	Gene_or_gene_product"	"IGF binding proteins	80	100	Gene_or_gene_product"	"vasculature	108	119	Anatomical_system"	"vascular	185	193	Multi"	"[{""token"": ""IGF - 1"", ""start_span"": 57, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF - 1R"", ""start_span"": 66, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF binding proteins"", ""start_span"": 80, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""vasculature"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Anatomical_system""}, {""token"": ""vascular"", ""start_span"": 185, ""end_span"": 193, ""type"": ""Multi""}]"
Microvascular density and vascular endothelial growth factor immunoreactivity as predictors of regional lymph node metastasis from betel - associated oral squamous cell carcinoma.	"Microvascular	0	13	Tissue"	"vascular endothelial growth factor	26	60	Gene_or_gene_product"	"lymph node	104	114	Multi"	"betel	131	136	Organism_subdivision"	"oral squamous cell carcinoma	150	178	Cancer"	"[{""token"": ""Microvascular"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Tissue""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 26, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 104, ""end_span"": 114, ""type"": ""Multi""}, {""token"": ""betel"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Organism_subdivision""}, {""token"": ""oral squamous cell carcinoma"", ""start_span"": 150, ""end_span"": 178, ""type"": ""Cancer""}]"
PATIENTS AND METHODS: The paraffin sections from 49 subjects with OSCC were subjected to immunohistochemical studies to measure the highest MVD ( h - MVD) and cytoplasmic immunoreactivity of VEGF.	"paraffin sections	26	43	Cancer"	"subjects	52	60	Organism"	"OSCC	66	70	Cancer"	"cytoplasmic	159	170	Organism_substance"	"VEGF	191	195	Gene_or_gene_product"	"[{""token"": ""paraffin sections"", ""start_span"": 26, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""subjects"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Organism""}, {""token"": ""OSCC"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Cancer""}, {""token"": ""cytoplasmic"", ""start_span"": 159, ""end_span"": 170, ""type"": ""Organism_substance""}, {""token"": ""VEGF"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Gene_or_gene_product""}]"
The beclin 1 autophagy gene is monoallelically deleted in 40 - 75% of cases of human sporadic breast, ovarian, and prostate cancer.	"beclin 1	4	12	Gene_or_gene_product"	"human	79	84	Organism"	"breast	94	100	Cancer"	"ovarian	102	109	Cancer"	"prostate cancer	115	130	Cancer"	"[{""token"": ""beclin 1"", ""start_span"": 4, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Organism""}, {""token"": ""breast"", ""start_span"": 94, ""end_span"": 100, ""type"": ""Cancer""}, {""token"": ""ovarian"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Cancer""}, {""token"": ""prostate cancer"", ""start_span"": 115, ""end_span"": 130, ""type"": ""Cancer""}]"
Effects of dietary folate on ulcerative colitis - associated colorectal carcinogenesis in the interleukin 2 - and beta ( 2) - microglobulin - deficient mice.	"folate	19	25	Chemical"	"ulcerative colitis	29	47	Pathological_formation"	"colorectal	61	71	Multi"	"interleukin 2	94	107	Gene_or_gene_product"	"mice	152	156	Organism"	"[{""token"": ""folate"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""ulcerative colitis"", ""start_span"": 29, ""end_span"": 47, ""type"": ""Pathological_formation""}, {""token"": ""colorectal"", ""start_span"": 61, ""end_span"": 71, ""type"": ""Multi""}, {""token"": ""interleukin 2"", ""start_span"": 94, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Organism""}]"
Folate supplementation may reduce the risk of colorectal dysplasia and cancer in subjects with chronic ulcerative colitis ( UC).	"Folate	0	6	Chemical"	"colorectal dysplasia	46	66	Pathological_formation"	"cancer	71	77	Cancer"	"ulcerative colitis	103	121	Pathological_formation"	"UC	124	126	Pathological_formation"	"[{""token"": ""Folate"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical""}, {""token"": ""colorectal dysplasia"", ""start_span"": 46, ""end_span"": 66, ""type"": ""Pathological_formation""}, {""token"": ""cancer"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Cancer""}, {""token"": ""ulcerative colitis"", ""start_span"": 103, ""end_span"": 121, ""type"": ""Pathological_formation""}, {""token"": ""UC"", ""start_span"": 124, ""end_span"": 126, ""type"": ""Pathological_formation""}]"
This study investigated the effects of dietary folate on the development of UC - associated colon cancer in the IL - 2 ( null) x beta ( 2) m ( null) mice.	"folate	47	53	Chemical"	"UC	76	78	Pathological_formation"	"colon cancer	92	104	Cancer"	"IL - 2	112	118	Gene_or_gene_product"	"mice	149	153	Organism"	"[{""token"": ""folate"", ""start_span"": 47, ""end_span"": 53, ""type"": ""Chemical""}, {""token"": ""UC"", ""start_span"": 76, ""end_span"": 78, ""type"": ""Pathological_formation""}, {""token"": ""colon cancer"", ""start_span"": 92, ""end_span"": 104, ""type"": ""Cancer""}, {""token"": ""IL - 2"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Organism""}]"
The incidence of high - grade lesions ( high - grade dysplasia / carcinoma in situ and invasive adenocarcinoma) in the folate - supplemented group was 46% lower than that in the control group ( 35. 3% versus 65. 1%, P = 0. 009).	"high - grade lesions	17	37	Pathological_formation"	"high - grade dysplasia	40	62	Pathological_formation"	"carcinoma	65	74	Cancer"	"adenocarcinoma	96	110	Cancer"	"folate	119	125	Chemical"	"[{""token"": ""high - grade lesions"", ""start_span"": 17, ""end_span"": 37, ""type"": ""Pathological_formation""}, {""token"": ""high - grade dysplasia"", ""start_span"": 40, ""end_span"": 62, ""type"": ""Pathological_formation""}, {""token"": ""carcinoma"", ""start_span"": 65, ""end_span"": 74, ""type"": ""Cancer""}, {""token"": ""adenocarcinoma"", ""start_span"": 96, ""end_span"": 110, ""type"": ""Cancer""}, {""token"": ""folate"", ""start_span"": 119, ""end_span"": 125, ""type"": ""Chemical""}]"
These data indicate that dietary folate supplementation at 4x the basal dietary requirement significantly suppresses UC - associated colorectal carcinogenesis in the IL - 2 ( null) x beta ( 2) m ( null) mice.	"folate	33	39	Chemical"	"UC	117	119	Pathological_formation"	"colorectal	133	143	Multi"	"IL - 2	166	172	Gene_or_gene_product"	"mice	203	207	Organism"	"[{""token"": ""folate"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Chemical""}, {""token"": ""UC"", ""start_span"": 117, ""end_span"": 119, ""type"": ""Pathological_formation""}, {""token"": ""colorectal"", ""start_span"": 133, ""end_span"": 143, ""type"": ""Multi""}, {""token"": ""IL - 2"", ""start_span"": 166, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 203, ""end_span"": 207, ""type"": ""Organism""}]"
We discuss cell lineages, proliferation and interactions of endothelial cells, pericytes and smooth muscle cells, and macrophages.	"cell	11	15	Cell"	"endothelial cells	60	77	Cell"	"pericytes	79	88	Cell"	"smooth muscle cells	93	112	Cell"	"macrophages	118	129	Cell"	"[{""token"": ""cell"", ""start_span"": 11, ""end_span"": 15, ""type"": ""Cell""}, {""token"": ""endothelial cells"", ""start_span"": 60, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""pericytes"", ""start_span"": 79, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""smooth muscle cells"", ""start_span"": 93, ""end_span"": 112, ""type"": ""Cell""}, {""token"": ""macrophages"", ""start_span"": 118, ""end_span"": 129, ""type"": ""Cell""}]"
Expression of ING4 is significantly reduced in gliomas as compared with normal human brain tissue, and the extent of reduction correlates with the progression from lower to higher grades of tumours.	"ING4	14	18	Gene_or_gene_product"	"gliomas	47	54	Cancer"	"human	79	84	Organism"	"brain tissue	85	97	Tissue"	"tumours	190	197	Cancer"	"[{""token"": ""ING4"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""gliomas"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Organism""}, {""token"": ""brain tissue"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Tissue""}, {""token"": ""tumours"", ""start_span"": 190, ""end_span"": 197, ""type"": ""Cancer""}]"
This potentiation is accompanied by up - regulation of the expression of VEGF receptors ( kinase insert domain - containing receptor [ KDR] and fms - like tyrosine kinase [ Flt - 1]).	"VEGF	73	77	Gene_or_gene_product"	"kinase insert domain - containing receptor	90	132	Gene_or_gene_product"	"KDR	135	138	Gene_or_gene_product"	"fms - like tyrosine kinase	144	170	Gene_or_gene_product"	"Flt - 1	173	180	Gene_or_gene_product"	"[{""token"": ""VEGF"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""kinase insert domain - containing receptor"", ""start_span"": 90, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""fms - like tyrosine kinase"", ""start_span"": 144, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""Flt - 1"", ""start_span"": 173, ""end_span"": 180, ""type"": ""Gene_or_gene_product""}]"
Furthermore, thrombin increases the secretion of VEGF and enhances the expression and protein synthesis of matrix metalloprotease - 9 and alpha ( v) beta ( 3) integrin in human prostate cancer PC - 3 cells.	"thrombin	13	21	Gene_or_gene_product"	"VEGF	49	53	Gene_or_gene_product"	"matrix metalloprotease - 9	107	133	Gene_or_gene_product"	"human	171	176	Organism"	"prostate cancer PC - 3 cells	177	205	Cell"	"[{""token"": ""thrombin"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloprotease - 9"", ""start_span"": 107, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 171, ""end_span"": 176, ""type"": ""Organism""}, {""token"": ""prostate cancer PC - 3 cells"", ""start_span"": 177, ""end_span"": 205, ""type"": ""Cell""}]"
NIH3T3 transfectant containing human K - ras oncogene shows enhanced metastatic activity after in vivo tumor growth or co - culture with fibroblasts.	"NIH3T3 transfectant	0	19	Cell"	"human	31	36	Organism"	"K - ras	37	44	Gene_or_gene_product"	"tumor	103	108	Cancer"	"fibroblasts	137	148	Cell"	"[{""token"": ""NIH3T3 transfectant"", ""start_span"": 0, ""end_span"": 19, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Organism""}, {""token"": ""K - ras"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Cancer""}, {""token"": ""fibroblasts"", ""start_span"": 137, ""end_span"": 148, ""type"": ""Cell""}]"
This metastatic ability was enhanced remarkably after in vivo tumor growth ( subcutaneous tumor formation in nude mice) accompanied by increased mRNA expression and gene amplification of the human - derived K - ras oncogene, while it declined gradually as the passage number increased in vitro, with corresponding decreases of gene amplification and mRNA expression.	"tumor	62	67	Cancer"	"tumor	90	95	Cancer"	"nude mice	109	118	Organism"	"human	191	196	Organism"	"K - ras	207	214	Gene_or_gene_product"	"[{""token"": ""tumor"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Cancer""}, {""token"": ""nude mice"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 191, ""end_span"": 196, ""type"": ""Organism""}, {""token"": ""K - ras"", ""start_span"": 207, ""end_span"": 214, ""type"": ""Gene_or_gene_product""}]"
Lactoferrin enhances Fas expression and apoptosis in the colon mucosa of azoxymethane - treated rats.	"Lactoferrin	0	11	Gene_or_gene_product"	"Fas	21	24	Gene_or_gene_product"	"colon mucosa	57	69	Multi"	"azoxymethane	73	85	Chemical"	"rats	96	100	Organism"	"[{""token"": ""Lactoferrin"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""colon mucosa"", ""start_span"": 57, ""end_span"": 69, ""type"": ""Multi""}, {""token"": ""azoxymethane"", ""start_span"": 73, ""end_span"": 85, ""type"": ""Chemical""}, {""token"": ""rats"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Organism""}]"
Overexpression of DLC1 but not DLC1 - Ser88Ala mutant promotes cancerous properties of breast cancer cells.	"DLC1	18	22	Gene_or_gene_product"	"DLC1	31	35	Gene_or_gene_product"	"Ser88Ala	38	46	Amino_acid"	"cancerous	63	72	Cancer"	"breast cancer cells	87	106	Cell"	"[{""token"": ""DLC1"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""DLC1"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ser88Ala"", ""start_span"": 38, ""end_span"": 46, ""type"": ""Amino_acid""}, {""token"": ""cancerous"", ""start_span"": 63, ""end_span"": 72, ""type"": ""Cancer""}, {""token"": ""breast cancer cells"", ""start_span"": 87, ""end_span"": 106, ""type"": ""Cell""}]"
However, how the tumor suppressive functions of p53 become concerted with the extracellular cues arriving at the cell surface during tissue homeostasis, remains largely unknown.	"tumor	17	22	Cancer"	"p53	48	51	Gene_or_gene_product"	"extracellular	78	91	Immaterial_anatomical_entity"	"cell surface	113	125	Cellular_component"	"tissue	133	139	Tissue"	"[{""token"": ""tumor"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular"", ""start_span"": 78, ""end_span"": 91, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""cell surface"", ""start_span"": 113, ""end_span"": 125, ""type"": ""Cellular_component""}, {""token"": ""tissue"", ""start_span"": 133, ""end_span"": 139, ""type"": ""Tissue""}]"
We hypothesized that IGF - 1 - transfected smooth muscle cells ( SMCs) would enhance cell survival and improve engraftment after cell transplantation.	"IGF - 1	21	28	Gene_or_gene_product"	"smooth muscle cells	43	62	Cell"	"SMCs	65	69	Cell"	"cell	85	89	Cell"	"cell	129	133	Cell"	"[{""token"": ""IGF - 1"", ""start_span"": 21, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""smooth muscle cells"", ""start_span"": 43, ""end_span"": 62, ""type"": ""Cell""}, {""token"": ""SMCs"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Cell""}]"
The IGF - 1 gene was transfected into male SMCs and compared with SMCs transfected with a plasmid vector ( vector control) and nontransfected SMCs ( cell control).	"IGF - 1	4	11	Gene_or_gene_product"	"SMCs	43	47	Cell"	"SMCs	66	70	Cell"	"SMCs	142	146	Cell"	"cell	149	153	Cell"	"[{""token"": ""IGF - 1"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""SMCs"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""SMCs"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Cell""}, {""token"": ""SMCs"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Cell""}]"
IGF - 1 - transfected cells demonstrated greater cell proliferation, stimulated angiogenesis, and decreased caspase - 3 activity after simulated ischemia and reperfusion ( P less than 0. 05 for all groups compared with vector or cell controls).	"IGF - 1	0	7	Gene_or_gene_product"	"cells	22	27	Cell"	"cell	49	53	Cell"	"caspase - 3	108	119	Gene_or_gene_product"	"cell	229	233	Cell"	"[{""token"": ""IGF - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""caspase - 3"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 229, ""end_span"": 233, ""type"": ""Cell""}]"
After GM - CSF or IL - 3, a 1. 2 - to 2. 4 - fold increase in S - phase cells was observed in nine of 14 GM - CSF and seven of 11 IL - 3 cases.	"GM - CSF	6	14	Gene_or_gene_product"	"IL - 3	18	24	Gene_or_gene_product"	"cells	72	77	Cell"	"GM - CSF	105	113	Gene_or_gene_product"	"IL - 3	130	136	Gene_or_gene_product"	"[{""token"": ""GM - CSF"", ""start_span"": 6, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 3"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""GM - CSF"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 3"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}]"
As a consequence, these tumors generate more lactate, which is effluxed from cells by monocarboxylate transporters ( MCTs).	"tumors	24	30	Cancer"	"lactate	45	52	Chemical"	"cells	77	82	Cell"	"monocarboxylate transporters	86	114	Gene_or_gene_product"	"MCTs	117	121	Gene_or_gene_product"	"[{""token"": ""tumors"", ""start_span"": 24, ""end_span"": 30, ""type"": ""Cancer""}, {""token"": ""lactate"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Cell""}, {""token"": ""monocarboxylate transporters"", ""start_span"": 86, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""MCTs"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}]"
RESULTS: MCT 1 and 2 were the primary isoforms expressed in human glioblastoma multiforme and glioma - derived cell lines.	"MCT 1	9	14	Gene_or_gene_product"	"2	19	20	Gene_or_gene_product"	"human	60	65	Organism"	"glioblastoma multiforme	66	89	Cell"	"glioma - derived cell lines	94	121	Cell"	"[{""token"": ""MCT 1"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""2"", ""start_span"": 19, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Organism""}, {""token"": ""glioblastoma multiforme"", ""start_span"": 66, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""glioma - derived cell lines"", ""start_span"": 94, ""end_span"": 121, ""type"": ""Cell""}]"
2 - methoxyestradiol inhibits hypoxia - inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma.	"2 - methoxyestradiol	0	20	Chemical"	"hypoxia - inducible factor 1alpha	30	63	Gene_or_gene_product"	"tumor	65	70	Cancer"	"paclitaxel	109	119	Chemical"	"head and neck squamous cell carcinoma	132	169	Cancer"	"[{""token"": ""2 - methoxyestradiol"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Chemical""}, {""token"": ""hypoxia - inducible factor 1alpha"", ""start_span"": 30, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Cancer""}, {""token"": ""paclitaxel"", ""start_span"": 109, ""end_span"": 119, ""type"": ""Chemical""}, {""token"": ""head and neck squamous cell carcinoma"", ""start_span"": 132, ""end_span"": 169, ""type"": ""Cancer""}]"
2 - Methoxyestradiol ( 2ME2) is a natural compound with HIF - 1alpha inhibitory activity that is currently being evaluated in phase 1 and 2 clinical trials for advanced solid tumors and multiple myeloma.	"2 - Methoxyestradiol	0	20	Chemical"	"2ME2	23	27	Chemical"	"HIF - 1alpha	56	68	Gene_or_gene_product"	"solid tumors	169	181	Cancer"	"myeloma	195	202	Cancer"	"[{""token"": ""2 - Methoxyestradiol"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Chemical""}, {""token"": ""2ME2"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Chemical""}, {""token"": ""HIF - 1alpha"", ""start_span"": 56, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""solid tumors"", ""start_span"": 169, ""end_span"": 181, ""type"": ""Cancer""}, {""token"": ""myeloma"", ""start_span"": 195, ""end_span"": 202, ""type"": ""Cancer""}]"
2ME2 resulted in decreased nuclear HIF - 1alpha - binding activity and affected the expression of downstream genes, such as bid, a proapoptotic bcl - 2 family member, and vascular endothelial growth factor, a proangiogenic cytokine.	"2ME2	0	4	Chemical"	"HIF - 1alpha	35	47	Gene_or_gene_product"	"bid	124	127	Gene_or_gene_product"	"bcl - 2	144	151	Gene_or_gene_product"	"vascular endothelial growth factor	171	205	Gene_or_gene_product"	"[{""token"": ""2ME2"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""HIF - 1alpha"", ""start_span"": 35, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""bid"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""bcl - 2"", ""start_span"": 144, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 171, ""end_span"": 205, ""type"": ""Gene_or_gene_product""}]"
HIF - 2alpha expression in human fetal paraganglia and neuroblastoma: relation to sympathetic differentiation, glucose deficiency, and hypoxia.	"HIF - 2alpha	0	12	Gene_or_gene_product"	"human	27	32	Organism"	"fetal paraganglia	33	50	Cell"	"neuroblastoma	55	68	Cancer"	"glucose	111	118	Chemical"	"[{""token"": ""HIF - 2alpha"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Organism""}, {""token"": ""fetal paraganglia"", ""start_span"": 33, ""end_span"": 50, ""type"": ""Cell""}, {""token"": ""neuroblastoma"", ""start_span"": 55, ""end_span"": 68, ""type"": ""Cancer""}, {""token"": ""glucose"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Chemical""}]"
HIFs are also expressed during normal development; for example, HIF - 2alpha is specifically expressed and appears to be involved in the development of the murine sympathetic nervous system ( SNS).	"HIFs	0	4	Gene_or_gene_product"	"HIF - 2alpha	64	76	Gene_or_gene_product"	"murine	156	162	Organism"	"sympathetic nervous system	163	189	Anatomical_system"	"SNS	192	195	Anatomical_system"	"[{""token"": ""HIFs"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 2alpha"", ""start_span"": 64, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine"", ""start_span"": 156, ""end_span"": 162, ""type"": ""Organism""}, {""token"": ""sympathetic nervous system"", ""start_span"": 163, ""end_span"": 189, ""type"": ""Anatomical_system""}, {""token"": ""SNS"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Anatomical_system""}]"
Tissue factor ( TF) is an essential initiator of blood coagulation that is expressed in various stages of atherosclerotic lesions in humans and other animals.	"Tissue factor	0	13	Gene_or_gene_product"	"TF	16	18	Gene_or_gene_product"	"blood	49	54	Organism_substance"	"atherosclerotic lesions	106	129	Pathological_formation"	"humans	133	139	Organism"	"[{""token"": ""Tissue factor"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""TF"", ""start_span"": 16, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Organism_substance""}, {""token"": ""atherosclerotic lesions"", ""start_span"": 106, ""end_span"": 129, ""type"": ""Pathological_formation""}, {""token"": ""humans"", ""start_span"": 133, ""end_span"": 139, ""type"": ""Organism""}]"
Angiogenin is up - regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival.	"Angiogenin	0	10	Gene_or_gene_product"	"nucleus	36	43	Cellular_component"	"cytoplasm	48	57	Organism_substance"	"human	61	66	Organism"	"breast carcinoma	75	91	Cancer"	"[{""token"": ""Angiogenin"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""nucleus"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Cellular_component""}, {""token"": ""cytoplasm"", ""start_span"": 48, ""end_span"": 57, ""type"": ""Organism_substance""}, {""token"": ""human"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Organism""}, {""token"": ""breast carcinoma"", ""start_span"": 75, ""end_span"": 91, ""type"": ""Cancer""}]"
We show here that p10, which arises from the use of an alternative splice donor site within intron 1, is conserved in the mouse genome and is widely expressed in mouse tissues.	"p10	18	21	Gene_or_gene_product"	"intron 1	92	100	Cellular_component"	"mouse	122	127	Organism"	"mouse	162	167	Organism"	"tissues	168	175	Tissue"	"[{""token"": ""p10"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""intron 1"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Cellular_component""}, {""token"": ""mouse"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Organism""}, {""token"": ""mouse"", ""start_span"": 162, ""end_span"": 167, ""type"": ""Organism""}, {""token"": ""tissues"", ""start_span"": 168, ""end_span"": 175, ""type"": ""Tissue""}]"
These results indicate that the INK4B locus, similarly to INK4A - ARF, harbors two different splicing variants that can be involved in the regulation of both the p53 and retinoblastoma pathways, the two major molecular pathways in tumor suppression.	"INK4B	32	37	Gene_or_gene_product"	"INK4A - ARF	58	69	Gene_or_gene_product"	"p53	162	165	Gene_or_gene_product"	"retinoblastoma	170	184	Gene_or_gene_product"	"tumor	231	236	Cancer"	"[{""token"": ""INK4B"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""INK4A - ARF"", ""start_span"": 58, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 162, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}, {""token"": ""retinoblastoma"", ""start_span"": 170, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 231, ""end_span"": 236, ""type"": ""Cancer""}]"
OBJECTIVE: To determine the impact of thalidomide and angiostatin on tumor growth, angiogenesis, and apoptosis in a xenograft model of cervical cancer.	"thalidomide	38	49	Chemical"	"angiostatin	54	65	Gene_or_gene_product"	"tumor	69	74	Cancer"	"xenograft	116	125	Cancer"	"cervical cancer	135	150	Cancer"	"[{""token"": ""thalidomide"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""angiostatin"", ""start_span"": 54, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Cancer""}, {""token"": ""xenograft"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Cancer""}, {""token"": ""cervical cancer"", ""start_span"": 135, ""end_span"": 150, ""type"": ""Cancer""}]"
METHODS: Human umbilical endothelial cells were treated with angiostatin or thalidomide and bFGF - induced proliferation was assessed with the MTT assay.	"Human	9	14	Organism"	"endothelial cells	25	42	Cell"	"angiostatin	61	72	Gene_or_gene_product"	"thalidomide	76	87	Chemical"	"bFGF	92	96	Gene_or_gene_product"	"[{""token"": ""Human"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Organism""}, {""token"": ""endothelial cells"", ""start_span"": 25, ""end_span"": 42, ""type"": ""Cell""}, {""token"": ""angiostatin"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""thalidomide"", ""start_span"": 76, ""end_span"": 87, ""type"": ""Chemical""}, {""token"": ""bFGF"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}]"
CONCLUSIONS: Angiostatin and thalidomide inhibit tumor growth, angiogenesis, and induce apoptosis in this xenograft model of cervical cancer.	"Angiostatin	13	24	Gene_or_gene_product"	"thalidomide	29	40	Chemical"	"tumor	49	54	Cancer"	"xenograft	106	115	Cancer"	"cervical cancer	125	140	Cancer"	"[{""token"": ""Angiostatin"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""thalidomide"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Cancer""}, {""token"": ""xenograft"", ""start_span"": 106, ""end_span"": 115, ""type"": ""Cancer""}, {""token"": ""cervical cancer"", ""start_span"": 125, ""end_span"": 140, ""type"": ""Cancer""}]"
Blood vessels, capillaries, and endothelial pseudopods were found at greater than 100 microns from the capsule ( subcortex).	"Blood vessels	0	13	Multi"	"capillaries	15	26	Tissue"	"endothelial pseudopods	32	54	Cellular_component"	"capsule	103	110	Cancer"	"subcortex	113	122	Cancer"	"[{""token"": ""Blood vessels"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Multi""}, {""token"": ""capillaries"", ""start_span"": 15, ""end_span"": 26, ""type"": ""Tissue""}, {""token"": ""endothelial pseudopods"", ""start_span"": 32, ""end_span"": 54, ""type"": ""Cellular_component""}, {""token"": ""capsule"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Cancer""}, {""token"": ""subcortex"", ""start_span"": 113, ""end_span"": 122, ""type"": ""Cancer""}]"
Here, we provide an overview of the many roles of RUNX1 in hematopoietic self - renewal and differentiation and summarize the information that is currently available on the many mechanisms of RUNX1 deregulation in human leukemia.	"RUNX1	50	55	Gene_or_gene_product"	"hematopoietic	59	72	Cell"	"RUNX1	192	197	Gene_or_gene_product"	"human	214	219	Organism"	"leukemia	220	228	Cancer"	"[{""token"": ""RUNX1"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""hematopoietic"", ""start_span"": 59, ""end_span"": 72, ""type"": ""Cell""}, {""token"": ""RUNX1"", ""start_span"": 192, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 214, ""end_span"": 219, ""type"": ""Organism""}, {""token"": ""leukemia"", ""start_span"": 220, ""end_span"": 228, ""type"": ""Cancer""}]"
HKa and D5 reduce the localization of paxillin to the focal adhesions after S1P and VEGF stimulation.	"HKa	0	3	Gene_or_gene_product"	"paxillin	38	46	Gene_or_gene_product"	"focal adhesions	54	69	Cellular_component"	"S1P	76	79	Gene_or_gene_product"	"VEGF	84	88	Gene_or_gene_product"	"[{""token"": ""HKa"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""paxillin"", ""start_span"": 38, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""focal adhesions"", ""start_span"": 54, ""end_span"": 69, ""type"": ""Cellular_component""}, {""token"": ""S1P"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}]"
Therefore we suggest that HKa through its D5 domain alters P13 - kinase - Akt signaling to inhibit endothelial cell migration through alterations in the focal adhesions.	"HKa	26	29	Gene_or_gene_product"	"P13 - kinase	59	71	Gene_or_gene_product"	"Akt	74	77	Gene_or_gene_product"	"endothelial cell	99	115	Cell"	"focal adhesions	153	168	Cellular_component"	"[{""token"": ""HKa"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""P13 - kinase"", ""start_span"": 59, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 99, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""focal adhesions"", ""start_span"": 153, ""end_span"": 168, ""type"": ""Cellular_component""}]"
Effect of thalidomide affecting VEGF secretion, cell migration, adhesion and capillary tube formation of human endothelial EA. hy 926 cells.	"thalidomide	10	21	Chemical"	"VEGF	32	36	Gene_or_gene_product"	"cell	48	52	Cell"	"capillary tube	77	91	Tissue"	"human	105	110	Organism"	"[{""token"": ""thalidomide"", ""start_span"": 10, ""end_span"": 21, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""capillary tube"", ""start_span"": 77, ""end_span"": 91, ""type"": ""Tissue""}, {""token"": ""human"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Organism""}]"
We have evaluated the effect of thalidomide on VEGF secretion, cell migration, adhesion as well as in capillary formation of human endothelial cell line EA. hy 926.	"thalidomide	32	43	Chemical"	"VEGF	47	51	Gene_or_gene_product"	"cell	63	67	Cell"	"capillary	102	111	Tissue"	"human	125	130	Organism"	"[{""token"": ""thalidomide"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""capillary"", ""start_span"": 102, ""end_span"": 111, ""type"": ""Tissue""}, {""token"": ""human"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Organism""}]"
Thalidomide at the concentrations of 0. 01 microM and 10 microM inhibited VEGF secretion into supernatants, decreased the number of formed capillary tubes and increased cell adhesion to collagen.	"Thalidomide	0	11	Chemical"	"VEGF	74	78	Gene_or_gene_product"	"capillary tubes	139	154	Tissue"	"cell	169	173	Cell"	"collagen	186	194	Gene_or_gene_product"	"[{""token"": ""Thalidomide"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""capillary tubes"", ""start_span"": 139, ""end_span"": 154, ""type"": ""Tissue""}, {""token"": ""cell"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Cell""}, {""token"": ""collagen"", ""start_span"": 186, ""end_span"": 194, ""type"": ""Gene_or_gene_product""}]"
This study aims to verify the relationship between p63 expression and several clinicopathological features and tumor markers of clinical significance in breast pathology including key regulators of the cell cycle, oncogenes, apoptosis - related proteins, metalloproteinases and their inhibitors.	"p63	51	54	Gene_or_gene_product"	"tumor	111	116	Cancer"	"breast pathology	153	169	Cancer"	"cell	202	206	Cell"	"metalloproteinases	255	273	Gene_or_gene_product"	"[{""token"": ""p63"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Cancer""}, {""token"": ""breast pathology"", ""start_span"": 153, ""end_span"": 169, ""type"": ""Cancer""}, {""token"": ""cell"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Cell""}, {""token"": ""metalloproteinases"", ""start_span"": 255, ""end_span"": 273, ""type"": ""Gene_or_gene_product""}]"
Thrombospondin - 1 ( TSP - 1) is a potent angiogenesis inhibitor, and down - regulation of TSP - 1 has been suggested to alter tumor growth by modulating angiogenesis in a variety of tumor types.	"Thrombospondin - 1	0	18	Gene_or_gene_product"	"TSP - 1	21	28	Gene_or_gene_product"	"TSP - 1	91	98	Gene_or_gene_product"	"tumor	127	132	Cancer"	"tumor	183	188	Cancer"	"[{""token"": ""Thrombospondin - 1"", ""start_span"": 0, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 1"", ""start_span"": 21, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 1"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 127, ""end_span"": 132, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 183, ""end_span"": 188, ""type"": ""Cancer""}]"
Expression of TSP - 1 is up - regulated by the tumor suppressor gene, p53, and down - regulated by oncogenes such as Myc and Ras.	"TSP - 1	14	21	Gene_or_gene_product"	"tumor	47	52	Cancer"	"p53	70	73	Gene_or_gene_product"	"Myc	117	120	Gene_or_gene_product"	"Ras	125	128	Gene_or_gene_product"	"[{""token"": ""TSP - 1"", ""start_span"": 14, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""Myc"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ras"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}]"
Low density lipoprotein receptor - related protein - 1 ( LRP - 1) is a catabolic receptor for extracellular matrix ( ECM) structural proteins and for proteins that bind to ECM.	"Low density lipoprotein receptor - related protein - 1	0	54	Gene_or_gene_product"	"LRP - 1	57	64	Gene_or_gene_product"	"extracellular matrix	94	114	Cellular_component"	"ECM	117	120	Cellular_component"	"ECM	172	175	Cellular_component"	"[{""token"": ""Low density lipoprotein receptor - related protein - 1"", ""start_span"": 0, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""LRP - 1"", ""start_span"": 57, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular matrix"", ""start_span"": 94, ""end_span"": 114, ""type"": ""Cellular_component""}, {""token"": ""ECM"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Cellular_component""}, {""token"": ""ECM"", ""start_span"": 172, ""end_span"": 175, ""type"": ""Cellular_component""}]"
The collagen receptor, uPAR - AP / Endo - 180, is also increased in LRP - 1 - deficient MEFs.	"collagen	4	12	Gene_or_gene_product"	"uPAR - AP	23	32	Gene_or_gene_product"	"Endo - 180	35	45	Gene_or_gene_product"	"LRP - 1	68	75	Gene_or_gene_product"	"MEFs	88	92	Cell"	"[{""token"": ""collagen"", ""start_span"": 4, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""uPAR - AP"", ""start_span"": 23, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""Endo - 180"", ""start_span"": 35, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""LRP - 1"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEFs"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Cell""}]"
The oxidative burst of neutrophils stimulated by Annexin V was reduced in the saline - treated MTX group, while L - Car abolished this inhibition.	"neutrophils	23	34	Cell"	"Annexin V	49	58	Gene_or_gene_product"	"saline	78	84	Chemical"	"MTX	95	98	Chemical"	"L - Car	112	119	Chemical"	"[{""token"": ""neutrophils"", ""start_span"": 23, ""end_span"": 34, ""type"": ""Cell""}, {""token"": ""Annexin V"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""saline"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Chemical""}, {""token"": ""MTX"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Chemical""}, {""token"": ""L - Car"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Chemical""}]"
Previously we observed that neural cell adhesion molecule ( NCAM) deficiency in beta tumor cells facilitates metastasis into distant organs and local lymph nodes.	"neural cell adhesion molecule	28	57	Gene_or_gene_product"	"NCAM	60	64	Gene_or_gene_product"	"beta tumor cells	80	96	Cell"	"organs	133	139	Organ"	"lymph nodes	150	161	Multi"	"[{""token"": ""neural cell adhesion molecule"", ""start_span"": 28, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""NCAM"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta tumor cells"", ""start_span"": 80, ""end_span"": 96, ""type"": ""Cell""}, {""token"": ""organs"", ""start_span"": 133, ""end_span"": 139, ""type"": ""Organ""}, {""token"": ""lymph nodes"", ""start_span"": 150, ""end_span"": 161, ""type"": ""Multi""}]"
To directly address whether pericyte dysfunction increases the metastatic potential of solid tumors, we studied beta cell tumorigenesis in primary pericyte - deficient Pdgfb ( ret / ret) mice.	"pericyte	28	36	Cell"	"solid tumors	87	99	Cancer"	"beta cell	112	121	Cell"	"pericyte	147	155	Cell"	"Pdgfb	168	173	Gene_or_gene_product"	"[{""token"": ""pericyte"", ""start_span"": 28, ""end_span"": 36, ""type"": ""Cell""}, {""token"": ""solid tumors"", ""start_span"": 87, ""end_span"": 99, ""type"": ""Cancer""}, {""token"": ""beta cell"", ""start_span"": 112, ""end_span"": 121, ""type"": ""Cell""}, {""token"": ""pericyte"", ""start_span"": 147, ""end_span"": 155, ""type"": ""Cell""}, {""token"": ""Pdgfb"", ""start_span"": 168, ""end_span"": 173, ""type"": ""Gene_or_gene_product""}]"
This resulted in beta tumor cell metastases in distant organs and local lymph nodes, demonstrating a role for pericytes in limiting tumor cell metastasis.	"beta tumor cell	17	32	Cell"	"organs	55	61	Organ"	"lymph nodes	72	83	Multi"	"pericytes	110	119	Cell"	"tumor cell	132	142	Cell"	"[{""token"": ""beta tumor cell"", ""start_span"": 17, ""end_span"": 32, ""type"": ""Cell""}, {""token"": ""organs"", ""start_span"": 55, ""end_span"": 61, ""type"": ""Organ""}, {""token"": ""lymph nodes"", ""start_span"": 72, ""end_span"": 83, ""type"": ""Multi""}, {""token"": ""pericytes"", ""start_span"": 110, ""end_span"": 119, ""type"": ""Cell""}, {""token"": ""tumor cell"", ""start_span"": 132, ""end_span"": 142, ""type"": ""Cell""}]"
These data support a new model for how tumor cells trigger metastasis by perturbing pericyte - endothelial cell - cell interactions.	"tumor cells	39	50	Cell"	"pericyte	84	92	Cell"	"endothelial	95	106	Cell"	"cell	107	111	Cell"	"cell	114	118	Cell"	"[{""token"": ""tumor cells"", ""start_span"": 39, ""end_span"": 50, ""type"": ""Cell""}, {""token"": ""pericyte"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""endothelial"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Cell""}]"
The low apoptosis phenotype is dominant in Runx2 / MYC tumors, indicating that Runx2 confers a potent survival advantage to MYC - expressing tumor cells.	"Runx2	43	48	Gene_or_gene_product"	"MYC	51	54	Gene_or_gene_product"	"Runx2	79	84	Gene_or_gene_product"	"MYC	124	127	Gene_or_gene_product"	"tumor cells	141	152	Cell"	"[{""token"": ""Runx2"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""MYC"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""Runx2"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""MYC"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cells"", ""start_span"": 141, ""end_span"": 152, ""type"": ""Cell""}]"
Inhibition of the mammalian target of rapamycin ( mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel.	"mammalian target of rapamycin	18	47	Gene_or_gene_product"	"mTOR	50	54	Gene_or_gene_product"	"rapamycin	59	68	Chemical"	"CaSki cells	99	110	Cell"	"paclitaxel	114	124	Chemical"	"[{""token"": ""mammalian target of rapamycin"", ""start_span"": 18, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""rapamycin"", ""start_span"": 59, ""end_span"": 68, ""type"": ""Chemical""}, {""token"": ""CaSki cells"", ""start_span"": 99, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""paclitaxel"", ""start_span"": 114, ""end_span"": 124, ""type"": ""Chemical""}]"
Pre - treatment with rapamycin inhibited activation of mTOR signalling and significantly enhanced the sensitivity of CaSki cells to paclitaxel by increasing apoptotic cell death.	"rapamycin	21	30	Chemical"	"mTOR	55	59	Gene_or_gene_product"	"CaSki cells	117	128	Cell"	"paclitaxel	132	142	Chemical"	"cell	167	171	Cell"	"[{""token"": ""rapamycin"", ""start_span"": 21, ""end_span"": 30, ""type"": ""Chemical""}, {""token"": ""mTOR"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""CaSki cells"", ""start_span"": 117, ""end_span"": 128, ""type"": ""Cell""}, {""token"": ""paclitaxel"", ""start_span"": 132, ""end_span"": 142, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Cell""}]"
This review will summarize the current position of CECs, EPCs and EMPs in cell biology terms, with particular emphasis on their relationship to malignant disease.	"CECs	51	55	Cell"	"EPCs	57	61	Cell"	"EMPs	66	70	Cellular_component"	"cell	74	78	Cell"	"malignant disease	144	161	Cancer"	"[{""token"": ""CECs"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""EPCs"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Cell""}, {""token"": ""EMPs"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""malignant disease"", ""start_span"": 144, ""end_span"": 161, ""type"": ""Cancer""}]"
BACKGROUND: Abnormal hemostasis in cancer patients has previously been described, however the correlation between the plasma fibrinogen level and cancer metastasis and prognosis has not been reported in a large - scale clinical study.	"cancer	35	41	Cancer"	"patients	42	50	Organism"	"plasma	118	124	Organism_substance"	"fibrinogen	125	135	Gene_or_gene_product"	"cancer	146	152	Cancer"	"[{""token"": ""cancer"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 42, ""end_span"": 50, ""type"": ""Organism""}, {""token"": ""plasma"", ""start_span"": 118, ""end_span"": 124, ""type"": ""Organism_substance""}, {""token"": ""fibrinogen"", ""start_span"": 125, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 146, ""end_span"": 152, ""type"": ""Cancer""}]"
Patients with hyperfibrinogenemia showed worse clinical outcome in T2 gastric cancer, however, there was no correlation of plasma fibrinogen level with prognosis in T3 / T4 gastric cancer.	"Patients	0	8	Organism"	"T2 gastric cancer	67	84	Cancer"	"plasma	123	129	Organism_substance"	"fibrinogen	130	140	Gene_or_gene_product"	"T3 / T4 gastric cancer	165	187	Cancer"	"[{""token"": ""Patients"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""T2 gastric cancer"", ""start_span"": 67, ""end_span"": 84, ""type"": ""Cancer""}, {""token"": ""plasma"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Organism_substance""}, {""token"": ""fibrinogen"", ""start_span"": 130, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""T3 / T4 gastric cancer"", ""start_span"": 165, ""end_span"": 187, ""type"": ""Cancer""}]"
CONCLUSIONS: Our findings suggest that transcriptional repression of HRK is caused by promoter hypermethylation in PCNSL, and that the loss of HRK associated with the methylation profile of other genes is a potential step in the modulation of cellular death by apoptosis during PCNSL tumorigenesis.	"HRK	69	72	Gene_or_gene_product"	"PCNSL	115	120	Cancer"	"HRK	143	146	Gene_or_gene_product"	"cellular	243	251	Cell"	"PCNSL	278	283	Cancer"	"[{""token"": ""HRK"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""PCNSL"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Cancer""}, {""token"": ""HRK"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 243, ""end_span"": 251, ""type"": ""Cell""}, {""token"": ""PCNSL"", ""start_span"": 278, ""end_span"": 283, ""type"": ""Cancer""}]"
Differential mechanisms of radiosensitization by 2 - deoxy - D - glucose in the monolayers and multicellular spheroids of a human glioma cell line.	"2 - deoxy - D - glucose	49	72	Chemical"	"monolayers	80	90	Cell"	"multicellular spheroids	95	118	Cell"	"human	124	129	Organism"	"glioma cell line	130	146	Cell"	"[{""token"": ""2 - deoxy - D - glucose"", ""start_span"": 49, ""end_span"": 72, ""type"": ""Chemical""}, {""token"": ""monolayers"", ""start_span"": 80, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""multicellular spheroids"", ""start_span"": 95, ""end_span"": 118, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Organism""}, {""token"": ""glioma cell line"", ""start_span"": 130, ""end_span"": 146, ""type"": ""Cell""}]"
Presence of 2 - DG ( 5 mM) for 2 - 4 h inhibited the glucose usage and lactate production by 70% in spheroids, while a 35% reduction was observed in monolayer cells.	"2 - DG	12	18	Chemical"	"glucose	53	60	Chemical"	"lactate	71	78	Chemical"	"spheroids	100	109	Cell"	"monolayer cells	149	164	Cell"	"[{""token"": ""2 - DG"", ""start_span"": 12, ""end_span"": 18, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""lactate"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Chemical""}, {""token"": ""spheroids"", ""start_span"": 100, ""end_span"": 109, ""type"": ""Cell""}, {""token"": ""monolayer cells"", ""start_span"": 149, ""end_span"": 164, ""type"": ""Cell""}]"
METHODS: Immunohistochemistry was used to determine the distribution of opticin in normal human CBE, and in hyperplastic and neoplastic CBE lesions.	"opticin	72	79	Gene_or_gene_product"	"human	90	95	Organism"	"CBE	96	99	Tissue"	"hyperplastic	108	120	Cancer"	"neoplastic CBE lesions	125	147	Cancer"	"[{""token"": ""opticin"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Organism""}, {""token"": ""CBE"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Tissue""}, {""token"": ""hyperplastic"", ""start_span"": 108, ""end_span"": 120, ""type"": ""Cancer""}, {""token"": ""neoplastic CBE lesions"", ""start_span"": 125, ""end_span"": 147, ""type"": ""Cancer""}]"
By contrast, none of eight neoplastic lesions ( two adenoma and six adenocarcinoma) of CBE stained for opticin.	"neoplastic lesions	27	45	Cancer"	"adenoma	52	59	Cancer"	"adenocarcinoma	68	82	Cancer"	"CBE	87	90	Tissue"	"opticin	103	110	Gene_or_gene_product"	"[{""token"": ""neoplastic lesions"", ""start_span"": 27, ""end_span"": 45, ""type"": ""Cancer""}, {""token"": ""adenoma"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Cancer""}, {""token"": ""adenocarcinoma"", ""start_span"": 68, ""end_span"": 82, ""type"": ""Cancer""}, {""token"": ""CBE"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Tissue""}, {""token"": ""opticin"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}]"
Collagen - poly glycolic acid hybrid matrix with basic fibroblast growth factor accelerated angiogenesis and granulation tissue formation in diabetic mice.	"Collagen	0	8	Gene_or_gene_product"	"poly glycolic acid	11	29	Chemical"	"basic fibroblast growth factor	49	79	Gene_or_gene_product"	"granulation tissue	109	127	Tissue"	"mice	150	154	Organism"	"[{""token"": ""Collagen"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""poly glycolic acid"", ""start_span"": 11, ""end_span"": 29, ""type"": ""Chemical""}, {""token"": ""basic fibroblast growth factor"", ""start_span"": 49, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""granulation tissue"", ""start_span"": 109, ""end_span"": 127, ""type"": ""Tissue""}, {""token"": ""mice"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Organism""}]"
Combined mutations of p27 ( - / -) and Men1 ( + / -), in contrast, did not exhibit noticeable synergistic stimulation of Rb kinase activity, cell proliferation, and tumor growth.	"p27	22	25	Gene_or_gene_product"	"Men1	39	43	Gene_or_gene_product"	"Rb	121	123	Gene_or_gene_product"	"cell	141	145	Cell"	"tumor	165	170	Cancer"	"[{""token"": ""p27"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""Men1"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rb"", ""start_span"": 121, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Cancer""}]"
These results demonstrate that functional collaboration exists between p18 and Men1 and suggest that Men1 may regulate additional factor ( s) that interact with p18 and p27 differently.	"p18	71	74	Gene_or_gene_product"	"Men1	79	83	Gene_or_gene_product"	"Men1	101	105	Gene_or_gene_product"	"p18	161	164	Gene_or_gene_product"	"p27	169	172	Gene_or_gene_product"	"[{""token"": ""p18"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""Men1"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""Men1"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""p18"", ""start_span"": 161, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""p27"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}]"
Juice and peels, for example, possess potent antioxidant properties, while juice, peel and oil are all weakly estrogenic and heuristically of interest for the treatment of menopausal symptoms and sequellae.	"Juice	0	5	Organism_substance"	"peels	10	15	Tissue"	"juice	75	80	Organism_substance"	"peel	82	86	Tissue"	"oil	91	94	Organism_substance"	"[{""token"": ""Juice"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism_substance""}, {""token"": ""peels"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Tissue""}, {""token"": ""juice"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Organism_substance""}, {""token"": ""peel"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Tissue""}, {""token"": ""oil"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Organism_substance""}]"
20 - Hydroxyeicosatetraenoic acid ( 20 - HETE) is formed by the omega - hydroxylation of arachidonic acid by cytochrome P450 4A and 4F enzymes, and it induces angiogenic responses in vivo.	"20 - Hydroxyeicosatetraenoic acid	0	33	Chemical"	"20 - HETE	36	45	Chemical"	"arachidonic acid	89	105	Chemical"	"cytochrome P450 4A	109	127	Gene_or_gene_product"	"4F	132	134	Gene_or_gene_product"	"[{""token"": ""20 - Hydroxyeicosatetraenoic acid"", ""start_span"": 0, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""20 - HETE"", ""start_span"": 36, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""arachidonic acid"", ""start_span"": 89, ""end_span"": 105, ""type"": ""Chemical""}, {""token"": ""cytochrome P450 4A"", ""start_span"": 109, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""4F"", ""start_span"": 132, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}]"
Relationship of cellular immunity, cytokines and CRP with clinical course in breast cancer patients with endocrine - dependent distant metastases treated with immunotherapy.	"cellular	16	24	Cell"	"CRP	49	52	Gene_or_gene_product"	"breast cancer	77	90	Cancer"	"patients	91	99	Organism"	"endocrine	105	114	Anatomical_system"	"[{""token"": ""cellular"", ""start_span"": 16, ""end_span"": 24, ""type"": ""Cell""}, {""token"": ""CRP"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer"", ""start_span"": 77, ""end_span"": 90, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 91, ""end_span"": 99, ""type"": ""Organism""}, {""token"": ""endocrine"", ""start_span"": 105, ""end_span"": 114, ""type"": ""Anatomical_system""}]"
Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis.	"Trib1	0	5	Gene_or_gene_product"	"Evi1	10	14	Gene_or_gene_product"	"Hoxa	30	34	Gene_or_gene_product"	"Meis1	39	44	Gene_or_gene_product"	"myeloid	48	55	Cell"	"[{""token"": ""Trib1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""Evi1"", ""start_span"": 10, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hoxa"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""Meis1"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""myeloid"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Cell""}]"
The present study evaluated the effect of cumene hydroperoxide ( Cum - OOH) on the induction of activator protein - 1 ( AP - 1), which is linked to the expression of genes regulating cell proliferation, growth and transformation.	"cumene hydroperoxide	42	62	Chemical"	"Cum - OOH	65	74	Chemical"	"activator protein - 1	96	117	Gene_or_gene_product"	"AP - 1	120	126	Gene_or_gene_product"	"cell	183	187	Cell"	"[{""token"": ""cumene hydroperoxide"", ""start_span"": 42, ""end_span"": 62, ""type"": ""Chemical""}, {""token"": ""Cum - OOH"", ""start_span"": 65, ""end_span"": 74, ""type"": ""Chemical""}, {""token"": ""activator protein - 1"", ""start_span"": 96, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 1"", ""start_span"": 120, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 183, ""end_span"": 187, ""type"": ""Cell""}]"
Previously, we reported that topical exposure to Cum - OOH caused formation of free radicals and oxidative stress in the skin of vitamin E - deficient mice.	"Cum - OOH	49	58	Chemical"	"free radicals	79	92	Chemical"	"skin	121	125	Organ"	"vitamin E	129	138	Chemical"	"mice	151	155	Organism"	"[{""token"": ""Cum - OOH"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""free radicals"", ""start_span"": 79, ""end_span"": 92, ""type"": ""Chemical""}, {""token"": ""skin"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Organ""}, {""token"": ""vitamin E"", ""start_span"": 129, ""end_span"": 138, ""type"": ""Chemical""}, {""token"": ""mice"", ""start_span"": 151, ""end_span"": 155, ""type"": ""Organism""}]"
Mice primed with dimethyl - benz [ a] anthracene ( DMBA) were topically exposed to Cum - OOH ( 82. 6 micromol) or the positive control, 12 - O - tetradecanoylphorbol - 13 - acetate ( TPA, 17 nmol), twice weekly for 29 weeks.	"Mice	0	4	Organism"	"DMBA	51	55	Chemical"	"Cum - OOH	83	92	Chemical"	"12 - O - tetradecanoylphorbol - 13 - acetate	136	180	Chemical"	"TPA	183	186	Chemical"	"[{""token"": ""Mice"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Organism""}, {""token"": ""DMBA"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Chemical""}, {""token"": ""Cum - OOH"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Chemical""}, {""token"": ""12 - O - tetradecanoylphorbol - 13 - acetate"", ""start_span"": 136, ""end_span"": 180, ""type"": ""Chemical""}, {""token"": ""TPA"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Chemical""}]"
John ' s wort ( Hypericum perforatum), has emerged as key player not only in the antidepressant activity of the plant but also as an inhibitor of bacteria lymphocyte and tumor cell proliferation, and matrix proteinases.	"John ' s wort	0	13	Organism"	"Hypericum perforatum	16	36	Organism"	"lymphocyte	155	165	Cell"	"tumor cell	170	180	Cell"	"matrix proteinases	200	218	Gene_or_gene_product"	"[{""token"": ""John ' s wort"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Organism""}, {""token"": ""Hypericum perforatum"", ""start_span"": 16, ""end_span"": 36, ""type"": ""Organism""}, {""token"": ""lymphocyte"", ""start_span"": 155, ""end_span"": 165, ""type"": ""Cell""}, {""token"": ""tumor cell"", ""start_span"": 170, ""end_span"": 180, ""type"": ""Cell""}, {""token"": ""matrix proteinases"", ""start_span"": 200, ""end_span"": 218, ""type"": ""Gene_or_gene_product""}]"
METHODS: We assessed antiapoptotic and proapoptotic markers in vascular and perivascular cells in lung biopsy samples from 18 patients with CHD, 7 with reversible and 11 with irreversible PHT, and 6 control patients.	"vascular	63	71	Cell"	"perivascular cells	76	94	Cell"	"lung biopsy samples	98	117	Multi"	"patients	126	134	Organism"	"patients	207	215	Organism"	"[{""token"": ""vascular"", ""start_span"": 63, ""end_span"": 71, ""type"": ""Cell""}, {""token"": ""perivascular cells"", ""start_span"": 76, ""end_span"": 94, ""type"": ""Cell""}, {""token"": ""lung biopsy samples"", ""start_span"": 98, ""end_span"": 117, ""type"": ""Multi""}, {""token"": ""patients"", ""start_span"": 126, ""end_span"": 134, ""type"": ""Organism""}, {""token"": ""patients"", ""start_span"": 207, ""end_span"": 215, ""type"": ""Organism""}]"
Newly forming vessels have thin caliber, a markedly reduced vessel lumen, markedly reduced pericyte recruitment, and deficient vascular perfusion.	"vessels	14	21	Multi"	"caliber	32	39	Immaterial_anatomical_entity"	"vessel lumen	60	72	Immaterial_anatomical_entity"	"pericyte	91	99	Cell"	"vascular	127	135	Multi"	"[{""token"": ""vessels"", ""start_span"": 14, ""end_span"": 21, ""type"": ""Multi""}, {""token"": ""caliber"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""vessel lumen"", ""start_span"": 60, ""end_span"": 72, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""pericyte"", ""start_span"": 91, ""end_span"": 99, ""type"": ""Cell""}, {""token"": ""vascular"", ""start_span"": 127, ""end_span"": 135, ""type"": ""Multi""}]"
Interference with Dll4 - Notch signaling may be particularly desirable in tumors that have highly induced Dll4 - Notch pathway.	"Dll4	18	22	Gene_or_gene_product"	"Notch	25	30	Gene_or_gene_product"	"tumors	74	80	Cancer"	"Dll4	106	110	Gene_or_gene_product"	"Notch	113	118	Gene_or_gene_product"	"[{""token"": ""Dll4"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""Notch"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Cancer""}, {""token"": ""Dll4"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""Notch"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}]"
Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation.	"Tsg101	0	6	Gene_or_gene_product"	"human	46	51	Organism"	"breast cancers	52	66	Cancer"	"transgenic mice	102	117	Organism"	"mammary cancer	156	170	Cancer"	"[{""token"": ""Tsg101"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Organism""}, {""token"": ""breast cancers"", ""start_span"": 52, ""end_span"": 66, ""type"": ""Cancer""}, {""token"": ""transgenic mice"", ""start_span"": 102, ""end_span"": 117, ""type"": ""Organism""}, {""token"": ""mammary cancer"", ""start_span"": 156, ""end_span"": 170, ""type"": ""Cancer""}]"
The evaluation of immunostaining of Bcl - xL, Bax, and p53 was analyzed in 10 different tumor fields, and the mean percentage of tumor cells with positive staining was evaluated.	"Bcl - xL	36	44	Gene_or_gene_product"	"Bax	46	49	Gene_or_gene_product"	"p53	55	58	Gene_or_gene_product"	"tumor	88	93	Cancer"	"tumor cells	129	140	Cell"	"[{""token"": ""Bcl - xL"", ""start_span"": 36, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Cancer""}, {""token"": ""tumor cells"", ""start_span"": 129, ""end_span"": 140, ""type"": ""Cell""}]"
We found positive Bcl - xL, Bax, and p53 immunostaining in 44. 6%, 28. 6%, and 58. 9% of the studied primary tumors and in 63. 6%, 45. 5%, and 72. 7% of lymph node metastases, respectively.	"Bcl - xL	18	26	Gene_or_gene_product"	"Bax	28	31	Gene_or_gene_product"	"p53	37	40	Gene_or_gene_product"	"tumors	109	115	Cancer"	"lymph node	153	163	Multi"	"[{""token"": ""Bcl - xL"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 109, ""end_span"": 115, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 153, ""end_span"": 163, ""type"": ""Multi""}]"
We show that HIF - 1alpha and VEGF are increased through A3 adenosine receptor stimulation, whereas the effects on IL - 8 are mediated via the A2B subtype.	"HIF - 1alpha	13	25	Gene_or_gene_product"	"VEGF	30	34	Gene_or_gene_product"	"A3 adenosine receptor	57	78	Gene_or_gene_product"	"IL - 8	115	121	Gene_or_gene_product"	"A2B	143	146	Gene_or_gene_product"	"[{""token"": ""HIF - 1alpha"", ""start_span"": 13, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""A3 adenosine receptor"", ""start_span"": 57, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 8"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""A2B"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}]"
Subcellular localisation of BAG - 1 and its regulation of vitamin D receptor - mediated transactivation and involucrin expression in oral keratinocytes: implications for oral carcinogenesis.	"BAG - 1	28	35	Gene_or_gene_product"	"vitamin D receptor	58	76	Gene_or_gene_product"	"involucrin	108	118	Gene_or_gene_product"	"oral keratinocytes	133	151	Cell"	"oral	170	174	Organism_subdivision"	"[{""token"": ""BAG - 1"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""vitamin D receptor"", ""start_span"": 58, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""involucrin"", ""start_span"": 108, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""oral keratinocytes"", ""start_span"": 133, ""end_span"": 151, ""type"": ""Cell""}, {""token"": ""oral"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Organism_subdivision""}]"
BAG - 1 regulates cellular growth, differentiation and survival through interactions with diverse proteins, including the vitamin D receptor ( VDR), a key regulator of keratinocyte growth and differentiation.	"BAG - 1	0	7	Gene_or_gene_product"	"cellular	18	26	Cell"	"vitamin D receptor	122	140	Gene_or_gene_product"	"VDR	143	146	Gene_or_gene_product"	"keratinocyte	168	180	Cell"	"[{""token"": ""BAG - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""vitamin D receptor"", ""start_span"": 122, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""VDR"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""keratinocyte"", ""start_span"": 168, ""end_span"": 180, ""type"": ""Cell""}]"
In oral keratinocytes BAG - 1L, but not BAG - 1M and BAG - 1S, enhanced VDR transactivation in response to 1alpha, 25 - dihydroxyvitamin D3.	"oral keratinocytes	3	21	Cell"	"BAG - 1L	22	30	Gene_or_gene_product"	"BAG - 1M	40	48	Gene_or_gene_product"	"BAG - 1S	53	61	Gene_or_gene_product"	"VDR	72	75	Gene_or_gene_product"	"[{""token"": ""oral keratinocytes"", ""start_span"": 3, ""end_span"": 21, ""type"": ""Cell""}, {""token"": ""BAG - 1L"", ""start_span"": 22, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAG - 1M"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAG - 1S"", ""start_span"": 53, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""VDR"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}]"
Wnt signaling plays a critical role in regulating stem / progenitor cells in the mammary gland as well as other tissue compartments.	"Wnt	0	3	Gene_or_gene_product"	"stem	50	54	Cell"	"progenitor cells	57	73	Cell"	"mammary gland	81	94	Organ"	"tissue compartments	112	131	Multi"	"[{""token"": ""Wnt"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""stem"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Cell""}, {""token"": ""progenitor cells"", ""start_span"": 57, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""mammary gland"", ""start_span"": 81, ""end_span"": 94, ""type"": ""Organ""}, {""token"": ""tissue compartments"", ""start_span"": 112, ""end_span"": 131, ""type"": ""Multi""}]"
Better stem cell and progenitor cell markers as well as the ability to specifically target oncogenes into different mammary cell types will be needed to determine the spectrum of oncogene transformation for stem cells versus more differentiated cells.	"stem cell	7	16	Cell"	"progenitor cell	21	36	Cell"	"mammary cell	116	128	Cell"	"stem cells	207	217	Cell"	"cells	245	250	Cell"	"[{""token"": ""stem cell"", ""start_span"": 7, ""end_span"": 16, ""type"": ""Cell""}, {""token"": ""progenitor cell"", ""start_span"": 21, ""end_span"": 36, ""type"": ""Cell""}, {""token"": ""mammary cell"", ""start_span"": 116, ""end_span"": 128, ""type"": ""Cell""}, {""token"": ""stem cells"", ""start_span"": 207, ""end_span"": 217, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 245, ""end_span"": 250, ""type"": ""Cell""}]"
The aim of this study was to characterize the distribution of hCAP - 18 / LL - 37 in normal and cancerous ovarian tissue and to examine the effects of LL - 37 on ovarian cancer cells.	"hCAP - 18	62	71	Gene_or_gene_product"	"LL - 37	74	81	Gene_or_gene_product"	"ovarian tissue	106	120	Tissue"	"LL - 37	151	158	Gene_or_gene_product"	"ovarian cancer cells	162	182	Cell"	"[{""token"": ""hCAP - 18"", ""start_span"": 62, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""LL - 37"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian tissue"", ""start_span"": 106, ""end_span"": 120, ""type"": ""Tissue""}, {""token"": ""LL - 37"", ""start_span"": 151, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian cancer cells"", ""start_span"": 162, ""end_span"": 182, ""type"": ""Cell""}]"
Expression of hCAP - 18 / LL - 37 was localized to immune and granulosa cells of normal ovarian tissue.	"hCAP - 18	14	23	Gene_or_gene_product"	"LL - 37	26	33	Gene_or_gene_product"	"immune	51	57	Cell"	"granulosa cells	62	77	Cell"	"normal ovarian tissue	81	102	Tissue"	"[{""token"": ""hCAP - 18"", ""start_span"": 14, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""LL - 37"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""immune"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Cell""}, {""token"": ""granulosa cells"", ""start_span"": 62, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""normal ovarian tissue"", ""start_span"": 81, ""end_span"": 102, ""type"": ""Tissue""}]"
By contrast, ovarian tumors displayed significantly higher levels of hCAP - 18 / LL - 37 where expression was observed in tumor and stromal cells.	"ovarian tumors	13	27	Cancer"	"hCAP - 18	69	78	Gene_or_gene_product"	"LL - 37	81	88	Gene_or_gene_product"	"tumor	122	127	Cell"	"stromal cells	132	145	Cell"	"[{""token"": ""ovarian tumors"", ""start_span"": 13, ""end_span"": 27, ""type"": ""Cancer""}, {""token"": ""hCAP - 18"", ""start_span"": 69, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""LL - 37"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Cell""}, {""token"": ""stromal cells"", ""start_span"": 132, ""end_span"": 145, ""type"": ""Cell""}]"
Angiopoietin - 1 prevents VEGF - induced endothelial permeability by sequestering Src through mDia.	"Angiopoietin - 1	0	16	Gene_or_gene_product"	"VEGF	26	30	Gene_or_gene_product"	"endothelial	41	52	Tissue"	"Src	82	85	Gene_or_gene_product"	"mDia	94	98	Gene_or_gene_product"	"[{""token"": ""Angiopoietin - 1"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial"", ""start_span"": 41, ""end_span"": 52, ""type"": ""Tissue""}, {""token"": ""Src"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""mDia"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}]"
Ang1 inhibits the activation of Src by VEGF, the most upstream component of the pathway linking VEGF receptors to VE - cadherin internalization.	"Ang1	0	4	Gene_or_gene_product"	"Src	32	35	Gene_or_gene_product"	"VEGF	39	43	Gene_or_gene_product"	"VEGF	96	100	Gene_or_gene_product"	"VE - cadherin	114	127	Gene_or_gene_product"	"[{""token"": ""Ang1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""Src"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""VE - cadherin"", ""start_span"": 114, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}]"
Indeed, Ang1 promotes the activation of mDia through RhoA, resulting in the association of mDia with Src.	"Ang1	8	12	Gene_or_gene_product"	"mDia	40	44	Gene_or_gene_product"	"RhoA	53	57	Gene_or_gene_product"	"mDia	91	95	Gene_or_gene_product"	"Src	101	104	Gene_or_gene_product"	"[{""token"": ""Ang1"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""mDia"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""RhoA"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""mDia"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""Src"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}]"
Furthermore, treatment of immunocompetent mice in the spontaneous lung metastases model with rAAV2 / 5 - VAS after primary tumor excision prolonged their median survival from 21 to 51. 5 days.	"mice	42	46	Organism"	"lung	66	70	Organ"	"rAAV2	93	98	Organism"	"5 - VAS	101	108	Organism"	"tumor	123	128	Cancer"	"[{""token"": ""mice"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Organism""}, {""token"": ""lung"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Organ""}, {""token"": ""rAAV2"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Organism""}, {""token"": ""5 - VAS"", ""start_span"": 101, ""end_span"": 108, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Cancer""}]"
LeTx also substantially inhibited the extracellular release of angioproliferative factors including vascular endothelial growth factor, interleukin - 8, and basic fibroblast growth factor.	"LeTx	0	4	Chemical"	"extracellular	38	51	Immaterial_anatomical_entity"	"vascular endothelial growth factor	100	134	Gene_or_gene_product"	"interleukin - 8	136	151	Gene_or_gene_product"	"basic fibroblast growth factor	157	187	Gene_or_gene_product"	"[{""token"": ""LeTx"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""extracellular"", ""start_span"": 38, ""end_span"": 51, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 100, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 8"", ""start_span"": 136, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""basic fibroblast growth factor"", ""start_span"": 157, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}]"
Proteomic comparison of nasopharyngeal cancer cell lines C666 - 1 and NP69 identifies down - regulation of annexin II and beta2 - tubulin for nasopharyngeal carcinoma.	"nasopharyngeal cancer cell lines C666 - 1	24	65	Cell"	"NP69	70	74	Cell"	"annexin II	107	117	Gene_or_gene_product"	"beta2 - tubulin	122	137	Gene_or_gene_product"	"nasopharyngeal carcinoma	142	166	Cancer"	"[{""token"": ""nasopharyngeal cancer cell lines C666 - 1"", ""start_span"": 24, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""NP69"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""annexin II"", ""start_span"": 107, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta2 - tubulin"", ""start_span"": 122, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""nasopharyngeal carcinoma"", ""start_span"": 142, ""end_span"": 166, ""type"": ""Cancer""}]"
OBJECTIVES: To compare the proteomic expression profile between an Epstein - Barr virus - associated NPC cell line ( C666 - 1) and a normal NP cell line ( NP69).	"Epstein - Barr virus	67	87	Organism"	"NPC cell line	101	114	Cell"	"C666 - 1	117	125	Cell"	"NP cell line	140	152	Cell"	"NP69	155	159	Cell"	"[{""token"": ""Epstein - Barr virus"", ""start_span"": 67, ""end_span"": 87, ""type"": ""Organism""}, {""token"": ""NPC cell line"", ""start_span"": 101, ""end_span"": 114, ""type"": ""Cell""}, {""token"": ""C666 - 1"", ""start_span"": 117, ""end_span"": 125, ""type"": ""Cell""}, {""token"": ""NP cell line"", ""start_span"": 140, ""end_span"": 152, ""type"": ""Cell""}, {""token"": ""NP69"", ""start_span"": 155, ""end_span"": 159, ""type"": ""Cell""}]"
MMTV - cre - mediated inactivation of fur without over - expression of PLAG1 caused smaller but histologically normal salivary glands.	"MMTV	0	4	Organism"	"cre	7	10	Gene_or_gene_product"	"fur	38	41	Gene_or_gene_product"	"PLAG1	71	76	Gene_or_gene_product"	"salivary glands	118	133	Organ"	"[{""token"": ""MMTV"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Organism""}, {""token"": ""cre"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""fur"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLAG1"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""salivary glands"", ""start_span"": 118, ""end_span"": 133, ""type"": ""Organ""}]"
The aptamer - induced dimerization and inactivation of M2 - PK led to a significant decrease in the PK mass - action ratio as well as ATP: ADP ratio in the target cells.	"M2 - PK	55	62	Gene_or_gene_product"	"PK	100	102	Gene_or_gene_product"	"ATP	134	137	Chemical"	"ADP	139	142	Chemical"	"cells	163	168	Cell"	"[{""token"": ""M2 - PK"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""PK"", ""start_span"": 100, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""ATP"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Chemical""}, {""token"": ""ADP"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Cell""}]"
The samples were transferred to Kyushu University Hospital ( Beppu, Japan) where they were analyzed by quantitative real - time reverse transcription - PCR for three epithelial cell markers, carcinoembryonic antigen, cytokeratin - 19, and cytokeratin - 7, as well as VEGFR - 1.	"epithelial cell	166	181	Cell"	"carcinoembryonic antigen	191	215	Gene_or_gene_product"	"cytokeratin - 19	217	233	Gene_or_gene_product"	"cytokeratin - 7	239	254	Gene_or_gene_product"	"VEGFR - 1	267	276	Gene_or_gene_product"	"[{""token"": ""epithelial cell"", ""start_span"": 166, ""end_span"": 181, ""type"": ""Cell""}, {""token"": ""carcinoembryonic antigen"", ""start_span"": 191, ""end_span"": 215, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytokeratin - 19"", ""start_span"": 217, ""end_span"": 233, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytokeratin - 7"", ""start_span"": 239, ""end_span"": 254, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 1"", ""start_span"": 267, ""end_span"": 276, ""type"": ""Gene_or_gene_product""}]"
To examine the mechanism by which ethanol influences angiogenesis in wounds, we employed two different in vitro angiogenesis assays to determine whether acute ethanol exposure ( 100 mg / dl) would have long - lasting effects on VEGF - induced capillary network formation.	"ethanol	34	41	Chemical"	"wounds	69	75	Pathological_formation"	"ethanol	159	166	Chemical"	"VEGF	228	232	Gene_or_gene_product"	"capillary network	243	260	Multi"	"[{""token"": ""ethanol"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Chemical""}, {""token"": ""wounds"", ""start_span"": 69, ""end_span"": 75, ""type"": ""Pathological_formation""}, {""token"": ""ethanol"", ""start_span"": 159, ""end_span"": 166, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 228, ""end_span"": 232, ""type"": ""Gene_or_gene_product""}, {""token"": ""capillary network"", ""start_span"": 243, ""end_span"": 260, ""type"": ""Multi""}]"
Ethanol exposure resulted in reduced VEGF - induced cord formation on collagen and reduced capillary network structure on Matrigel in vitro.	"Ethanol	0	7	Chemical"	"VEGF	37	41	Gene_or_gene_product"	"cord	52	56	Tissue"	"collagen	70	78	Gene_or_gene_product"	"capillary network	91	108	Multi"	"[{""token"": ""Ethanol"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""cord"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Tissue""}, {""token"": ""collagen"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""capillary network"", ""start_span"": 91, ""end_span"": 108, ""type"": ""Multi""}]"
However, mice treated with t - butanol, an alcohol not metabolized by alcohol dehydrogenase, exhibited no change in wound vascularity.	"mice	9	13	Organism"	"t - butanol	27	38	Chemical"	"alcohol	43	50	Chemical"	"alcohol dehydrogenase	70	91	Gene_or_gene_product"	"wound	116	121	Pathological_formation"	"[{""token"": ""mice"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Organism""}, {""token"": ""t - butanol"", ""start_span"": 27, ""end_span"": 38, ""type"": ""Chemical""}, {""token"": ""alcohol"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Chemical""}, {""token"": ""alcohol dehydrogenase"", ""start_span"": 70, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""wound"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Pathological_formation""}]"
Opinions on 3 areas were sought: pulp therapy for cariously involved primary teeth; indirect pulp treatment ( IPT) for cariously involved immature permanent teeth; and innovative treatment options including pulpal revascularization and regeneration.	"pulp	33	37	Tissue"	"teeth	77	82	Organ"	"pulp	93	97	Tissue"	"teeth	157	162	Organ"	"pulpal	207	213	Tissue"	"[{""token"": ""pulp"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Tissue""}, {""token"": ""teeth"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Organ""}, {""token"": ""pulp"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Tissue""}, {""token"": ""teeth"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Organ""}, {""token"": ""pulpal"", ""start_span"": 207, ""end_span"": 213, ""type"": ""Tissue""}]"
TP catalyzes the conversion of thymidine to thymine and doxyribose - 1 - phosphate ( dR - 1 - P).	"TP	0	2	Gene_or_gene_product"	"thymidine	31	40	Chemical"	"thymine	44	51	Chemical"	"doxyribose - 1 - phosphate	56	82	Chemical"	"dR - 1 - P	85	95	Chemical"	"[{""token"": ""TP"", ""start_span"": 0, ""end_span"": 2, ""type"": ""Gene_or_gene_product""}, {""token"": ""thymidine"", ""start_span"": 31, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""thymine"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Chemical""}, {""token"": ""doxyribose - 1 - phosphate"", ""start_span"": 56, ""end_span"": 82, ""type"": ""Chemical""}, {""token"": ""dR - 1 - P"", ""start_span"": 85, ""end_span"": 95, ""type"": ""Chemical""}]"
OBJECTIVE: PTEN ( phosphatase and tensin homologue deleted on chromosome 10) is a tumor suppressor gene identified on human chromosome 10q23.	"PTEN	11	15	Gene_or_gene_product"	"phosphatase and tensin homologue deleted on chromosome 10	18	75	Gene_or_gene_product"	"tumor	82	87	Cancer"	"human	118	123	Organism"	"chromosome 10q23	124	140	Cellular_component"	"[{""token"": ""PTEN"", ""start_span"": 11, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphatase and tensin homologue deleted on chromosome 10"", ""start_span"": 18, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 118, ""end_span"": 123, ""type"": ""Organism""}, {""token"": ""chromosome 10q23"", ""start_span"": 124, ""end_span"": 140, ""type"": ""Cellular_component""}]"
The purpose of this study was to determine whether upregulation of PTEN gene by transfection wild - type PTEN gene to ovarian cancer cells can inhibit growth and migration and to explore the potential for PTEN gene therapy of ovarian cancers.	"PTEN	67	71	Gene_or_gene_product"	"PTEN	105	109	Gene_or_gene_product"	"ovarian cancer cells	118	138	Cell"	"PTEN	205	209	Gene_or_gene_product"	"ovarian cancers	226	241	Cancer"	"[{""token"": ""PTEN"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTEN"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian cancer cells"", ""start_span"": 118, ""end_span"": 138, ""type"": ""Cell""}, {""token"": ""PTEN"", ""start_span"": 205, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian cancers"", ""start_span"": 226, ""end_span"": 241, ""type"": ""Cancer""}]"
Enhanced expression of PTEN by gene transfer is sufficient to reverse the malignant phenotype of ovarian cancer cells and transfection of ovarian cancer cells with wild - type PTEN gene might be another novel approach for therapeutic intervention in ovarian cancer.	"PTEN	23	27	Gene_or_gene_product"	"ovarian cancer cells	97	117	Cell"	"ovarian cancer cells	138	158	Cell"	"PTEN	176	180	Gene_or_gene_product"	"ovarian cancer	250	264	Cancer"	"[{""token"": ""PTEN"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian cancer cells"", ""start_span"": 97, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""ovarian cancer cells"", ""start_span"": 138, ""end_span"": 158, ""type"": ""Cell""}, {""token"": ""PTEN"", ""start_span"": 176, ""end_span"": 180, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian cancer"", ""start_span"": 250, ""end_span"": 264, ""type"": ""Cancer""}]"
FM - MSC or BM - MSC obtained from Lewis rats were injected into a MHC - mismatched August - Copenhagen - Irish rat model of hind limb ischemia.	"FM - MSC	0	8	Cell"	"BM - MSC	12	20	Cell"	"rats	41	45	Organism"	"rat	112	115	Organism"	"hind limb	125	134	Organism_subdivision"	"[{""token"": ""FM - MSC"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Cell""}, {""token"": ""BM - MSC"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""rats"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Organism""}, {""token"": ""rat"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Organism""}, {""token"": ""hind limb"", ""start_span"": 125, ""end_span"": 134, ""type"": ""Organism_subdivision""}]"
In nonischemic hind limb tissues, allogeneic FM - MSC and BM - MSC injection were associated with a comparatively small amount of T lymphocyte infiltration, compared with the injection of allogeneic splenic lymphocytes.	"hind limb tissues	15	32	Tissue"	"FM - MSC	45	53	Cell"	"BM - MSC	58	66	Cell"	"T lymphocyte	130	142	Cell"	"splenic lymphocytes	199	218	Cell"	"[{""token"": ""hind limb tissues"", ""start_span"": 15, ""end_span"": 32, ""type"": ""Tissue""}, {""token"": ""FM - MSC"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""BM - MSC"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""T lymphocyte"", ""start_span"": 130, ""end_span"": 142, ""type"": ""Cell""}, {""token"": ""splenic lymphocytes"", ""start_span"": 199, ""end_span"": 218, ""type"": ""Cell""}]"
In conclusion, allogeneic FM - MSC injection did not elicit a lymphocyte proliferative response and provided significant improvement in a rat model of hind limb ischemia, comparable to the response to BM - MSC.	"FM - MSC	26	34	Cell"	"lymphocyte	62	72	Cell"	"rat	80	83	Organism"	"hind limb	151	160	Organism_subdivision"	"BM - MSC	201	209	Cell"	"[{""token"": ""FM - MSC"", ""start_span"": 26, ""end_span"": 34, ""type"": ""Cell""}, {""token"": ""lymphocyte"", ""start_span"": 62, ""end_span"": 72, ""type"": ""Cell""}, {""token"": ""rat"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Organism""}, {""token"": ""hind limb"", ""start_span"": 151, ""end_span"": 160, ""type"": ""Organism_subdivision""}, {""token"": ""BM - MSC"", ""start_span"": 201, ""end_span"": 209, ""type"": ""Cell""}]"
However, glycolysis and GLUT - 1 can also be induced independent of HIF - 1alpha by other factors, such as c - Myc and phosphorylated Akt ( pAkt).	"GLUT - 1	24	32	Gene_or_gene_product"	"HIF - 1alpha	68	80	Gene_or_gene_product"	"c - Myc	107	114	Gene_or_gene_product"	"Akt	134	137	Gene_or_gene_product"	"pAkt	140	144	Gene_or_gene_product"	"[{""token"": ""GLUT - 1"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 68, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Myc"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""pAkt"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"
This study investigates HIF - 1alpha, c - Myc, pAkt, and aerobic glycolysis in low - passage breast cancer cells under the assumption that these represent the in vivo condition better than established lines.	"HIF - 1alpha	24	36	Gene_or_gene_product"	"c - Myc	38	45	Gene_or_gene_product"	"pAkt	47	51	Gene_or_gene_product"	"breast cancer cells	93	112	Cell"	"lines	201	206	Cell"	"[{""token"": ""HIF - 1alpha"", ""start_span"": 24, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Myc"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""pAkt"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer cells"", ""start_span"": 93, ""end_span"": 112, ""type"": ""Cell""}, {""token"": ""lines"", ""start_span"": 201, ""end_span"": 206, ""type"": ""Cell""}]"
Ultrastructural evidence reveals that at 8 weeks the grafts are composed primarily of collagen and fibroblasts with rough endoplasmic reticulum and vesicles.	"grafts	53	59	Tissue"	"collagen	86	94	Gene_or_gene_product"	"fibroblasts	99	110	Cell"	"endoplasmic reticulum	122	143	Cellular_component"	"vesicles	148	156	Cellular_component"	"[{""token"": ""grafts"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Tissue""}, {""token"": ""collagen"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblasts"", ""start_span"": 99, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""endoplasmic reticulum"", ""start_span"": 122, ""end_span"": 143, ""type"": ""Cellular_component""}, {""token"": ""vesicles"", ""start_span"": 148, ""end_span"": 156, ""type"": ""Cellular_component""}]"
Finally, dynamic host - to - graft interactions - - including phagocytic migration, astrocytic hypertrophy and infiltration within the grafts, and angiogenesis - - are features that constitute the structural integration of primary skin fibroblasts grafted within the adult rat central nervous system.	"graft	29	34	Tissue"	"grafts	135	141	Tissue"	"skin fibroblasts	231	247	Cell"	"rat	273	276	Organism"	"central nervous system	277	299	Anatomical_system"	"[{""token"": ""graft"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Tissue""}, {""token"": ""grafts"", ""start_span"": 135, ""end_span"": 141, ""type"": ""Tissue""}, {""token"": ""skin fibroblasts"", ""start_span"": 231, ""end_span"": 247, ""type"": ""Cell""}, {""token"": ""rat"", ""start_span"": 273, ""end_span"": 276, ""type"": ""Organism""}, {""token"": ""central nervous system"", ""start_span"": 277, ""end_span"": 299, ""type"": ""Anatomical_system""}]"
Our aim was to compare the angiogenesis associated with subcutaneous adipose tissue ( SAT) and visceral adipose tissue ( VAT) from the same obese patients in an in vivo model.	"subcutaneous adipose tissue	56	83	Tissue"	"SAT	86	89	Tissue"	"visceral adipose tissue	95	118	Tissue"	"VAT	121	124	Tissue"	"patients	146	154	Organism"	"[{""token"": ""subcutaneous adipose tissue"", ""start_span"": 56, ""end_span"": 83, ""type"": ""Tissue""}, {""token"": ""SAT"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Tissue""}, {""token"": ""visceral adipose tissue"", ""start_span"": 95, ""end_span"": 118, ""type"": ""Tissue""}, {""token"": ""VAT"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Tissue""}, {""token"": ""patients"", ""start_span"": 146, ""end_span"": 154, ""type"": ""Organism""}]"
A connection between CAM and adipose tissue vessels was evidenced by immunohistochemistry, with recruitment of both avian and human endothelial cells.	"CAM	21	24	Multi"	"adipose tissue vessels	29	51	Tissue"	"avian	116	121	Organism"	"human	126	131	Organism"	"endothelial cells	132	149	Cell"	"[{""token"": ""CAM"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Multi""}, {""token"": ""adipose tissue vessels"", ""start_span"": 29, ""end_span"": 51, ""type"": ""Tissue""}, {""token"": ""avian"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Organism""}, {""token"": ""endothelial cells"", ""start_span"": 132, ""end_span"": 149, ""type"": ""Cell""}]"
M - CSF signals through the MAPK / ERK pathway via Sp1 to induce VEGF production and induces angiogenesis in vivo.	"M - CSF	0	7	Gene_or_gene_product"	"MAPK	28	32	Gene_or_gene_product"	"ERK	35	38	Gene_or_gene_product"	"Sp1	51	54	Gene_or_gene_product"	"VEGF	65	69	Gene_or_gene_product"	"[{""token"": ""M - CSF"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""Sp1"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}]"
Further analysis revealed that M - CSF induced VEGF through the MAPK / ERK signaling pathway via the transcription factor, Sp1.	"M - CSF	31	38	Gene_or_gene_product"	"VEGF	47	51	Gene_or_gene_product"	"MAPK	64	68	Gene_or_gene_product"	"ERK	71	74	Gene_or_gene_product"	"Sp1	123	126	Gene_or_gene_product"	"[{""token"": ""M - CSF"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""Sp1"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}]"
To evaluate the biological significance of M - CSF induced VEGF production, we used an in vivo angiogenesis model to illustrate the ability of M - CSF to recruit mononuclear phagocytes, increase VEGF levels, and enhance angiogenesis.	"M - CSF	43	50	Gene_or_gene_product"	"VEGF	59	63	Gene_or_gene_product"	"M - CSF	143	150	Gene_or_gene_product"	"mononuclear phagocytes	162	184	Cell"	"VEGF	195	199	Gene_or_gene_product"	"[{""token"": ""M - CSF"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""M - CSF"", ""start_span"": 143, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""mononuclear phagocytes"", ""start_span"": 162, ""end_span"": 184, ""type"": ""Cell""}, {""token"": ""VEGF"", ""start_span"": 195, ""end_span"": 199, ""type"": ""Gene_or_gene_product""}]"
Inhibition of NF - kappaB significantly reduced transcript levels and autocrine production of BMP - 2 by rhTNF - alpha stimulated C4 - 2B cells and to a lesser extent by the parental LNCaP cells.	"NF - kappaB	14	25	Gene_or_gene_product"	"BMP - 2	94	101	Gene_or_gene_product"	"rhTNF - alpha	105	118	Gene_or_gene_product"	"C4 - 2B cells	130	143	Cell"	"LNCaP cells	183	194	Cell"	"[{""token"": ""NF - kappaB"", ""start_span"": 14, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""BMP - 2"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""rhTNF - alpha"", ""start_span"": 105, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""C4 - 2B cells"", ""start_span"": 130, ""end_span"": 143, ""type"": ""Cell""}, {""token"": ""LNCaP cells"", ""start_span"": 183, ""end_span"": 194, ""type"": ""Cell""}]"
Notably, the activation of BMPRII by BMP - 2 is required for modulation of Smad activation by NF - kappaB in PC cells.	"BMPRII	27	33	Gene_or_gene_product"	"BMP - 2	37	44	Gene_or_gene_product"	"Smad	75	79	Gene_or_gene_product"	"NF - kappaB	94	105	Gene_or_gene_product"	"PC cells	109	117	Cell"	"[{""token"": ""BMPRII"", ""start_span"": 27, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""BMP - 2"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 94, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""PC cells"", ""start_span"": 109, ""end_span"": 117, ""type"": ""Cell""}]"
In addition, it inhibits human umbilical vein endothelial cell proliferation, migration, adhesion, tubular network formation, and bFGF - induced neovascularization in a chick chorioallantoic membrane.	"human umbilical vein endothelial cell	25	62	Cell"	"tubular network	99	114	Multi"	"bFGF	130	134	Gene_or_gene_product"	"chick	169	174	Organism"	"chorioallantoic membrane	175	199	Multi"	"[{""token"": ""human umbilical vein endothelial cell"", ""start_span"": 25, ""end_span"": 62, ""type"": ""Cell""}, {""token"": ""tubular network"", ""start_span"": 99, ""end_span"": 114, ""type"": ""Multi""}, {""token"": ""bFGF"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""chick"", ""start_span"": 169, ""end_span"": 174, ""type"": ""Organism""}, {""token"": ""chorioallantoic membrane"", ""start_span"": 175, ""end_span"": 199, ""type"": ""Multi""}]"
VEGF, angiopoietin - 1 and - 2 in bronchial asthma: new molecular targets in airway angiogenesis and microvascular remodeling.	"VEGF	0	4	Gene_or_gene_product"	"angiopoietin - 1	6	22	Gene_or_gene_product"	"- 2	27	30	Gene_or_gene_product"	"airway	77	83	Multi"	"microvascular	101	114	Multi"	"[{""token"": ""VEGF"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""angiopoietin - 1"", ""start_span"": 6, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 2"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""airway"", ""start_span"": 77, ""end_span"": 83, ""type"": ""Multi""}, {""token"": ""microvascular"", ""start_span"": 101, ""end_span"": 114, ""type"": ""Multi""}]"
Thus, VEGF, Ang - 1 and - 2 may play complementary and coordinated roles in airway angiogenesis and microvascular remodeling, and these structural changes are potentially reversible by therapeutic intervention.	"VEGF	6	10	Gene_or_gene_product"	"Ang - 1	12	19	Gene_or_gene_product"	"- 2	24	27	Gene_or_gene_product"	"airway	76	82	Multi"	"microvascular	100	113	Multi"	"[{""token"": ""VEGF"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ang - 1"", ""start_span"": 12, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 2"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""airway"", ""start_span"": 76, ""end_span"": 82, ""type"": ""Multi""}, {""token"": ""microvascular"", ""start_span"": 100, ""end_span"": 113, ""type"": ""Multi""}]"
SD rats underwent MI received intramyocardial injection of MSCs from young donor rats ( n = 8), old donor rats ( n = 8), respectively.	"SD rats	0	7	Organism"	"intramyocardial	30	45	Immaterial_anatomical_entity"	"MSCs	59	63	Cell"	"rats	81	85	Organism"	"rats	106	110	Organism"	"[{""token"": ""SD rats"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Organism""}, {""token"": ""intramyocardial"", ""start_span"": 30, ""end_span"": 45, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""MSCs"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""rats"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Organism""}, {""token"": ""rats"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Organism""}]"
To investigate the endothelial proliferation and the potential signaling pathways affected by PTEN methylation, proliferating cell nuclear antigen as well as phosphor - Akt and phosphor - Erk1, 2 were detected by immunofluorescence and Western blot, respectively, in CCM specimens.	"endothelial	19	30	Cell"	"PTEN	94	98	Gene_or_gene_product"	"proliferating cell nuclear antigen	112	146	Gene_or_gene_product"	"phosphor - Akt	158	172	Gene_or_gene_product"	"CCM	267	270	Pathological_formation"	"[{""token"": ""endothelial"", ""start_span"": 19, ""end_span"": 30, ""type"": ""Cell""}, {""token"": ""PTEN"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""proliferating cell nuclear antigen"", ""start_span"": 112, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphor - Akt"", ""start_span"": 158, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCM"", ""start_span"": 267, ""end_span"": 270, ""type"": ""Pathological_formation""}]"
Immunostaining and Western blot revealed a more significant PTEN downregulation in PTEN - methylated CCMs in comparison to PTEN - unmethylated CCMs.	"PTEN	60	64	Gene_or_gene_product"	"PTEN	83	87	Gene_or_gene_product"	"CCMs	101	105	Pathological_formation"	"PTEN	123	127	Gene_or_gene_product"	"CCMs	143	147	Pathological_formation"	"[{""token"": ""PTEN"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTEN"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCMs"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Pathological_formation""}, {""token"": ""PTEN"", ""start_span"": 123, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCMs"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Pathological_formation""}]"
Reduced PTEN expression was inversely correlated to the expression of proliferating cell nuclear antigen and to the activation of Erk1, 2, but not of Akt.	"PTEN	8	12	Gene_or_gene_product"	"proliferating cell nuclear antigen	70	104	Gene_or_gene_product"	"Erk1	130	134	Gene_or_gene_product"	"2	136	137	Gene_or_gene_product"	"Akt	150	153	Gene_or_gene_product"	"[{""token"": ""PTEN"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""proliferating cell nuclear antigen"", ""start_span"": 70, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""Erk1"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""2"", ""start_span"": 136, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}]"
The biological effect of the perfluorocarbon - based artificial oxygen carrier ( Oxygent) was investigated in tissue - engineered trachea ( TET) construction.	"perfluorocarbon	29	44	Chemical"	"oxygen	64	70	Chemical"	"Oxygent	81	88	Chemical"	"tissue - engineered trachea	110	137	Multi"	"TET	140	143	Multi"	"[{""token"": ""perfluorocarbon"", ""start_span"": 29, ""end_span"": 44, ""type"": ""Chemical""}, {""token"": ""oxygen"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Chemical""}, {""token"": ""Oxygent"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Chemical""}, {""token"": ""tissue - engineered trachea"", ""start_span"": 110, ""end_span"": 137, ""type"": ""Multi""}, {""token"": ""TET"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Multi""}]"
Functional studies showed that Sema7A stimulates cytoskeletal reorganization in human melanocytes, resulting in adhesion and dendrite formation.	"Sema7A	31	37	Gene_or_gene_product"	"cytoskeletal	49	61	Cellular_component"	"human	80	85	Organism"	"melanocytes	86	97	Cell"	"dendrite	125	133	Cellular_component"	"[{""token"": ""Sema7A"", ""start_span"": 31, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytoskeletal"", ""start_span"": 49, ""end_span"": 61, ""type"": ""Cellular_component""}, {""token"": ""human"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism""}, {""token"": ""melanocytes"", ""start_span"": 86, ""end_span"": 97, ""type"": ""Cell""}, {""token"": ""dendrite"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Cellular_component""}]"
Ectopic PTTG overexpression in a representative ESCC cell line, EC9706, increased in vitro cell migration and invasion and promoted in vivo lymph node metastasis.	"PTTG	8	12	Gene_or_gene_product"	"ESCC cell line	48	62	Cell"	"EC9706	64	70	Cell"	"cell	91	95	Cell"	"lymph node	140	150	Multi"	"[{""token"": ""PTTG"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""ESCC cell line"", ""start_span"": 48, ""end_span"": 62, ""type"": ""Cell""}, {""token"": ""EC9706"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""lymph node"", ""start_span"": 140, ""end_span"": 150, ""type"": ""Multi""}]"
By using mass spectrometric analysis, we identified that PTTG up - regulated S100A4 and galectin - 1 secretion and down - regulated tissue inhibitor of metalloproteinase - 2 secretion to the culture media.	"PTTG	57	61	Gene_or_gene_product"	"S100A4	77	83	Gene_or_gene_product"	"galectin - 1	88	100	Gene_or_gene_product"	"tissue	132	138	Tissue"	"metalloproteinase - 2	152	173	Gene_or_gene_product"	"[{""token"": ""PTTG"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""S100A4"", ""start_span"": 77, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""galectin - 1"", ""start_span"": 88, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Tissue""}, {""token"": ""metalloproteinase - 2"", ""start_span"": 152, ""end_span"": 173, ""type"": ""Gene_or_gene_product""}]"
So we established that these pathways were crucial to endothelial cell proliferation under vascular endothelial growth factor ( VEGF) and fibroblast growth factor ( FGF) stimulation.	"endothelial cell	54	70	Cell"	"vascular endothelial growth factor	91	125	Gene_or_gene_product"	"VEGF	128	132	Gene_or_gene_product"	"fibroblast growth factor	138	162	Gene_or_gene_product"	"FGF	165	168	Gene_or_gene_product"	"[{""token"": ""endothelial cell"", ""start_span"": 54, ""end_span"": 70, ""type"": ""Cell""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 91, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblast growth factor"", ""start_span"": 138, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}]"
Depletion of Rab7a decreased VEGFR2 Y1175 phosphorylation but increased p42 / 44 ( pERK1 / 2) MAPK phosphorylation.	"Rab7a	13	18	Gene_or_gene_product"	"VEGFR2	29	35	Gene_or_gene_product"	"p42 / 44	72	80	Gene_or_gene_product"	"pERK1 / 2	83	92	Gene_or_gene_product"	"MAPK	94	98	Gene_or_gene_product"	"[{""token"": ""Rab7a"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR2"", ""start_span"": 29, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""p42 / 44"", ""start_span"": 72, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""pERK1 / 2"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}]"
CONCLUSIONS: Rab5a and Rab7a regulate VEGFR2 trafficking toward early and late endosomes.	"Rab5a	13	18	Gene_or_gene_product"	"Rab7a	23	28	Gene_or_gene_product"	"VEGFR2	38	44	Gene_or_gene_product"	"early	64	69	Cellular_component"	"late endosomes	74	88	Cellular_component"	"[{""token"": ""Rab5a"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rab7a"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR2"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""early"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Cellular_component""}, {""token"": ""late endosomes"", ""start_span"": 74, ""end_span"": 88, ""type"": ""Cellular_component""}]"
Our data suggest that VEGFR2 - mediated regulation of endothelial function is dependent on different but specific Rab - mediated GTP hydrolysis activity required for endosomal trafficking.	"VEGFR2	22	28	Gene_or_gene_product"	"endothelial	54	65	Cell"	"Rab	114	117	Gene_or_gene_product"	"GTP	129	132	Chemical"	"endosomal	166	175	Cellular_component"	"[{""token"": ""VEGFR2"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial"", ""start_span"": 54, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""Rab"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""GTP"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Chemical""}, {""token"": ""endosomal"", ""start_span"": 166, ""end_span"": 175, ""type"": ""Cellular_component""}]"
We show that restoration of FOXO3a in FOXO3a - deficient LAC cells increases sensitivity to apoptosis caused by a DNA - damaging intermediate of NNK.	"FOXO3a	28	34	Gene_or_gene_product"	"FOXO3a	38	44	Gene_or_gene_product"	"LAC cells	57	66	Cell"	"DNA	114	117	Cellular_component"	"NNK	145	148	Chemical"	"[{""token"": ""FOXO3a"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""FOXO3a"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""LAC cells"", ""start_span"": 57, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Cellular_component""}, {""token"": ""NNK"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Chemical""}]"
The polycomb gene Bmi - 1 is required for the self - renewal of stem cells from diverse tissues, including the central nervous system ( CNS).	"Bmi - 1	18	25	Gene_or_gene_product"	"stem cells	64	74	Cell"	"tissues	88	95	Tissue"	"central nervous system	111	133	Anatomical_system"	"CNS	136	139	Anatomical_system"	"[{""token"": ""Bmi - 1"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""stem cells"", ""start_span"": 64, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""tissues"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Tissue""}, {""token"": ""central nervous system"", ""start_span"": 111, ""end_span"": 133, ""type"": ""Anatomical_system""}, {""token"": ""CNS"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Anatomical_system""}]"
Bmi - 1 expression is elevated in most human gliomas, irrespective of grade, raising the question of whether Bmi - 1 over - expression is sufficient to promote self - renewal or tumorigenesis by CNS stem / progenitor cells.	"Bmi - 1	0	7	Gene_or_gene_product"	"human	39	44	Organism"	"gliomas	45	52	Cancer"	"Bmi - 1	109	116	Gene_or_gene_product"	"CNS stem / progenitor cells	195	222	Cell"	"[{""token"": ""Bmi - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Organism""}, {""token"": ""gliomas"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Cancer""}, {""token"": ""Bmi - 1"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""CNS stem / progenitor cells"", ""start_span"": 195, ""end_span"": 222, ""type"": ""Cell""}]"
Bmi - 1 transgenic mice were born with enlarged lateral ventricles and a minority developed idiopathic hydrocephalus as adults, but none of the transgenic mice formed detectable CNS tumors, even when aged.	"Bmi - 1	0	7	Gene_or_gene_product"	"mice	19	23	Organism"	"lateral ventricles	48	66	Multi"	"mice	155	159	Organism"	"CNS tumors	178	188	Cancer"	"[{""token"": ""Bmi - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Organism""}, {""token"": ""lateral ventricles"", ""start_span"": 48, ""end_span"": 66, ""type"": ""Multi""}, {""token"": ""mice"", ""start_span"": 155, ""end_span"": 159, ""type"": ""Organism""}, {""token"": ""CNS tumors"", ""start_span"": 178, ""end_span"": 188, ""type"": ""Cancer""}]"
Consistent with this hypothesis, inhibition of Erbb2 in v - ras ( Ha) transgenic mice before UV exposure resulted in both 56% fewer skin tumors and tumors that were 70% smaller.	"Erbb2	47	52	Gene_or_gene_product"	"v - ras	56	63	Gene_or_gene_product"	"Ha	66	68	Gene_or_gene_product"	"skin tumors	132	143	Cancer"	"tumors	148	154	Cancer"	"[{""token"": ""Erbb2"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""v - ras"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ha"", ""start_span"": 66, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""skin tumors"", ""start_span"": 132, ""end_span"": 143, ""type"": ""Cancer""}, {""token"": ""tumors"", ""start_span"": 148, ""end_span"": 154, ""type"": ""Cancer""}]"
The EGFR - GEP100 - Arf6 - AMAP1 signaling pathway specific to breast cancer invasion and metastasis.	"EGFR	4	8	Gene_or_gene_product"	"GEP100	11	17	Gene_or_gene_product"	"Arf6	20	24	Gene_or_gene_product"	"AMAP1	27	32	Gene_or_gene_product"	"breast cancer	63	76	Cancer"	"[{""token"": ""EGFR"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""GEP100"", ""start_span"": 11, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""Arf6"", ""start_span"": 20, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""AMAP1"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer"", ""start_span"": 63, ""end_span"": 76, ""type"": ""Cancer""}]"
We recently identified GEP100 ( BRAG2) to be responsible for the Arf6 activation to induce invasion and metastasis, by directly binding to ligand - activated epidermal growth factor receptor ( EGFR).	"GEP100	23	29	Gene_or_gene_product"	"BRAG2	32	37	Gene_or_gene_product"	"Arf6	65	69	Gene_or_gene_product"	"epidermal growth factor receptor	158	190	Gene_or_gene_product"	"EGFR	193	197	Gene_or_gene_product"	"[{""token"": ""GEP100"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""BRAG2"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""Arf6"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""epidermal growth factor receptor"", ""start_span"": 158, ""end_span"": 190, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGFR"", ""start_span"": 193, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}]"
Upon investigation, intrachromosomal gene amplification of Met, a receptor tyrosine kinase implicated in melanoma progression, was identified in Cdkn2a - deficient tumors.	"intrachromosomal	20	36	Cellular_component"	"Met	59	62	Gene_or_gene_product"	"tyrosine	75	83	Amino_acid"	"melanoma	105	113	Cancer"	"Cdkn2a	145	151	Gene_or_gene_product"	"[{""token"": ""intrachromosomal"", ""start_span"": 20, ""end_span"": 36, ""type"": ""Cellular_component""}, {""token"": ""Met"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""tyrosine"", ""start_span"": 75, ""end_span"": 83, ""type"": ""Amino_acid""}, {""token"": ""melanoma"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""Cdkn2a"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}]"
The effect of platelets on the content of urokinase plasminogen activator ( uPA) and VEGF in SKOV3 cell conditioned medium was measured using an ELISA assay.	"platelets	14	23	Cell"	"urokinase plasminogen activator	42	73	Gene_or_gene_product"	"uPA	76	79	Gene_or_gene_product"	"VEGF	85	89	Gene_or_gene_product"	"SKOV3 cell	93	103	Cell"	"[{""token"": ""platelets"", ""start_span"": 14, ""end_span"": 23, ""type"": ""Cell""}, {""token"": ""urokinase plasminogen activator"", ""start_span"": 42, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""uPA"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""SKOV3 cell"", ""start_span"": 93, ""end_span"": 103, ""type"": ""Cell""}]"
miR - 378, miR - 296, and the miR - 17 - 92 cluster contribute to tumor angiogenesis.	"miR - 378	0	9	Gene_or_gene_product"	"miR - 296	11	20	Gene_or_gene_product"	"miR - 17 -	30	40	Gene_or_gene_product"	"92	41	43	Gene_or_gene_product"	"tumor	66	71	Cancer"	"[{""token"": ""miR - 378"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""miR - 296"", ""start_span"": 11, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""miR - 17 -"", ""start_span"": 30, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""92"", ""start_span"": 41, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Cancer""}]"
Here we have demonstrated that mechanical strain - dependent induction of the CCN1 gene involves signaling cascades through RhoA - mediated actin remodeling and the p38 stress - activated protein kinase ( SAPK).	"CCN1	78	82	Gene_or_gene_product"	"RhoA	124	128	Gene_or_gene_product"	"actin	140	145	Cellular_component"	"p38 stress - activated protein kinase	165	202	Gene_or_gene_product"	"SAPK	205	209	Gene_or_gene_product"	"[{""token"": ""CCN1"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""RhoA"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""actin"", ""start_span"": 140, ""end_span"": 145, ""type"": ""Cellular_component""}, {""token"": ""p38 stress - activated protein kinase"", ""start_span"": 165, ""end_span"": 202, ""type"": ""Gene_or_gene_product""}, {""token"": ""SAPK"", ""start_span"": 205, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}]"
Actin signaling controls serum response factor ( SRF) activity via SRF interaction with the myocardin - related transcriptional activator ( MRTF) - A and tethering to a single CArG box sequence within the CCN1 promoter.	"Actin	0	5	Gene_or_gene_product"	"serum response factor	25	46	Gene_or_gene_product"	"SRF	49	52	Gene_or_gene_product"	"SRF	67	70	Gene_or_gene_product"	"CCN1	205	209	Gene_or_gene_product"	"[{""token"": ""Actin"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""serum response factor"", ""start_span"": 25, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""SRF"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""SRF"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCN1"", ""start_span"": 205, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}]"
Mechanical strain induced CBP - mediated acetylation of histones 3 and 4 at the SRF - binding site and within the CCN1 gene coding region.	"CBP	26	29	Gene_or_gene_product"	"histones 3	56	66	Gene_or_gene_product"	"4	71	72	Gene_or_gene_product"	"SRF	80	83	Gene_or_gene_product"	"CCN1	114	118	Gene_or_gene_product"	"[{""token"": ""CBP"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""histones 3"", ""start_span"": 56, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""4"", ""start_span"": 71, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""SRF"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCN1"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}]"
Similarly, mechanical overload - induced CCN1 gene expression in vivo was associated with nuclear localization of MRTF - A and enrichment of the CCN1 promoter with both MRTF - A and acetylated histone H3.	"CCN1	41	45	Gene_or_gene_product"	"MRTF - A	114	122	Gene_or_gene_product"	"CCN1	145	149	Gene_or_gene_product"	"MRTF - A	169	177	Gene_or_gene_product"	"histone H3	193	203	Gene_or_gene_product"	"[{""token"": ""CCN1"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""MRTF - A"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCN1"", ""start_span"": 145, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}, {""token"": ""MRTF - A"", ""start_span"": 169, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}, {""token"": ""histone H3"", ""start_span"": 193, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}]"
Reciprocal bone marrow transplants that involved both wild - type and PECAM - 1 - deficient mice revealed that the impaired angiogenic response resulted from a loss of endothelial, but not leukocyte, PECAM - 1.	"bone marrow	11	22	Multi"	"PECAM - 1	70	79	Gene_or_gene_product"	"endothelial	168	179	Cell"	"leukocyte	189	198	Cell"	"PECAM - 1	200	209	Gene_or_gene_product"	"[{""token"": ""bone marrow"", ""start_span"": 11, ""end_span"": 22, ""type"": ""Multi""}, {""token"": ""PECAM - 1"", ""start_span"": 70, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial"", ""start_span"": 168, ""end_span"": 179, ""type"": ""Cell""}, {""token"": ""leukocyte"", ""start_span"": 189, ""end_span"": 198, ""type"": ""Cell""}, {""token"": ""PECAM - 1"", ""start_span"": 200, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}]"
Furthermore, the expression of PECAM - 1 promoted filopodia formation and increased the protein expression levels of Cdc42, a Rho GTPase that is known to promote the formation of filopodia.	"PECAM - 1	31	40	Gene_or_gene_product"	"filopodia	50	59	Cellular_component"	"Cdc42	117	122	Gene_or_gene_product"	"Rho	126	129	Gene_or_gene_product"	"filopodia	179	188	Cellular_component"	"[{""token"": ""PECAM - 1"", ""start_span"": 31, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""filopodia"", ""start_span"": 50, ""end_span"": 59, ""type"": ""Cellular_component""}, {""token"": ""Cdc42"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rho"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""filopodia"", ""start_span"": 179, ""end_span"": 188, ""type"": ""Cellular_component""}]"
In the developing retinal vasculature, numerous, long filamentous filopodia, emanating from endothelial cells at the tips of angiogenic sprouts, were observed in wild - type animals, but to a lesser extent in the PECAM - 1 - null mice.	"retinal vasculature	18	37	Multi"	"long filamentous filopodia	49	75	Cellular_component"	"endothelial cells	92	109	Cell"	"sprouts	136	143	Tissue"	"PECAM - 1	213	222	Gene_or_gene_product"	"[{""token"": ""retinal vasculature"", ""start_span"": 18, ""end_span"": 37, ""type"": ""Multi""}, {""token"": ""long filamentous filopodia"", ""start_span"": 49, ""end_span"": 75, ""type"": ""Cellular_component""}, {""token"": ""endothelial cells"", ""start_span"": 92, ""end_span"": 109, ""type"": ""Cell""}, {""token"": ""sprouts"", ""start_span"": 136, ""end_span"": 143, ""type"": ""Tissue""}, {""token"": ""PECAM - 1"", ""start_span"": 213, ""end_span"": 222, ""type"": ""Gene_or_gene_product""}]"
Together, these data further establish the involvement of endothelial PECAM - 1 in angiogenesis and suggest that, in vivo, PECAM - 1 may stimulate endothelial cell motility by promoting the formation of filopodia.	"endothelial	58	69	Cell"	"PECAM - 1	70	79	Gene_or_gene_product"	"PECAM - 1	123	132	Gene_or_gene_product"	"endothelial cell	147	163	Cell"	"filopodia	203	212	Cellular_component"	"[{""token"": ""endothelial"", ""start_span"": 58, ""end_span"": 69, ""type"": ""Cell""}, {""token"": ""PECAM - 1"", ""start_span"": 70, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""PECAM - 1"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 147, ""end_span"": 163, ""type"": ""Cell""}, {""token"": ""filopodia"", ""start_span"": 203, ""end_span"": 212, ""type"": ""Cellular_component""}]"
Pretreatment with DMI followed by combination of DMI and FA decreased GR - mediated transcription more than pretreatment with FA.	"DMI	18	21	Chemical"	"DMI	49	52	Chemical"	"FA	57	59	Chemical"	"GR	70	72	Gene_or_gene_product"	"FA	126	128	Chemical"	"[{""token"": ""DMI"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Chemical""}, {""token"": ""DMI"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Chemical""}, {""token"": ""FA"", ""start_span"": 57, ""end_span"": 59, ""type"": ""Chemical""}, {""token"": ""GR"", ""start_span"": 70, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""FA"", ""start_span"": 126, ""end_span"": 128, ""type"": ""Chemical""}]"
Down - regulation of Mcl - 1 resulted in an increase in Mcl - 1 - free Bim, activation of Bax, and then signaling of mitochondria - mediated apoptosis.	"Mcl - 1	21	28	Gene_or_gene_product"	"Mcl - 1	56	63	Gene_or_gene_product"	"Bim	71	74	Gene_or_gene_product"	"Bax	90	93	Gene_or_gene_product"	"mitochondria	117	129	Cellular_component"	"[{""token"": ""Mcl - 1"", ""start_span"": 21, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""Mcl - 1"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bim"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondria"", ""start_span"": 117, ""end_span"": 129, ""type"": ""Cellular_component""}]"
Additionally, glutathione depletion and extracellular signal - regulated kinase ( ERK) inactivation was observed in EPOX - treated cells.	"glutathione	14	25	Chemical"	"extracellular signal - regulated kinase	40	79	Gene_or_gene_product"	"ERK	82	85	Gene_or_gene_product"	"EPOX	116	120	Chemical"	"cells	131	136	Cell"	"[{""token"": ""glutathione"", ""start_span"": 14, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""extracellular signal - regulated kinase"", ""start_span"": 40, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""EPOX"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Cell""}]"
CONCLUSIONS: This study provides evidence that EPOX induces glutathione depletion, ERK inactivation, and Mcl - 1 degradation on endothelial cells, which leads to inhibition of angiogenesis.	"EPOX	47	51	Chemical"	"glutathione	60	71	Chemical"	"ERK	83	86	Gene_or_gene_product"	"Mcl - 1	105	112	Gene_or_gene_product"	"endothelial cells	128	145	Cell"	"[{""token"": ""EPOX"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Chemical""}, {""token"": ""glutathione"", ""start_span"": 60, ""end_span"": 71, ""type"": ""Chemical""}, {""token"": ""ERK"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""Mcl - 1"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 128, ""end_span"": 145, ""type"": ""Cell""}]"
Predictive markers for anti - VEGF agents have not yet been identified and questions regarding the usefulness of bevacizumab in the adjuvant setting as well as its continued use beyond progression remain unanswered, in spite of negative data on bevacizumab in treating patients with adjuvant colon cancer.	"anti - VEGF	23	34	Gene_or_gene_product"	"bevacizumab	113	124	Chemical"	"bevacizumab	245	256	Chemical"	"patients	269	277	Organism"	"colon cancer	292	304	Cancer"	"[{""token"": ""anti - VEGF"", ""start_span"": 23, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""bevacizumab"", ""start_span"": 113, ""end_span"": 124, ""type"": ""Chemical""}, {""token"": ""bevacizumab"", ""start_span"": 245, ""end_span"": 256, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 269, ""end_span"": 277, ""type"": ""Organism""}, {""token"": ""colon cancer"", ""start_span"": 292, ""end_span"": 304, ""type"": ""Cancer""}]"
Elevated vascular endothelial growth factor ( VEGF) secretion by malignant cells enhanced recruitment of endothelial cells ( EC) in heterotypic cocultures.	"vascular endothelial growth factor	9	43	Gene_or_gene_product"	"VEGF	46	50	Gene_or_gene_product"	"malignant cells	65	80	Cell"	"endothelial cells	105	122	Cell"	"EC	125	127	Cell"	"[{""token"": ""vascular endothelial growth factor"", ""start_span"": 9, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignant cells"", ""start_span"": 65, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""endothelial cells"", ""start_span"": 105, ""end_span"": 122, ""type"": ""Cell""}, {""token"": ""EC"", ""start_span"": 125, ""end_span"": 127, ""type"": ""Cell""}]"
Significantly, phenotypic reversion of malignant cells via reexpression of HoxD10, which is lost in malignant progression, significantly attenuated VEGF expression in a hypoxia - inducible factor 1alpha - independent fashion and reduced EC migration.	"malignant cells	39	54	Cell"	"HoxD10	75	81	Gene_or_gene_product"	"VEGF	148	152	Gene_or_gene_product"	"hypoxia - inducible factor 1alpha	169	202	Gene_or_gene_product"	"EC	237	239	Cell"	"[{""token"": ""malignant cells"", ""start_span"": 39, ""end_span"": 54, ""type"": ""Cell""}, {""token"": ""HoxD10"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 148, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""hypoxia - inducible factor 1alpha"", ""start_span"": 169, ""end_span"": 202, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 237, ""end_span"": 239, ""type"": ""Cell""}]"
These data show that disrupting cytostructure activates the angiogenic switch even in the absence of proliferation and / or hypoxia and restoring organization of malignant clusters reduces VEGF expression and EC activation to levels found in quiescent nonmalignant epithelium.	"cytostructure	32	45	Cellular_component"	"malignant clusters	162	180	Cancer"	"VEGF	189	193	Gene_or_gene_product"	"EC	209	211	Cell"	"nonmalignant epithelium	252	275	Tissue"	"[{""token"": ""cytostructure"", ""start_span"": 32, ""end_span"": 45, ""type"": ""Cellular_component""}, {""token"": ""malignant clusters"", ""start_span"": 162, ""end_span"": 180, ""type"": ""Cancer""}, {""token"": ""VEGF"", ""start_span"": 189, ""end_span"": 193, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 209, ""end_span"": 211, ""type"": ""Cell""}, {""token"": ""nonmalignant epithelium"", ""start_span"": 252, ""end_span"": 275, ""type"": ""Tissue""}]"
Simultaneous and continuous exposure of HT - 29 and HMVEC - d cells to low concentrations SN - 38 + L - OHP + 5 - FU for 144 h showed a strong antagonism and an unfavorable dose - reduction index.	"HT - 29	40	47	Cell"	"HMVEC - d cells	52	67	Cell"	"SN - 38	90	97	Chemical"	"L - OHP	100	107	Chemical"	"5 - FU	110	116	Chemical"	"[{""token"": ""HT - 29"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""HMVEC - d cells"", ""start_span"": 52, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""SN - 38"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Chemical""}, {""token"": ""L - OHP"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Chemical""}, {""token"": ""5 - FU"", ""start_span"": 110, ""end_span"": 116, ""type"": ""Chemical""}]"
In contrast, tube formation was significantly reduced by SMI496, a beta1 I - like domain inhibitor and by function - blocking anti - alpha2beta1 but not - alpha1beta1 antibodies.	"tube	13	17	Tissue"	"SMI496	57	63	Chemical"	"beta1	67	72	Gene_or_gene_product"	"anti - alpha2beta1	126	144	Chemical"	"- alpha1beta1 antibodies	153	177	Chemical"	"[{""token"": ""tube"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Tissue""}, {""token"": ""SMI496"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Chemical""}, {""token"": ""beta1"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""anti - alpha2beta1"", ""start_span"": 126, ""end_span"": 144, ""type"": ""Chemical""}, {""token"": ""- alpha1beta1 antibodies"", ""start_span"": 153, ""end_span"": 177, ""type"": ""Chemical""}]"
Moreover, SMI496 caused cell retraction and cytoskeletal collapse of endothelial cells as well as delayed endothelial cell wound healing.	"SMI496	10	16	Chemical"	"cell	24	28	Cell"	"endothelial cells	69	86	Cell"	"endothelial cell	106	122	Cell"	"wound	123	128	Pathological_formation"	"[{""token"": ""SMI496"", ""start_span"": 10, ""end_span"": 16, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""endothelial cells"", ""start_span"": 69, ""end_span"": 86, ""type"": ""Cell""}, {""token"": ""endothelial cell"", ""start_span"": 106, ""end_span"": 122, ""type"": ""Cell""}, {""token"": ""wound"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Pathological_formation""}]"
VDAs can be divided into biologics, such as ligand - based, and small - molecule agents; this second group includes small - molecule VDAs like flavonoids, such as 5, 6 - dimethylxanthenone - 4 - acetic acid ( DMXAA), and microtubule - destabilizing agents.	"VDAs	0	4	Chemical"	"small - molecule VDAs	116	137	Chemical"	"flavonoids	143	153	Chemical"	"DMXAA	209	214	Chemical"	"microtubule - destabilizing agents	221	255	Chemical"	"[{""token"": ""VDAs"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""small - molecule VDAs"", ""start_span"": 116, ""end_span"": 137, ""type"": ""Chemical""}, {""token"": ""flavonoids"", ""start_span"": 143, ""end_span"": 153, ""type"": ""Chemical""}, {""token"": ""DMXAA"", ""start_span"": 209, ""end_span"": 214, ""type"": ""Chemical""}, {""token"": ""microtubule - destabilizing agents"", ""start_span"": 221, ""end_span"": 255, ""type"": ""Chemical""}]"
In addition, the expression of Bcl - 2, uPA, MMP - 2 and MMP - 9 was decreased, while Bax level was elevated.	"Bcl - 2	31	38	Gene_or_gene_product"	"uPA	40	43	Gene_or_gene_product"	"MMP - 2	45	52	Gene_or_gene_product"	"MMP - 9	57	64	Gene_or_gene_product"	"Bax	86	89	Gene_or_gene_product"	"[{""token"": ""Bcl - 2"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""uPA"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 2"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 57, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}]"
These diagrams show the relative rates of glycolysis, the tricarboxylic acid cycle, electron transport, and the malate - aspartate shuttle in these tumors.	"tricarboxylic acid	58	76	Chemical"	"electron	84	92	Chemical"	"malate	112	118	Chemical"	"aspartate	121	130	Chemical"	"tumors	148	154	Cancer"	"[{""token"": ""tricarboxylic acid"", ""start_span"": 58, ""end_span"": 76, ""type"": ""Chemical""}, {""token"": ""electron"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Chemical""}, {""token"": ""malate"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Chemical""}, {""token"": ""aspartate"", ""start_span"": 121, ""end_span"": 130, ""type"": ""Chemical""}, {""token"": ""tumors"", ""start_span"": 148, ""end_span"": 154, ""type"": ""Cancer""}]"
Large amounts of cytosolic NADH were oxidized by the mitochondrial respiratory chain via the NADH shuttle, comprising anywhere from about 20 to 80% of the total flow of reducing equivalents to oxygen in these tumors.	"NADH	27	31	Chemical"	"mitochondrial	53	66	Cellular_component"	"NADH	93	97	Chemical"	"oxygen	193	199	Chemical"	"tumors	209	215	Cancer"	"[{""token"": ""NADH"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Chemical""}, {""token"": ""mitochondrial"", ""start_span"": 53, ""end_span"": 66, ""type"": ""Cellular_component""}, {""token"": ""NADH"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Chemical""}, {""token"": ""oxygen"", ""start_span"": 193, ""end_span"": 199, ""type"": ""Chemical""}, {""token"": ""tumors"", ""start_span"": 209, ""end_span"": 215, ""type"": ""Cancer""}]"
Taken together, these results showed that, in addition to the MAPK pathway previously reported being a downstream target of stimulated Grm1, AKT2 is another downstream target in Grm1 mediated melanocyte transformation.	"MAPK	62	66	Gene_or_gene_product"	"Grm1	135	139	Gene_or_gene_product"	"AKT2	141	145	Gene_or_gene_product"	"Grm1	178	182	Gene_or_gene_product"	"melanocyte	192	202	Cell"	"[{""token"": ""MAPK"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""Grm1"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""AKT2"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""Grm1"", ""start_span"": 178, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanocyte"", ""start_span"": 192, ""end_span"": 202, ""type"": ""Cell""}]"
Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta - and JNK1 - dependent inflammation.	"Tobacco	0	7	Organism"	"lung	23	27	Organ"	"IKKbeta	56	63	Gene_or_gene_product"	"JNK1	70	74	Gene_or_gene_product"	"inflammation	87	99	Pathological_formation"	"[{""token"": ""Tobacco"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Organism""}, {""token"": ""lung"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Organ""}, {""token"": ""IKKbeta"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK1"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""inflammation"", ""start_span"": 87, ""end_span"": 99, ""type"": ""Pathological_formation""}]"
Dose - and time - dependent effects of doxorubicin on cytotoxicity, cell cycle and apoptotic cell death in human colon cancer cells.	"doxorubicin	39	50	Chemical"	"cell	68	72	Cell"	"cell	93	97	Cell"	"human	107	112	Organism"	"colon cancer cells	113	131	Cell"	"[{""token"": ""doxorubicin"", ""start_span"": 39, ""end_span"": 50, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Organism""}, {""token"": ""colon cancer cells"", ""start_span"": 113, ""end_span"": 131, ""type"": ""Cell""}]"
Additionally, bolus ( 3h) doxorubicin incubation led to phosphorylation of p53 at serine 392, induction of p21, G2 arrest and increase of proapoptotic protein Bax.	"doxorubicin	26	37	Chemical"	"p53	75	78	Gene_or_gene_product"	"serine 392	82	92	Amino_acid"	"p21	107	110	Gene_or_gene_product"	"Bax	159	162	Gene_or_gene_product"	"[{""token"": ""doxorubicin"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""p53"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""serine 392"", ""start_span"": 82, ""end_span"": 92, ""type"": ""Amino_acid""}, {""token"": ""p21"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}]"
AIMS: As one of the five lactate dehydrogenase ( LDH) isoenzymes, LDH5 has the highest efficiency to catalyze pyruvate transformation to lactate.	"lactate dehydrogenase	25	46	Gene_or_gene_product"	"LDH	49	52	Gene_or_gene_product"	"LDH5	66	70	Gene_or_gene_product"	"pyruvate	110	118	Chemical"	"lactate	137	144	Chemical"	"[{""token"": ""lactate dehydrogenase"", ""start_span"": 25, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""LDH"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""LDH5"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""pyruvate"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Chemical""}, {""token"": ""lactate"", ""start_span"": 137, ""end_span"": 144, ""type"": ""Chemical""}]"
Betulin induces mitochondrial cytochrome c release associated apoptosis in human cancer cells.	"Betulin	0	7	Chemical"	"mitochondrial	16	29	Cellular_component"	"cytochrome c	30	42	Gene_or_gene_product"	"human	75	80	Organism"	"cancer cells	81	93	Cell"	"[{""token"": ""Betulin"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""mitochondrial"", ""start_span"": 16, ""end_span"": 29, ""type"": ""Cellular_component""}, {""token"": ""cytochrome c"", ""start_span"": 30, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Organism""}, {""token"": ""cancer cells"", ""start_span"": 81, ""end_span"": 93, ""type"": ""Cell""}]"
Betulin, unlike its chemical derivative betulinic acid, did not directly trigger mitochondrial cytochrome c release in isolated mitochondria.	"Betulin	0	7	Chemical"	"betulinic acid	40	54	Chemical"	"mitochondrial	81	94	Cellular_component"	"cytochrome c	95	107	Gene_or_gene_product"	"mitochondria	128	140	Cellular_component"	"[{""token"": ""Betulin"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""betulinic acid"", ""start_span"": 40, ""end_span"": 54, ""type"": ""Chemical""}, {""token"": ""mitochondrial"", ""start_span"": 81, ""end_span"": 94, ""type"": ""Cellular_component""}, {""token"": ""cytochrome c"", ""start_span"": 95, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondria"", ""start_span"": 128, ""end_span"": 140, ""type"": ""Cellular_component""}]"
The sequential activation of caspase - 9 and caspase - 3 / - 7 and the cleavage of poly ( ADP - ribose) polymerase ( PARP) were observed behind those mitochondrial events.	"caspase - 9	29	40	Gene_or_gene_product"	"caspase - 3	45	56	Gene_or_gene_product"	"- 7	59	62	Gene_or_gene_product"	"PARP	117	121	Gene_or_gene_product"	"mitochondrial	150	163	Cellular_component"	"[{""token"": ""caspase - 9"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase - 3"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 7"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""PARP"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondrial"", ""start_span"": 150, ""end_span"": 163, ""type"": ""Cellular_component""}]"
Furthermore, specific downregulation of either caspase - 9, Bax, or Bak by siRNA effectively reduced PARP cleavage and caspase - 3 activation.	"caspase - 9	47	58	Gene_or_gene_product"	"Bax	60	63	Gene_or_gene_product"	"Bak	68	71	Gene_or_gene_product"	"PARP	101	105	Gene_or_gene_product"	"caspase - 3	119	130	Gene_or_gene_product"	"[{""token"": ""caspase - 9"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bak"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""PARP"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase - 3"", ""start_span"": 119, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}]"
Adenovirus 5 E1A enhances histone deacetylase inhibitors - induced apoptosis through Egr - 1 - mediated Bim upregulation.	"Adenovirus 5	0	12	Organism"	"E1A	13	16	Gene_or_gene_product"	"histone deacetylase	26	45	Gene_or_gene_product"	"Egr - 1	85	92	Gene_or_gene_product"	"Bim	104	107	Gene_or_gene_product"	"[{""token"": ""Adenovirus 5"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Organism""}, {""token"": ""E1A"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""histone deacetylase"", ""start_span"": 26, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""Egr - 1"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bim"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}]"
Adenovirus 5 early region 1A ( E1A) has been shown to exhibit high tumor suppressor activity, and gene therapy using E1A has been tested in clinical trials.	"Adenovirus 5	0	12	Organism"	"early region 1A	13	28	Gene_or_gene_product"	"E1A	31	34	Gene_or_gene_product"	"tumor	67	72	Cancer"	"E1A	117	120	Gene_or_gene_product"	"[{""token"": ""Adenovirus 5"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Organism""}, {""token"": ""early region 1A"", ""start_span"": 13, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""E1A"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Cancer""}, {""token"": ""E1A"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}]"
SAHA downregulated Bcl - XL and upregulated proapoptotic BH3 - only protein Bim, whose expression was further enhanced by E1A in cancer cells.	"SAHA	0	4	Chemical"	"Bcl - XL	19	27	Gene_or_gene_product"	"Bim	76	79	Gene_or_gene_product"	"E1A	122	125	Gene_or_gene_product"	"cancer cells	129	141	Cell"	"[{""token"": ""SAHA"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""Bcl - XL"", ""start_span"": 19, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bim"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""E1A"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cells"", ""start_span"": 129, ""end_span"": 141, ""type"": ""Cell""}]"
Induction of FOXO3a activity in doxorubicin - sensitive MCF - 7 cells was sufficient to promote Akt phosphorylation and arrest cell proliferation.	"FOXO3a	13	19	Gene_or_gene_product"	"doxorubicin	32	43	Chemical"	"MCF - 7 cells	56	69	Cell"	"Akt	96	99	Gene_or_gene_product"	"cell	127	131	Cell"	"[{""token"": ""FOXO3a"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""doxorubicin"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Chemical""}, {""token"": ""MCF - 7 cells"", ""start_span"": 56, ""end_span"": 69, ""type"": ""Cell""}, {""token"": ""Akt"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Cell""}]"
As such, sustained nuclear FOXO3a expression in breast cancer may culminate in cancer progression and the development of an aggressive phenotype similar to that observed in cytotoxic chemotherapy resistant breast cancer cell models.	"nuclear	19	26	Cellular_component"	"FOXO3a	27	33	Gene_or_gene_product"	"breast cancer	48	61	Cancer"	"cancer	79	85	Cancer"	"breast cancer cell	206	224	Cell"	"[{""token"": ""nuclear"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Cellular_component""}, {""token"": ""FOXO3a"", ""start_span"": 27, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer"", ""start_span"": 48, ""end_span"": 61, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 79, ""end_span"": 85, ""type"": ""Cancer""}, {""token"": ""breast cancer cell"", ""start_span"": 206, ""end_span"": 224, ""type"": ""Cell""}]"
Brick1 is an essential regulator of actin cytoskeleton required for embryonic development and cell transformation.	"Brick1	0	6	Gene_or_gene_product"	"actin	36	41	Gene_or_gene_product"	"cytoskeleton	42	54	Cellular_component"	"embryonic	68	77	Developing_anatomical_structure"	"cell	94	98	Cell"	"[{""token"": ""Brick1"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""actin"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytoskeleton"", ""start_span"": 42, ""end_span"": 54, ""type"": ""Cellular_component""}, {""token"": ""embryonic"", ""start_span"": 68, ""end_span"": 77, ""type"": ""Developing_anatomical_structure""}, {""token"": ""cell"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Cell""}]"
BACKGROUND: The Ras association domain family 1 ( RASSF1) gene is a Ras effector encoding two major mRNA forms, RASSF1A and RASSF1C, derived by alternative promoter selection and alternative mRNA splicing.	"Ras association domain family 1	16	47	Gene_or_gene_product"	"RASSF1	50	56	Gene_or_gene_product"	"Ras	68	71	Gene_or_gene_product"	"RASSF1A	112	119	Gene_or_gene_product"	"RASSF1C	124	131	Gene_or_gene_product"	"[{""token"": ""Ras association domain family 1"", ""start_span"": 16, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""RASSF1"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ras"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""RASSF1A"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""RASSF1C"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}]"
We found that silencing RASSF1C mRNA in breast cancer cell lines ( MDA - MB231 and T47D) caused a small but significant decrease in cell proliferation.	"RASSF1C	24	31	Gene_or_gene_product"	"breast cancer cell lines	40	64	Cell"	"MDA - MB231	67	78	Cell"	"T47D	83	87	Cell"	"cell	132	136	Cell"	"[{""token"": ""RASSF1C"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer cell lines"", ""start_span"": 40, ""end_span"": 64, ""type"": ""Cell""}, {""token"": ""MDA - MB231"", ""start_span"": 67, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""T47D"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Cell""}]"
Conversely, inducible over - expression of RASSF1C in breast cancer cells ( MDA - MB231 and T47D) resulted in a small increase in cell proliferation.	"RASSF1C	43	50	Gene_or_gene_product"	"breast cancer cells	54	73	Cell"	"MDA - MB231	76	87	Cell"	"T47D	92	96	Cell"	"cell	130	134	Cell"	"[{""token"": ""RASSF1C"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer cells"", ""start_span"": 54, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""MDA - MB231"", ""start_span"": 76, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""T47D"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Cell""}]"
The disintegrin - like and cysteine - rich domains of ADAM - 9 mediate interactions between melanoma cells and fibroblasts.	"disintegrin	4	15	Gene_or_gene_product"	"cysteine	27	35	Amino_acid"	"ADAM - 9	54	62	Gene_or_gene_product"	"melanoma cells	92	106	Cell"	"fibroblasts	111	122	Cell"	"[{""token"": ""disintegrin"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""cysteine"", ""start_span"": 27, ""end_span"": 35, ""type"": ""Amino_acid""}, {""token"": ""ADAM - 9"", ""start_span"": 54, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanoma cells"", ""start_span"": 92, ""end_span"": 106, ""type"": ""Cell""}, {""token"": ""fibroblasts"", ""start_span"": 111, ""end_span"": 122, ""type"": ""Cell""}]"
It has also been demonstrated that MTSS1 is involved in the Shh signaling pathway in the developing hair follicle and in basal cell carcinomas of the skin.	"MTSS1	35	40	Gene_or_gene_product"	"Shh	60	63	Gene_or_gene_product"	"hair follicle	100	113	Multi"	"basal cell carcinomas	121	142	Cancer"	"skin	150	154	Organ"	"[{""token"": ""MTSS1"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""Shh"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""hair follicle"", ""start_span"": 100, ""end_span"": 113, ""type"": ""Multi""}, {""token"": ""basal cell carcinomas"", ""start_span"": 121, ""end_span"": 142, ""type"": ""Cancer""}, {""token"": ""skin"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Organ""}]"
Tumor size, serosal invasion, lymph node metastasis, peritoneal dissemination, and TNM classification was significantly correlated with sVAP - 1 level.	"Tumor	0	5	Cancer"	"serosal	12	19	Multi"	"lymph node	30	40	Multi"	"peritoneal	53	63	Multi"	"sVAP - 1	136	144	Gene_or_gene_product"	"[{""token"": ""Tumor"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cancer""}, {""token"": ""serosal"", ""start_span"": 12, ""end_span"": 19, ""type"": ""Multi""}, {""token"": ""lymph node"", ""start_span"": 30, ""end_span"": 40, ""type"": ""Multi""}, {""token"": ""peritoneal"", ""start_span"": 53, ""end_span"": 63, ""type"": ""Multi""}, {""token"": ""sVAP - 1"", ""start_span"": 136, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"
Induction of Id - 1 by FGF - 2 involves activity of EGR - 1 and sensitizes neuroblastoma cells to cell death.	"Id - 1	13	19	Gene_or_gene_product"	"FGF - 2	23	30	Gene_or_gene_product"	"EGR - 1	52	59	Gene_or_gene_product"	"neuroblastoma cells	75	94	Cell"	"cell	98	102	Cell"	"[{""token"": ""Id - 1"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF - 2"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGR - 1"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuroblastoma cells"", ""start_span"": 75, ""end_span"": 94, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Cell""}]"
Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki - 67 growth fraction.	"Vimentin	0	8	Gene_or_gene_product"	"human	40	45	Organism"	"breast carcinomas	46	63	Cancer"	"estrogen receptor	73	90	Gene_or_gene_product"	"Ki - 67	100	107	Gene_or_gene_product"	"[{""token"": ""Vimentin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Organism""}, {""token"": ""breast carcinomas"", ""start_span"": 46, ""end_span"": 63, ""type"": ""Cancer""}, {""token"": ""estrogen receptor"", ""start_span"": 73, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ki - 67"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}]"
Vimentin expression was found preferentially in tumors with high GF ( greater than 15% Ki - 67 positive by immunoperoxidase staining) and low ER levels ( less than 60 fmols / mg protein by a monoclonal enzyme immunoassay).	"Vimentin	0	8	Gene_or_gene_product"	"tumors	48	54	Cancer"	"Ki - 67	87	94	Gene_or_gene_product"	"immunoperoxidase	107	123	Gene_or_gene_product"	"ER	142	144	Gene_or_gene_product"	"[{""token"": ""Vimentin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 48, ""end_span"": 54, ""type"": ""Cancer""}, {""token"": ""Ki - 67"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""immunoperoxidase"", ""start_span"": 107, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}, {""token"": ""ER"", ""start_span"": 142, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"
METHODS: The expression of Merlin protein in 45 cases of NSCLC and adjacent tissue of NSCLC and normal lung tissue was checked by immunohistochemistry.	"Merlin	27	33	Gene_or_gene_product"	"NSCLC	57	62	Cancer"	"tissue	76	82	Tissue"	"NSCLC	86	91	Cancer"	"lung tissue	103	114	Tissue"	"[{""token"": ""Merlin"", ""start_span"": 27, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""NSCLC"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Cancer""}, {""token"": ""tissue"", ""start_span"": 76, ""end_span"": 82, ""type"": ""Tissue""}, {""token"": ""NSCLC"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Cancer""}, {""token"": ""lung tissue"", ""start_span"": 103, ""end_span"": 114, ""type"": ""Tissue""}]"
Sunitinib is an oral multitargeted receptor tyrosine kinase inhibitor with antiangiogenic and antitumor activity that mainly targets vascular endothelial growth factor receptors ( VEGFRs).	"Sunitinib	0	9	Chemical"	"oral	16	20	Organism_subdivision"	"antitumor	94	103	Cancer"	"vascular endothelial growth factor receptors	133	177	Gene_or_gene_product"	"VEGFRs	180	186	Gene_or_gene_product"	"[{""token"": ""Sunitinib"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical""}, {""token"": ""oral"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Organism_subdivision""}, {""token"": ""antitumor"", ""start_span"": 94, ""end_span"": 103, ""type"": ""Cancer""}, {""token"": ""vascular endothelial growth factor receptors"", ""start_span"": 133, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFRs"", ""start_span"": 180, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}]"
Furthermore, in support of these findings, we found that sunitinib induced a reduction in the expression of the antiapoptotic molecule Bcl - 2 as well as dephosphorylation of the proapoptotic molecule BAD, which results in the activation of BAD in these cells.	"sunitinib	57	66	Chemical"	"Bcl - 2	135	142	Gene_or_gene_product"	"BAD	201	204	Gene_or_gene_product"	"BAD	241	244	Gene_or_gene_product"	"cells	254	259	Cell"	"[{""token"": ""sunitinib"", ""start_span"": 57, ""end_span"": 66, ""type"": ""Chemical""}, {""token"": ""Bcl - 2"", ""start_span"": 135, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAD"", ""start_span"": 201, ""end_span"": 204, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAD"", ""start_span"": 241, ""end_span"": 244, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 254, ""end_span"": 259, ""type"": ""Cell""}]"
Consistent with these apoptotic effects, our results showed that sunitinib inhibited phosphorylation of Akt and mTOR and was followed by a reduction of S6K1, which is a well - known target of mTOR.	"sunitinib	65	74	Chemical"	"Akt	104	107	Gene_or_gene_product"	"mTOR	112	116	Gene_or_gene_product"	"S6K1	152	156	Gene_or_gene_product"	"mTOR	192	196	Gene_or_gene_product"	"[{""token"": ""sunitinib"", ""start_span"": 65, ""end_span"": 74, ""type"": ""Chemical""}, {""token"": ""Akt"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""S6K1"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Gene_or_gene_product""}]"
Lack of IL - 17F did not reverse the splenomegaly but partially restored thymic atrophy, suggesting a local effect of IL - 17F in the intestine.	"IL - 17F	8	16	Gene_or_gene_product"	"splenomegaly	37	49	Pathological_formation"	"thymic	73	79	Organ"	"IL - 17F	118	126	Gene_or_gene_product"	"intestine	134	143	Organ"	"[{""token"": ""IL - 17F"", ""start_span"": 8, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""splenomegaly"", ""start_span"": 37, ""end_span"": 49, ""type"": ""Pathological_formation""}, {""token"": ""thymic"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Organ""}, {""token"": ""IL - 17F"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""intestine"", ""start_span"": 134, ""end_span"": 143, ""type"": ""Organ""}]"
The binding activity of NF - kappaB to DNA was examined in nuclear extracts using Trans - AM NF - kappaB ELISA kit.	"NF - kappaB	24	35	Gene_or_gene_product"	"DNA	39	42	Cellular_component"	"nuclear extracts	59	75	Organism_substance"	"Trans - AM	82	92	Gene_or_gene_product"	"NF - kappaB	93	104	Gene_or_gene_product"	"[{""token"": ""NF - kappaB"", ""start_span"": 24, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Cellular_component""}, {""token"": ""nuclear extracts"", ""start_span"": 59, ""end_span"": 75, ""type"": ""Organism_substance""}, {""token"": ""Trans - AM"", ""start_span"": 82, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 93, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}]"
Oncostatin M ( OSM), an IL - 6 family cytokine responsible for STAT3 activation, has been implicated in cancer development, progression, invasion, and metastasis.	"Oncostatin M	0	12	Gene_or_gene_product"	"OSM	15	18	Gene_or_gene_product"	"IL - 6	24	30	Gene_or_gene_product"	"STAT3	63	68	Gene_or_gene_product"	"cancer	104	110	Cancer"	"[{""token"": ""Oncostatin M"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""OSM"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 6"", ""start_span"": 24, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""STAT3"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 104, ""end_span"": 110, ""type"": ""Cancer""}]"
These findings identify c - MYC as an important molecular switch that alters the cellular response to OSM - mediated signaling from tumor suppressive to tumor promoting.	"c - MYC	24	31	Gene_or_gene_product"	"cellular	81	89	Cell"	"OSM	102	105	Gene_or_gene_product"	"tumor	132	137	Cancer"	"tumor	153	158	Cancer"	"[{""token"": ""c - MYC"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""OSM"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 153, ""end_span"": 158, ""type"": ""Cancer""}]"
Our results indicated that HTPB was a pan - HDAC inhibitor in suppressing cell viability specifically of lung cancer cells but not of the normal lung cells.	"HTPB	27	31	Chemical"	"HDAC	44	48	Gene_or_gene_product"	"cell	74	78	Cell"	"lung cancer cells	105	122	Cell"	"normal lung cells	138	155	Cell"	"[{""token"": ""HTPB"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Chemical""}, {""token"": ""HDAC"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""lung cancer cells"", ""start_span"": 105, ""end_span"": 122, ""type"": ""Cell""}, {""token"": ""normal lung cells"", ""start_span"": 138, ""end_span"": 155, ""type"": ""Cell""}]"
Protein up - regulation of HER2 in the epithelium with metaplasia or carcinoma in situ was not accompanied by HER2 gene amplification.	"HER2	27	31	Gene_or_gene_product"	"epithelium	39	49	Tissue"	"metaplasia	55	65	Cancer"	"carcinoma	69	78	Cancer"	"HER2	110	114	Gene_or_gene_product"	"[{""token"": ""HER2"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""epithelium"", ""start_span"": 39, ""end_span"": 49, ""type"": ""Tissue""}, {""token"": ""metaplasia"", ""start_span"": 55, ""end_span"": 65, ""type"": ""Cancer""}, {""token"": ""carcinoma"", ""start_span"": 69, ""end_span"": 78, ""type"": ""Cancer""}, {""token"": ""HER2"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}]"
CONCLUSION: The up - regulation of HER2 and B ( 1) R in precursor lesions of gallbladder carcinoma suggests cross - talk between these two receptors that may be of importance in the modulation of cell proliferation in gallbladder carcinogenesis.	"HER2	35	39	Gene_or_gene_product"	"precursor lesions	56	73	Pathological_formation"	"gallbladder carcinoma	77	98	Cancer"	"cell	196	200	Cell"	"gallbladder	218	229	Organ"	"[{""token"": ""HER2"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""precursor lesions"", ""start_span"": 56, ""end_span"": 73, ""type"": ""Pathological_formation""}, {""token"": ""gallbladder carcinoma"", ""start_span"": 77, ""end_span"": 98, ""type"": ""Cancer""}, {""token"": ""cell"", ""start_span"": 196, ""end_span"": 200, ""type"": ""Cell""}, {""token"": ""gallbladder"", ""start_span"": 218, ""end_span"": 229, ""type"": ""Organ""}]"
Glycolysis of 3T3 and Ehrlich ascites tumor cells was greatly enhanced by Nonidet P - 40 or Triton X - 100 at about 100 micrograms / mg cell protein.	"3T3	14	17	Cell"	"Ehrlich ascites tumor cells	22	49	Cell"	"Nonidet P - 40	74	88	Chemical"	"Triton X - 100	92	106	Chemical"	"cell	136	140	Cell"	"[{""token"": ""3T3"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Cell""}, {""token"": ""Ehrlich ascites tumor cells"", ""start_span"": 22, ""end_span"": 49, ""type"": ""Cell""}, {""token"": ""Nonidet P - 40"", ""start_span"": 74, ""end_span"": 88, ""type"": ""Chemical""}, {""token"": ""Triton X - 100"", ""start_span"": 92, ""end_span"": 106, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Cell""}]"
Nonidet P - 40 had no effect on glycolysis in cell - free extracts from Ehrlich ascites tumor cells to which soluble mitochondrial ATPase was added.	"Nonidet P - 40	0	14	Chemical"	"cell - free extracts	46	66	Organism_substance"	"Ehrlich ascites tumor cells	72	99	Cell"	"mitochondrial	117	130	Cellular_component"	"ATPase	131	137	Gene_or_gene_product"	"[{""token"": ""Nonidet P - 40"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Chemical""}, {""token"": ""cell - free extracts"", ""start_span"": 46, ""end_span"": 66, ""type"": ""Organism_substance""}, {""token"": ""Ehrlich ascites tumor cells"", ""start_span"": 72, ""end_span"": 99, ""type"": ""Cell""}, {""token"": ""mitochondrial"", ""start_span"": 117, ""end_span"": 130, ""type"": ""Cellular_component""}, {""token"": ""ATPase"", ""start_span"": 131, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"
The ras - encoded proteins are similar to regulatory G - proteins and are candidates for the unknown G - protein that modulates phosphatidylinositol ( PI) turnover.	"ras	4	7	Gene_or_gene_product"	"G - proteins	53	65	Gene_or_gene_product"	"G - protein	101	112	Gene_or_gene_product"	"phosphatidylinositol	128	148	Chemical"	"PI	151	153	Chemical"	"[{""token"": ""ras"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""G - proteins"", ""start_span"": 53, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""G - protein"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphatidylinositol"", ""start_span"": 128, ""end_span"": 148, ""type"": ""Chemical""}, {""token"": ""PI"", ""start_span"": 151, ""end_span"": 153, ""type"": ""Chemical""}]"
Here we show that exponentially growing NIH 3T3 fibroblasts recently transformed by Ha - ras or Ki - ras possess elevated DG concentrations without significant alterations in the levels of other polyphosphoinositide metabolites.	"NIH 3T3 fibroblasts	40	59	Cell"	"Ha - ras	84	92	Gene_or_gene_product"	"Ki - ras	96	104	Gene_or_gene_product"	"DG	122	124	Chemical"	"polyphosphoinositide	195	215	Chemical"	"[{""token"": ""NIH 3T3 fibroblasts"", ""start_span"": 40, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""Ha - ras"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ki - ras"", ""start_span"": 96, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""DG"", ""start_span"": 122, ""end_span"": 124, ""type"": ""Chemical""}, {""token"": ""polyphosphoinositide"", ""start_span"": 195, ""end_span"": 215, ""type"": ""Chemical""}]"
Ha - ras cells also show less binding of phorbol ester than control cells, suggesting that elevation of DG causes partial down - regulation in addition to activation of protein kinase C.	"Ha - ras	0	8	Gene_or_gene_product"	"phorbol ester	41	54	Chemical"	"cells	68	73	Cell"	"DG	104	106	Chemical"	"protein kinase C	169	185	Gene_or_gene_product"	"[{""token"": ""Ha - ras"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""phorbol ester"", ""start_span"": 41, ""end_span"": 54, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""DG"", ""start_span"": 104, ""end_span"": 106, ""type"": ""Chemical""}, {""token"": ""protein kinase C"", ""start_span"": 169, ""end_span"": 185, ""type"": ""Gene_or_gene_product""}]"
In these conditions, the rates of oxygen uptake, the CO2 evolution and the changes in the redox states of cytochromes indicate that glucose is preferred by Ehrlich ascites tumour cells as energy substrate.	"oxygen	34	40	Chemical"	"CO2	53	56	Chemical"	"cytochromes	106	117	Gene_or_gene_product"	"glucose	132	139	Chemical"	"Ehrlich ascites tumour cells	156	184	Cell"	"[{""token"": ""oxygen"", ""start_span"": 34, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""CO2"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Chemical""}, {""token"": ""cytochromes"", ""start_span"": 106, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Chemical""}, {""token"": ""Ehrlich ascites tumour cells"", ""start_span"": 156, ""end_span"": 184, ""type"": ""Cell""}]"
We conclude that the transforming properties of the activated Ha - ras gene in Rat - 1 cells can be suppressed at the post - translational level by the presence of the genome from diploid embryonic rat fibroblasts but additional controls of expression of the transforming gene are likely to exist.	"Ha - ras	62	70	Gene_or_gene_product"	"Rat - 1 cells	79	92	Cell"	"genome	168	174	Cellular_component"	"rat	198	201	Organism"	"fibroblasts	202	213	Cell"	"[{""token"": ""Ha - ras"", ""start_span"": 62, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rat - 1 cells"", ""start_span"": 79, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""genome"", ""start_span"": 168, ""end_span"": 174, ""type"": ""Cellular_component""}, {""token"": ""rat"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Organism""}, {""token"": ""fibroblasts"", ""start_span"": 202, ""end_span"": 213, ""type"": ""Cell""}]"
Utilizing antibody raised against the purified human erythrocyte glucose transporter, we have identified the glucose transporter as a membrane glycoprotein with a monomer Mr of approximately 41, 000.	"human	47	52	Organism"	"erythrocyte	53	64	Cell"	"glucose	65	72	Chemical"	"glucose	109	116	Chemical"	"membrane	134	142	Cellular_component"	"[{""token"": ""human"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Organism""}, {""token"": ""erythrocyte"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Cell""}, {""token"": ""glucose"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Chemical""}, {""token"": ""membrane"", ""start_span"": 134, ""end_span"": 142, ""type"": ""Cellular_component""}]"
B - cell lines established from two individuals with T - cell acute lymphocytic leukemia ( T - ALL) express HLA - DR antigens, whereas the isogenic T - cells do not.	"B - cell lines	0	14	Cell"	"T - cell acute lymphocytic leukemia	53	88	Cancer"	"T - ALL	91	98	Cancer"	"HLA - DR antigens	108	125	Gene_or_gene_product"	"T - cells	148	157	Cell"	"[{""token"": ""B - cell lines"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Cell""}, {""token"": ""T - cell acute lymphocytic leukemia"", ""start_span"": 53, ""end_span"": 88, ""type"": ""Cancer""}, {""token"": ""T - ALL"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Cancer""}, {""token"": ""HLA - DR antigens"", ""start_span"": 108, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""T - cells"", ""start_span"": 148, ""end_span"": 157, ""type"": ""Cell""}]"
The selective antimetastatic agents p - ( 3, 3 - dimethyl - 1 - triazeno) benzoic acid potassium salt ( DM - COOK), 5 - ( 3, 3 - dimethyl - 1 - triazeno) imidazole - 4 - carboxamide ( DTIC) and ( + / -) 1, 2 - di ( 3, 5 - dioxopiperazin - 1 - yl) propane ( ICRF - 159) have been shown to markedly depress the formation of spontaneous hematogenous metastases in mice bearing s. c.	"DM - COOK	104	113	Chemical"	"DTIC	184	188	Chemical"	"ICRF - 159	257	267	Chemical"	"metastases	347	357	Cancer"	"mice	361	365	Organism"	"[{""token"": ""DM - COOK"", ""start_span"": 104, ""end_span"": 113, ""type"": ""Chemical""}, {""token"": ""DTIC"", ""start_span"": 184, ""end_span"": 188, ""type"": ""Chemical""}, {""token"": ""ICRF - 159"", ""start_span"": 257, ""end_span"": 267, ""type"": ""Chemical""}, {""token"": ""metastases"", ""start_span"": 347, ""end_span"": 357, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 361, ""end_span"": 365, ""type"": ""Organism""}]"
The effects on hemostasis of DM - COOK, DTIC and ICRF - 159 have thus been examined in comparison with those of a purely cytotoxic agent, cyclophosphamide, in mice bearing i. m.	"DM - COOK	29	38	Chemical"	"DTIC	40	44	Chemical"	"ICRF - 159	49	59	Chemical"	"cyclophosphamide	138	154	Chemical"	"mice	159	163	Organism"	"[{""token"": ""DM - COOK"", ""start_span"": 29, ""end_span"": 38, ""type"": ""Chemical""}, {""token"": ""DTIC"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Chemical""}, {""token"": ""ICRF - 159"", ""start_span"": 49, ""end_span"": 59, ""type"": ""Chemical""}, {""token"": ""cyclophosphamide"", ""start_span"": 138, ""end_span"": 154, ""type"": ""Chemical""}, {""token"": ""mice"", ""start_span"": 159, ""end_span"": 163, ""type"": ""Organism""}]"
Slight variations are caused by drug treatment in tumor - bearing mice as compared with untreated tumor - bearing controls; the pattern of effects of the selective antimetastatic agents does not differ from that of the reference cytotoxic compound used, cyclophosphamide.	"tumor	50	55	Cancer"	"mice	66	70	Organism"	"tumor	98	103	Cancer"	"controls	114	122	Organism"	"cyclophosphamide	254	270	Chemical"	"[{""token"": ""tumor"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Cancer""}, {""token"": ""controls"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Organism""}, {""token"": ""cyclophosphamide"", ""start_span"": 254, ""end_span"": 270, ""type"": ""Chemical""}]"
The TB animals had significantly lower plasma glucose and higher blood lactic acid levels compared with NTB animals.	"animals	7	14	Organism"	"plasma	39	45	Organism_substance"	"glucose	46	53	Chemical"	"blood	65	70	Organism_substance"	"lactic acid	71	82	Chemical"	"[{""token"": ""animals"", ""start_span"": 7, ""end_span"": 14, ""type"": ""Organism""}, {""token"": ""plasma"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Organism_substance""}, {""token"": ""glucose"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Chemical""}, {""token"": ""blood"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Organism_substance""}, {""token"": ""lactic acid"", ""start_span"": 71, ""end_span"": 82, ""type"": ""Chemical""}]"
In these transformants, mitogen depletion elicited an increase in the Rb level comparable to that in normal C2 cells; wt SVLT, however, promoted the phosphorylation of a large part of the induced Rb.	"transformants	9	22	Cell"	"Rb	70	72	Gene_or_gene_product"	"C2 cells	108	116	Cell"	"SVLT	121	125	Gene_or_gene_product"	"Rb	196	198	Gene_or_gene_product"	"[{""token"": ""transformants"", ""start_span"": 9, ""end_span"": 22, ""type"": ""Cell""}, {""token"": ""Rb"", ""start_span"": 70, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""C2 cells"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Cell""}, {""token"": ""SVLT"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rb"", ""start_span"": 196, ""end_span"": 198, ""type"": ""Gene_or_gene_product""}]"
We have reported recently that the long terminal repeat ( LTR) of Moloney murine leukemia virus encodes a trans activator which induces transcription and expression of class I major histocompatibility complex genes and certain cytokine genes.	"long terminal repeat	35	55	Cellular_component"	"LTR	58	61	Cellular_component"	"Moloney murine leukemia virus	66	95	Organism"	"class I major histocompatibility complex	168	208	Gene_or_gene_product"	"cytokine	227	235	Gene_or_gene_product"	"[{""token"": ""long terminal repeat"", ""start_span"": 35, ""end_span"": 55, ""type"": ""Cellular_component""}, {""token"": ""LTR"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Cellular_component""}, {""token"": ""Moloney murine leukemia virus"", ""start_span"": 66, ""end_span"": 95, ""type"": ""Organism""}, {""token"": ""class I major histocompatibility complex"", ""start_span"": 168, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytokine"", ""start_span"": 227, ""end_span"": 235, ""type"": ""Gene_or_gene_product""}]"
Implications for a possible role of tumor cell / host TGF - beta interactions in human breast cancer progression.	"tumor cell	36	46	Cell"	"host	49	53	Cell"	"TGF - beta	54	64	Gene_or_gene_product"	"human	81	86	Organism"	"breast cancer	87	100	Cancer"	"[{""token"": ""tumor cell"", ""start_span"": 36, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""host"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""TGF - beta"", ""start_span"": 54, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 87, ""end_span"": 100, ""type"": ""Cancer""}]"
Finally, serum - free conditioned medium from MDA - 231 cells inhibited the NK cell activity of human blood lymphocytes.	"serum	9	14	Organism_substance"	"MDA - 231 cells	46	61	Cell"	"NK cell	76	83	Cell"	"human	96	101	Organism"	"blood lymphocytes	102	119	Cell"	"[{""token"": ""serum"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Organism_substance""}, {""token"": ""MDA - 231 cells"", ""start_span"": 46, ""end_span"": 61, ""type"": ""Cell""}, {""token"": ""NK cell"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Organism""}, {""token"": ""blood lymphocytes"", ""start_span"": 102, ""end_span"": 119, ""type"": ""Cell""}]"
Cytokines and growth factors induce tyrosine phosphorylation of signal transducers and activators of transcription ( STATs) that directly activate gene expression.	"Cytokines	0	9	Gene_or_gene_product"	"growth factors	14	28	Gene_or_gene_product"	"tyrosine	36	44	Amino_acid"	"signal transducers and activators of transcription	64	114	Gene_or_gene_product"	"STATs	117	122	Gene_or_gene_product"	"[{""token"": ""Cytokines"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""growth factors"", ""start_span"": 14, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""tyrosine"", ""start_span"": 36, ""end_span"": 44, ""type"": ""Amino_acid""}, {""token"": ""signal transducers and activators of transcription"", ""start_span"": 64, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""STATs"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}]"
Immunohistochemical staining demonstrated VEGF in the tissues surrounding the Matrigel plugs containing AdCMV. VEGF165 up to 3 weeks after injection, whereas no VEGF was found in the control plugs with AdCMV. beta gal.	"VEGF	42	46	Gene_or_gene_product"	"tissues	54	61	Tissue"	"VEGF165	111	118	Gene_or_gene_product"	"VEGF	161	165	Gene_or_gene_product"	"beta gal	209	217	Gene_or_gene_product"	"[{""token"": ""VEGF"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissues"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Tissue""}, {""token"": ""VEGF165"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta gal"", ""start_span"": 209, ""end_span"": 217, ""type"": ""Gene_or_gene_product""}]"
To determine the mechanisms whereby hematopoietic growth factors ( HGFs) modulate apoptosis in human myeloid leukemic cells, we evaluated the roles of protein and mRNA synthesis for altering apoptosis in growth factor - stimulated vs. quiescent leukemic TF1 cells.	"hematopoietic growth factors	36	64	Gene_or_gene_product"	"HGFs	67	71	Gene_or_gene_product"	"human	95	100	Organism"	"myeloid leukemic cells	101	123	Cell"	"leukemic TF1 cells	245	263	Cell"	"[{""token"": ""hematopoietic growth factors"", ""start_span"": 36, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""HGFs"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Organism""}, {""token"": ""myeloid leukemic cells"", ""start_span"": 101, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""leukemic TF1 cells"", ""start_span"": 245, ""end_span"": 263, ""type"": ""Cell""}]"
In the absence of both GM - CSF and fetal bovine serum ( FBS), 70% of the DNA was fragmented after 3 days in culture, with a characteristic apoptotic ladder - like pattern on agarose gel electrophoresis, whereas this proportion had initially been < 5%.	"GM - CSF	23	31	Gene_or_gene_product"	"fetal bovine serum	36	54	Organism_substance"	"FBS	57	60	Organism_substance"	"DNA	74	77	Cellular_component"	"agarose	175	182	Chemical"	"[{""token"": ""GM - CSF"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""fetal bovine serum"", ""start_span"": 36, ""end_span"": 54, ""type"": ""Organism_substance""}, {""token"": ""FBS"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Organism_substance""}, {""token"": ""DNA"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Cellular_component""}, {""token"": ""agarose"", ""start_span"": 175, ""end_span"": 182, ""type"": ""Chemical""}]"
In contrast, less than 5% of the DNA was fragmented in cells incubated with GM - CSF plus FBS or GM - CSF alone.	"DNA	33	36	Cellular_component"	"cells	55	60	Cell"	"GM - CSF	76	84	Gene_or_gene_product"	"FBS	90	93	Organism_substance"	"GM - CSF	97	105	Gene_or_gene_product"	"[{""token"": ""DNA"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Cellular_component""}, {""token"": ""cells"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""GM - CSF"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBS"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Organism_substance""}, {""token"": ""GM - CSF"", ""start_span"": 97, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}]"
The neoplastic transformation of cultured rat liver epithelial cells by various means has consistently been associated with the development of resistance to the mito - inhibitory effect of transforming growth factor beta ( TGF - beta), suggesting that such phenotype plays a mechanistic role during the transformation of these cells.	"rat	42	45	Organism"	"liver epithelial cells	46	68	Cell"	"transforming growth factor beta	189	220	Gene_or_gene_product"	"TGF - beta	223	233	Gene_or_gene_product"	"cells	327	332	Cell"	"[{""token"": ""rat"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Organism""}, {""token"": ""liver epithelial cells"", ""start_span"": 46, ""end_span"": 68, ""type"": ""Cell""}, {""token"": ""transforming growth factor beta"", ""start_span"": 189, ""end_span"": 220, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta"", ""start_span"": 223, ""end_span"": 233, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 327, ""end_span"": 332, ""type"": ""Cell""}]"
"We have studied the induction of the "" TGF - beta - resistant "" phenotype in a clonal strain of early passage WB - F344 normal cultured rat liver epithelial cells, the proliferation of which was markedly inhibited by TGF - beta."	"TGF - beta	39	49	Gene_or_gene_product"	"WB - F344	110	119	Cell"	"rat	136	139	Organism"	"liver epithelial cells	140	162	Cell"	"TGF - beta	217	227	Gene_or_gene_product"	"[{""token"": ""TGF - beta"", ""start_span"": 39, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""WB - F344"", ""start_span"": 110, ""end_span"": 119, ""type"": ""Cell""}, {""token"": ""rat"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Organism""}, {""token"": ""liver epithelial cells"", ""start_span"": 140, ""end_span"": 162, ""type"": ""Cell""}, {""token"": ""TGF - beta"", ""start_span"": 217, ""end_span"": 227, ""type"": ""Gene_or_gene_product""}]"
The results suggest that chronic exposure to high concentration of TGF - beta promotes the spontaneous neoplastic transformation of cultured rat liver epithelial cells, and that this process may represent one of the mechanisms of cellular adaptation for induction of the multidrug - resistant phenotype during the carcinogenesis of epithelial cells.	"TGF - beta	67	77	Gene_or_gene_product"	"rat	141	144	Organism"	"liver epithelial cells	145	167	Cell"	"cellular	230	238	Cell"	"epithelial cells	332	348	Cell"	"[{""token"": ""TGF - beta"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""rat"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Organism""}, {""token"": ""liver epithelial cells"", ""start_span"": 145, ""end_span"": 167, ""type"": ""Cell""}, {""token"": ""cellular"", ""start_span"": 230, ""end_span"": 238, ""type"": ""Cell""}, {""token"": ""epithelial cells"", ""start_span"": 332, ""end_span"": 348, ""type"": ""Cell""}]"
Protein tyrosine phosphorylation / dephosphorylation is a fundamental mechanism in the regulation of cell proliferation and neoplastic transformation; this metabolic process is modulated by the opposing activities of protein tyrosine kinases and protein tyrosine phosphatases ( PTPases).	"tyrosine	8	16	Amino_acid"	"cell	101	105	Cell"	"protein tyrosine kinases	217	241	Gene_or_gene_product"	"protein tyrosine phosphatases	246	275	Gene_or_gene_product"	"PTPases	278	285	Gene_or_gene_product"	"[{""token"": ""tyrosine"", ""start_span"": 8, ""end_span"": 16, ""type"": ""Amino_acid""}, {""token"": ""cell"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Cell""}, {""token"": ""protein tyrosine kinases"", ""start_span"": 217, ""end_span"": 241, ""type"": ""Gene_or_gene_product""}, {""token"": ""protein tyrosine phosphatases"", ""start_span"": 246, ""end_span"": 275, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTPases"", ""start_span"": 278, ""end_span"": 285, ""type"": ""Gene_or_gene_product""}]"
The relationship between P185neu - protein tyrosine kinase expression and specific PTPase expression may play a critical role in human breast tumorigenesis.	"P185neu	25	32	Gene_or_gene_product"	"protein tyrosine kinase	35	58	Gene_or_gene_product"	"PTPase	83	89	Gene_or_gene_product"	"human	129	134	Organism"	"breast	135	141	Organism_subdivision"	"[{""token"": ""P185neu"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""protein tyrosine kinase"", ""start_span"": 35, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTPase"", ""start_span"": 83, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 129, ""end_span"": 134, ""type"": ""Organism""}, {""token"": ""breast"", ""start_span"": 135, ""end_span"": 141, ""type"": ""Organism_subdivision""}]"
Boyden double - membrane analysis of chemotaxis showed that 9E3 / CEF4 was chemotactic for chicken peripheral blood mononuclear cells, as well as for heterophils.	"9E3	60	63	Gene_or_gene_product"	"CEF4	66	70	Gene_or_gene_product"	"chicken	91	98	Organism"	"peripheral blood mononuclear cells	99	133	Cell"	"heterophils	150	161	Cell"	"[{""token"": ""9E3"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""CEF4"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""chicken"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Organism""}, {""token"": ""peripheral blood mononuclear cells"", ""start_span"": 99, ""end_span"": 133, ""type"": ""Cell""}, {""token"": ""heterophils"", ""start_span"": 150, ""end_span"": 161, ""type"": ""Cell""}]"
Untransformed CEF and CEF transformed with Rous sarcoma virus also migrated to 9E3 / CEF4 protein, as measured by Boyden single - membrane analysis.	"CEF	14	17	Cell"	"CEF	22	25	Cell"	"Rous sarcoma virus	43	61	Organism"	"9E3	79	82	Gene_or_gene_product"	"CEF4	85	89	Gene_or_gene_product"	"[{""token"": ""CEF"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Cell""}, {""token"": ""CEF"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Cell""}, {""token"": ""Rous sarcoma virus"", ""start_span"": 43, ""end_span"": 61, ""type"": ""Organism""}, {""token"": ""9E3"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""CEF4"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}]"
In addition to having a direct effect on tumor cells, vitamins such as alpha - tocopheryl succinate and beta - carotene enhance the effect of other agents that induce differentiation in tumor cells.	"tumor cells	41	52	Cell"	"vitamins	54	62	Chemical"	"alpha - tocopheryl succinate	71	99	Chemical"	"beta - carotene	104	119	Chemical"	"tumor cells	186	197	Cell"	"[{""token"": ""tumor cells"", ""start_span"": 41, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""vitamins"", ""start_span"": 54, ""end_span"": 62, ""type"": ""Chemical""}, {""token"": ""alpha - tocopheryl succinate"", ""start_span"": 71, ""end_span"": 99, ""type"": ""Chemical""}, {""token"": ""beta - carotene"", ""start_span"": 104, ""end_span"": 119, ""type"": ""Chemical""}, {""token"": ""tumor cells"", ""start_span"": 186, ""end_span"": 197, ""type"": ""Cell""}]"
Expression of nm23 - H1 mRNA increased in 33 of 41 colon tumors, and expression of nm23 - H2 mRNA was elevated in 28 of 41 colon tumors relative to that in matched normal mucosa.	"nm23 - H1	14	23	Gene_or_gene_product"	"colon tumors	51	63	Cancer"	"nm23 - H2	83	92	Gene_or_gene_product"	"colon tumors	123	135	Cancer"	"mucosa	171	177	Multi"	"[{""token"": ""nm23 - H1"", ""start_span"": 14, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""colon tumors"", ""start_span"": 51, ""end_span"": 63, ""type"": ""Cancer""}, {""token"": ""nm23 - H2"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""colon tumors"", ""start_span"": 123, ""end_span"": 135, ""type"": ""Cancer""}, {""token"": ""mucosa"", ""start_span"": 171, ""end_span"": 177, ""type"": ""Multi""}]"
CONCLUSIONS: These results suggest that, despite correlation of nm23 - H1 allelic deletions with colon cancers associated with poor prognosis, nm23 - H1 and nm23 - H2 alleles do not directly mediate metastasis suppression in colon carcinoma.	"nm23 - H1	64	73	Gene_or_gene_product"	"colon cancers	97	110	Cancer"	"nm23 - H1	143	152	Gene_or_gene_product"	"nm23 - H2	157	166	Gene_or_gene_product"	"colon carcinoma	225	240	Cancer"	"[{""token"": ""nm23 - H1"", ""start_span"": 64, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""colon cancers"", ""start_span"": 97, ""end_span"": 110, ""type"": ""Cancer""}, {""token"": ""nm23 - H1"", ""start_span"": 143, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""nm23 - H2"", ""start_span"": 157, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""colon carcinoma"", ""start_span"": 225, ""end_span"": 240, ""type"": ""Cancer""}]"
IMPLICATIONS: These findings also contrast with the demonstration of nm23 metastasis suppressor activity in murine melanoma and with the correlation of loss of nm23 expression in breast cancer with poor prognosis.	"nm23	69	73	Gene_or_gene_product"	"murine	108	114	Organism"	"melanoma	115	123	Cancer"	"nm23	160	164	Gene_or_gene_product"	"breast cancer	179	192	Cancer"	"[{""token"": ""nm23"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Organism""}, {""token"": ""melanoma"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Cancer""}, {""token"": ""nm23"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer"", ""start_span"": 179, ""end_span"": 192, ""type"": ""Cancer""}]"
E mu - bcl - 2 transgene facilitates spontaneous transformation of early pre - B and immunoglobulin - secreting cells but not T cells.	"E mu - bcl - 2	0	14	Gene_or_gene_product"	"pre - B	73	80	Cell"	"immunoglobulin	85	99	Gene_or_gene_product"	"cells	112	117	Cell"	"T cells	126	133	Cell"	"[{""token"": ""E mu - bcl - 2"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""pre - B"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""immunoglobulin"", ""start_span"": 85, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""T cells"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Cell""}]"
Rearrangement of the c - myc gene was common in the plasmacytomas, implying a synergistic role for myc and bcl - 2 in their etiology, but was not detected in the lymphomas.	"c - myc	21	28	Gene_or_gene_product"	"plasmacytomas	52	65	Cancer"	"myc	99	102	Gene_or_gene_product"	"bcl - 2	107	114	Gene_or_gene_product"	"lymphomas	162	171	Cancer"	"[{""token"": ""c - myc"", ""start_span"": 21, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasmacytomas"", ""start_span"": 52, ""end_span"": 65, ""type"": ""Cancer""}, {""token"": ""myc"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""bcl - 2"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphomas"", ""start_span"": 162, ""end_span"": 171, ""type"": ""Cancer""}]"
Consistent with this hypothesis, co - injection of VPF / VEGF together with OPN resulted in rapid cleavage of OPN by endogenous thrombin.	"VPF	51	54	Gene_or_gene_product"	"VEGF	57	61	Gene_or_gene_product"	"OPN	76	79	Gene_or_gene_product"	"OPN	110	113	Gene_or_gene_product"	"thrombin	128	136	Gene_or_gene_product"	"[{""token"": ""VPF"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""OPN"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""OPN"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombin"", ""start_span"": 128, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}]"
Furthermore, in comparison with native OPN, thrombin - cleaved OPN stimulated a greater rate of EC migration in vitro, which was additive to the increased migration associated with induction of alpha v beta 3.	"OPN	39	42	Gene_or_gene_product"	"thrombin	44	52	Gene_or_gene_product"	"OPN	63	66	Gene_or_gene_product"	"EC	96	98	Cell"	"alpha v beta 3	194	208	Gene_or_gene_product"	"[{""token"": ""OPN"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombin"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""OPN"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 96, ""end_span"": 98, ""type"": ""Cell""}, {""token"": ""alpha v beta 3"", ""start_span"": 194, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}]"
PURPOSE: We studied retrospectively the interaction between c - erbB2 overexpression and adjuvant tomoxifen in node - negative breast cancer patients enrolled in the Gruppo Universitario Napoletano 1 ( GUN - 1) trial.	"c - erbB2	60	69	Gene_or_gene_product"	"tomoxifen	98	107	Chemical"	"node	111	115	Multi"	"breast cancer	127	140	Cancer"	"patients	141	149	Organism"	"[{""token"": ""c - erbB2"", ""start_span"": 60, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""tomoxifen"", ""start_span"": 98, ""end_span"": 107, ""type"": ""Chemical""}, {""token"": ""node"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Multi""}, {""token"": ""breast cancer"", ""start_span"": 127, ""end_span"": 140, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 141, ""end_span"": 149, ""type"": ""Organism""}]"
PATIENTS AND METHODS: c - erbB2, evaluated by immunohistochemistry in 145 of 173 patients randomly assigned to 2 - year adjuvant tamoxifen or no further therapy, was considered overexpressed if greater than 10% of the cells showed specific membrane staining.	"c - erbB2	22	31	Gene_or_gene_product"	"patients	81	89	Organism"	"tamoxifen	129	138	Chemical"	"cells	218	223	Cell"	"membrane	240	248	Cellular_component"	"[{""token"": ""c - erbB2"", ""start_span"": 22, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Organism""}, {""token"": ""tamoxifen"", ""start_span"": 129, ""end_span"": 138, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 218, ""end_span"": 223, ""type"": ""Cell""}, {""token"": ""membrane"", ""start_span"": 240, ""end_span"": 248, ""type"": ""Cellular_component""}]"
c - erbB2 was overexpressed in 43 of 145 patients ( 29. 7%), which directly correlated with tumor size and inversely with estrogen receptor ( ER) level.	"c - erbB2	0	9	Gene_or_gene_product"	"patients	41	49	Organism"	"tumor	92	97	Cancer"	"estrogen receptor	122	139	Gene_or_gene_product"	"ER	142	144	Gene_or_gene_product"	"[{""token"": ""c - erbB2"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 41, ""end_span"": 49, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Cancer""}, {""token"": ""estrogen receptor"", ""start_span"": 122, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""ER"", ""start_span"": 142, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"
Addition of c - erbB2 to a multivariate Cox model that contained menopausal status, tumor size, nuclear grade, and treatment as covariates did not affect the significance of the model for DSF or OAS, whereas addition of the first - order interaction between c - erbB2 and tamoxifen was statistically significant both for DFS and OAS.	"c - erbB2	12	21	Gene_or_gene_product"	"tumor	84	89	Cancer"	"nuclear	96	103	Cellular_component"	"c - erbB2	258	267	Gene_or_gene_product"	"tamoxifen	272	281	Chemical"	"[{""token"": ""c - erbB2"", ""start_span"": 12, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Cancer""}, {""token"": ""nuclear"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Cellular_component""}, {""token"": ""c - erbB2"", ""start_span"": 258, ""end_span"": 267, ""type"": ""Gene_or_gene_product""}, {""token"": ""tamoxifen"", ""start_span"": 272, ""end_span"": 281, ""type"": ""Chemical""}]"
The adenovirus type 5 55 - kDa E1B protein ( E1B - 55kDa) cooperates with E1A gene products to induce cell transformation.	"adenovirus type 5	4	21	Organism"	"E1B	31	34	Gene_or_gene_product"	"E1B	45	48	Gene_or_gene_product"	"E1A	74	77	Gene_or_gene_product"	"cell	102	106	Cell"	"[{""token"": ""adenovirus type 5"", ""start_span"": 4, ""end_span"": 21, ""type"": ""Organism""}, {""token"": ""E1B"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""E1B"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""E1A"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Cell""}]"
In pre - B acute lymphoblastic leukemia ( ALL) with t ( 1; 19) translocation, a fusion protein is created between E2A and a homeobox gene PBX.	"pre - B acute lymphoblastic leukemia	3	39	Cancer"	"ALL	42	45	Cancer"	"E2A	114	117	Gene_or_gene_product"	"homeobox	124	132	Gene_or_gene_product"	"PBX	138	141	Gene_or_gene_product"	"[{""token"": ""pre - B acute lymphoblastic leukemia"", ""start_span"": 3, ""end_span"": 39, ""type"": ""Cancer""}, {""token"": ""ALL"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Cancer""}, {""token"": ""E2A"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""homeobox"", ""start_span"": 124, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""PBX"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}]"
SOC activation in rat pulmonary arterial endothelial cells increased free cytosolic Ca2 + that was dependent on a membrane current having a net inward component of 5. 45 + / - 0. 90 pA / pF at - 80 mV.	"rat	18	21	Organism"	"pulmonary arterial endothelial cells	22	58	Cell"	"cytosolic	74	83	Organism_substance"	"Ca2 +	84	89	Chemical"	"membrane	114	122	Cellular_component"	"[{""token"": ""rat"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Organism""}, {""token"": ""pulmonary arterial endothelial cells"", ""start_span"": 22, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""cytosolic"", ""start_span"": 74, ""end_span"": 83, ""type"": ""Organism_substance""}, {""token"": ""Ca2 +"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Chemical""}, {""token"": ""membrane"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Cellular_component""}]"
Changes in endothelial cell shape accompanied SOC activation and were dependent on Ca2 + entry - induced reconfiguration of peripheral ( cortical) filamentous actin ( F - actin).	"endothelial cell	11	27	Cell"	"Ca2 +	83	88	Chemical"	"cortical	137	145	Multi"	"filamentous actin	147	164	Gene_or_gene_product"	"F - actin	167	176	Gene_or_gene_product"	"[{""token"": ""endothelial cell"", ""start_span"": 11, ""end_span"": 27, ""type"": ""Cell""}, {""token"": ""Ca2 +"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Chemical""}, {""token"": ""cortical"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Multi""}, {""token"": ""filamentous actin"", ""start_span"": 147, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""F - actin"", ""start_span"": 167, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}]"
Glucose and lactate metabolism in C6 glioma cells: evidence for the preferential utilization of lactate for cell oxidative metabolism.	"Glucose	0	7	Chemical"	"lactate	12	19	Chemical"	"C6 glioma cells	34	49	Cell"	"lactate	96	103	Chemical"	"cell	108	112	Cell"	"[{""token"": ""Glucose"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""lactate"", ""start_span"": 12, ""end_span"": 19, ""type"": ""Chemical""}, {""token"": ""C6 glioma cells"", ""start_span"": 34, ""end_span"": 49, ""type"": ""Cell""}, {""token"": ""lactate"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Cell""}]"
13C and 1H nuclear magnetic resonance spectroscopy ( NMR) was used to investigate the metabolism of L - lactate and D - glucose in C6 glioma cells.	"13C	0	3	Chemical"	"1H	8	10	Chemical"	"L - lactate	100	111	Chemical"	"D - glucose	116	127	Chemical"	"C6 glioma cells	131	146	Cell"	"[{""token"": ""13C"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical""}, {""token"": ""1H"", ""start_span"": 8, ""end_span"": 10, ""type"": ""Chemical""}, {""token"": ""L - lactate"", ""start_span"": 100, ""end_span"": 111, ""type"": ""Chemical""}, {""token"": ""D - glucose"", ""start_span"": 116, ""end_span"": 127, ""type"": ""Chemical""}, {""token"": ""C6 glioma cells"", ""start_span"": 131, ""end_span"": 146, ""type"": ""Cell""}]"
The pigment epithelium of the retina ( RPE) is derived from the optic cup and is essential for function and development of the eye.	"pigment epithelium	4	22	Tissue"	"retina	30	36	Multi"	"RPE	39	42	Tissue"	"optic cup	64	73	Multi"	"eye	127	130	Organ"	"[{""token"": ""pigment epithelium"", ""start_span"": 4, ""end_span"": 22, ""type"": ""Tissue""}, {""token"": ""retina"", ""start_span"": 30, ""end_span"": 36, ""type"": ""Multi""}, {""token"": ""RPE"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Tissue""}, {""token"": ""optic cup"", ""start_span"": 64, ""end_span"": 73, ""type"": ""Multi""}, {""token"": ""eye"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Organ""}]"
In transgenic embryos, RPE cells proliferated in the anterior part of the eye and near the optic nerve.	"embryos	14	21	Developing_anatomical_structure"	"RPE cells	23	32	Cell"	"anterior part	53	66	Multi"	"eye	74	77	Organ"	"optic nerve	91	102	Multi"	"[{""token"": ""embryos"", ""start_span"": 14, ""end_span"": 21, ""type"": ""Developing_anatomical_structure""}, {""token"": ""RPE cells"", ""start_span"": 23, ""end_span"": 32, ""type"": ""Cell""}, {""token"": ""anterior part"", ""start_span"": 53, ""end_span"": 66, ""type"": ""Multi""}, {""token"": ""eye"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Organ""}, {""token"": ""optic nerve"", ""start_span"": 91, ""end_span"": 102, ""type"": ""Multi""}]"
These were pigmented, and maintained expression of tyrosinase, TRP - 1, cytokeratin and SV40 Tag.	"tyrosinase	51	61	Gene_or_gene_product"	"TRP - 1	63	70	Gene_or_gene_product"	"cytokeratin	72	83	Gene_or_gene_product"	"SV40	88	92	Organism"	"Tag	93	96	Gene_or_gene_product"	"[{""token"": ""tyrosinase"", ""start_span"": 51, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRP - 1"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytokeratin"", ""start_span"": 72, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Organism""}, {""token"": ""Tag"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}]"
